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ABSTRACT 
Rebecca N. Bauer: The role of the inflammasome in the respiratory innate immune response to 
viruses and pollutants: insights for asthma pathogenesis 
(Under the direction of Ilona Jaspers) 
The respiratory mucosal innate immune system is composed of both structural cells, such 
as airway epithelial cells, and immune cells, such as macrophages, that together determine the 
appropriate immune response to inhaled stimuli. These cells use pattern recognition receptors to 
distinguish between harmless and harmful stimuli by recognizing conserved microbial pathogen-
associated molecular patterns (PAMPs) and endogenously derived damage-associated molecular 
patterns (DAMPs) from damaged tissue. Inappropriate immune responses to normally innocuous 
stimuli underpin the pathogenesis of a number of immune disorders, including asthma, a chronic 
inflammatory disease of the airway typified by difficulty breathing in response to a trigger. In 
this dissertation, we explored the contribution of the inflammasome signaling complex to 
respiratory mucosal host defense against two sources of asthma exacerbation: influenza A virus 
infection and inhalation of the oxidant air pollutant ozone (O3). The inflammasome is an innate 
immune complex composed of a pattern recognition receptor, the protease caspase-1, and an 
adaptor protein (PYCARD) that when formed induces activation of caspase-1-mediated 
processing of the pro-inflammatory mediators IL-1β and IL-18 or cell death. Our results show 
that caspase-1 and the inflammasome contribute to the airway epithelial cell innate immune 
response to influenza and that this pathway is modified by asthma, suggesting a role for caspase-
1 in virus-induced asthma exacerbation. Using a mouse model of allergic airway inflammation, 
we also show that caspase-1 may be involved in the development of allergic asthma, though its 
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function in asthma development is complex. In the context of O3, we found increased presence of 
several DAMPs that may activate inflammasome signaling in the airway of healthy volunteers 
exposed to O3, but no evidence to suggest that inflammasome signaling strongly contributes to 
the innate immune response to O3. Finally, we identified a mechanism by which O3 alters the 
interaction between epithelial cells and macrophages leading to the accumulation of DAMPs that 
may activate innate immune responses in the lung. In summary, our results shed light on the 
function of the inflammasome in the human respiratory innate immune response to viruses and 
pollutants, and provide insight on the contribution of inflammasome signaling to asthma 
pathogenesis.  
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Chapter 1: Introduction1 
1.1 Respiratory mucosal host defense against pathogens and pollutants 
The respiratory mucosal surface is the first line of defense against the inhaled 
environment, including pathogens and pollutants. A tightly regulated immune system is 
necessary to effectively maintain immunologic homeostasis while permitting the appropriate 
response to injury (1). The immune system is composed of both an innate and adaptive 
component. Innate immunity is the non-specific first response to infection or injury and is 
composed of both structural cells, such as epithelial cells, and resident and circulating innate 
immune cells, such as macrophages and neutrophils (2). The crosstalk between these cell types is 
necessary to determine the appropriate inflammatory response to a stimulus and to inform the 
adaptive immune system of injury. The adaptive immunity is an antigen specific, cell- and 
antibody-mediated immune response to eliminate specific invading pathogens (3). The adaptive 
immune response is mediated by B and T lymphocytes and typically results in immunological 
memory of the insult (4, 5). Effective interaction between the innate and adaptive immune 
systems is crucial not only to clear the insult, but also to protect the body from unnecessary 
inflammation and self-destruction. Diseases such as asthma occur when the immune system 
inappropriately responds to normally harmless stimuli (6). The chronic inflammation associated 
with asthma causes airway remodeling and bronchoconstriction that is exacerbated by a normally 
innocuous stimulus, leading to difficulties breathing (7).  
                                                 
1
Sections of this introduction were adapted from Bauer, RN; Diaz-Sanchez, D; Jaspers I. Effects of air pollutants on 
innate immunity: the role of toll-like receptors and nucleotide-binding oligomerization domain–like receptors. J 
Allergy Clin Immunol. 2012 Jan; 129(1):14-24  with permission from Elsevier are indicated throughout the 
introduction.  
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The work presented in this dissertation is largely centered on the role of the innate 
immune system in the respiratory mucosal host response to pathogens and pollutants and how 
these pathways may contribute to asthma pathogenesis. A brief overview of the innate immune 
cells in the airway and their contribution to allergy and asthma will be covered below. Given the 
important interplay between innate and adaptive immunity and the crucial role that lymphocytes 
play in asthma development and pathogenesis, adaptive immune cells will also be briefly 
discussed.  
1.1.1 Cells of the respiratory innate immune system 
Airway epithelial cells (EC). The respiratory epithelium represents the main barrier 
between the inhaled environment and underlying tissue and serves as the site of oxygen 
exchange (8). Tight junctions and other adhesion molecules link EC together to form a mostly 
impermeable membrane (9). The type of EC differs depending on the anatomical location along 
the airway. From the nasal airways to bronchioles, the respiratory epithelium is composed 
primarily of pseudostratified columnar epithelial cells, but also goblet cells (mucin-producing), 
basal cells (precursors for differentiated epithelial cells), and club cells (nonciliated, secretory 
bronchial epithelial cells) (10-13). Further along the bronchioles, the EC shift to cuboidal cells 
and then finally to alveolar EC at the terminal alveoli, the primary site of gas exchange in the 
lung (14). Alveolar EC are composed of both type 1 and type 2 cells, with squamous-type 1 cells 
classically thought to serve a more structural function and type 2 cells that produce surfactant 
and regulate water and ion transport (15). The complex architecture of the lung and diverse 
composition of EC that line the airway allow for both efficient gas exchange and protection of 
the airway from the inhaled environment (14).  
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Beyond acting as a physical barrier, the epithelium is an active participant in host 
defense. EC produce an epithelial lining fluid composed of mucins and surfactants that moisten 
the airway and trap inhaled toxins or pathogens (16, 17). The mucins produced by EC together 
with movement of cilia traps foreign stimuli and moves them up the airway through a 
mechanism termed the “mucociliary escalator” (17, 18). The epithelial lining fluid also contains 
antimicrobial mediators (e.g. β-defensins and lactoferrin) and antioxidants (e.g. glutathione) that 
protect the airway (17). Additionally, EC play a major role in the secretion of immunoglobulin A 
(IgA). IgA produced by plasma cells in the lamina propria binds to the polymeric 
immunoglobulin receptor on the basolateral side of EC, and is transported to the luminal side 
before secretion as secretory IgA, which neutralizes bacteria and toxins and prevents microbe 
adhesion to EC (19). EC produce a number of inflammatory and chemotactic mediators that alert 
nearby cells of damage or infection and are thus crucial to the initiation of innate immune 
responses in the airway (20).  
Alterations in EC function are associated with a number of airway diseases, including 
asthma, chronic obstructive pulmonary disease, and cystic fibrosis (8). Disruption of EC barrier 
function, increased goblet cell numbers, and remodeling of the airway epithelium are key 
characteristics of asthma, suggesting that alterations in the airway epithelium may significantly 
contribute the asthma pathogenesis (22).  EC produce a number of DAMPs and 
cytokines/chemokines that attract and activate other immune cells, such as dendritic cells and 
eosinophils, which are major contributors to both the initiation and progression of asthma and 
will be described below (21).  
Pulmonary macrophages (Mac). Pulmonary Mac, which are derived from monocytic 
precursors in the blood, compose the majority of resident immune cells in the healthy lung (23). 
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Mac are among the first cells to contact inhaled antigens, and thus serve a critical role in the 
initiation of innate immune responses (24). The primary functions of pulmonary Mac include 
phagocytosis of cellular/tissue debris and inhaled particulates, destruction of inhaled pathogens 
and infected cells by release of reactive oxidants through a mechanism termed respiratory burst, 
antigen presentation to T lymphocytes, and production of inflammatory and chemotactic 
mediators to regulate inflammation in the airway (23, 25). Adoptive transfer studies have shown 
that lung microenvironment plays a key role in determining Mac phenotype and function (26). 
Pulmonary Mac more resemble dendritic cells and have lower phagocytic and antigen 
presentation function compared to other tissue resident or infiltrating Mac (23, 26, 27). This 
subdued Mac phenotype is important to prevent inflammatory responses to the many harmless 
stimuli in the inhaled environment (1). Additionally, like EC, Mac phenotype and function may 
vary based on anatomical location within the lung, and previous studies have shown that 
bronchial Mac, interstitial Mac, and alveolar Mac differ in phenotype and function (28).  
Recently, Mac phenotypic characterization has received increased attention and Mac 
have been broadly subdivided into “classically activated” and “alternatively activated” subtypes 
(29). Classically activated Mac are induced by proinflammatory type 1 helper T lymphocyte 
(Th1) cytokines, such as IFNγ and LPS, and are characterized by production of proinflammatory 
cytokines and microbicidal reactive oxygen and nitrogen species. Conversely, alternatively 
activated Mac are characterized by production of anti-inflammatory and tissue repair mediators, 
such IL-10 and TGFβ, and expression of scavenger receptors, such as CD206 (macrophage 
mannose receptor) (25). However, these categories are primarily derived from in vitro 
experiments, and distinction of Mac as either “classical” or “alternative” does not explain the 
phenotypic plasticity exhibited by Mac in changing tissue microenvironments (29, 30). 
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Moreover, these categories were primarily derived in mice or from peripheral blood/ bone 
marrow-derived Mac. The application of alternative and classical characterization has not been 
well verified in the lung or using human Mac (31, 32).  
The pro- and anti-inflammatory functions of Mac may play dual roles in the pathogenesis 
of asthma and allergy (33). In a mouse model of adoptive transfer of Mac from unsensitized mice 
to allergen-sensitized mice ameliorated airway inflammation and airway hyperresponsiveness, 
highlighting that the anti-inflammatory functions of Mac may suppress asthma pathology (34). 
However, the pro-inflammatory functions of Mac can contribute to asthma pathogenesis by 
enhancing inflammatory cell migration to the airway. Mac from an ovalbumin mouse model of 
allergic asthma have been shown to produce more IL-17 that recruits neutrophils to airway, a 
characteristic of exacerbation and severe asthma (35). These diverging findings suggest that Mac 
function must be exteremely fine-tuned to mainatain a homeostatic state in the lung, and that 
more studies are needed to explore the anti-inflammatory versus pro-inflammatory functions of 
Mac in asthma pathogenesis. 
Dendritic cells (DC). DC are the major antigen presenting cell in the lung, and thus serve 
as important linkers of the innate and adaptive immune responses.   Two primary populations of 
DC exist in the lung, myeloid DCs (mDC) and plasmacystoid DCs (pDC), and the populations 
differ in recruitment and function. pDC are recruited to the lung upon viral infection, 
preferentially express Toll-like receptors specialized to recognize viruses (TLR7 and TLR9) and 
respond with massive amounts of antiviral mediators, whereas mDC are recruited continuously 
to the airway and serve as primary antigen presenting cells in the lung (36). DC lie on the 
basolateral side of EC and have long, branching extensions that extend between EC to “sample” 
the airway (1). DC recognize antigens and danger signals in the airway, uptake the antigen, and 
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process it into short fragments that are presented on major histocompatibility complex molecules 
to T cells (21). DC express co-stimulatory molecules such as CD40 that are required for T cell 
activation, and lack of co-stimulatory receptors can lead to T lymphocyte anergy, a mechanism 
of inactivation and tolerance (37). In addition, upon recognition of an antigen or danger signal 
DC produce cytokines and chemokines to attract other immune cells and promote T cell 
differentiation (38). As presentation of self-antigens or normally harmless allergens to T 
lymphocytes and differentiation of T lymphocytes to type 2 helper cells is considered an early 
step in the development of allergic asthma, DC have been shown to play major role in the 
development of asthma (39, 40). 
Neutrophils. Neutrophils, along with eosinophils and basophils, are members of the 
granulocyte family. Neutrophils are the first immune cells to be recruited to the site of 
inflammation or injury in the lung (41, 42). Chemokines produced by Mac and EC, such as IL-8 
and growth-regulated oncogene (GRO)-related peptides, induce recruitment of neutrophils to the 
lungs (42). Like Mac, neutrophils are phagocytic and play a role in clearing debris, particles, and 
pathogens (43). Additionally, neutrophils contain granules that harbor potent antimicrobial and 
cytotoxic proteins, including proteases (such as neutrophil elastase, cathepsin g, proteinase-3, 
and several matrix metalloproteinases), anti-microbial peptides (lactoferrin, α-defensins), and 
reactive species generated by enzymes such as myeloperoxidase and NADPH oxidase (44). 
These granules are released into phagocytic vacuoles to eliminate the ingested material or may 
be released into the surrounding tissue by degranulation to kill extracellular microbes, often 
causing tissue damage in the process. Finally, neutrophils can release Neutrophil extracellular 
traps (NETs), which contain antimicrobial granule proteins such as neutrophil elastase and 
chromatin to form fibers that trap bacteria and viruses (45).  Neutrophils are extremely short-
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lived. Though some neutrophils are removed by apoptosis, others may undergo necrosis leading 
to the release of granules that may damage the surrounding tissue (41). Neutrophils, via their 
high reactivity, have been shown to contribute to a number of airway diseases, including severe 
asthma, chronic obstructive pulmonary disease, and acute respiratory distress syndrome (42, 46).  
  Eosinophils. Eosinophils develop and mature in the bone marrow in the presence of IL-5, 
IL-3, and GM-CSF and are recruited to the airway upon an inflammatory insult by Th2 cytokines 
such as IL-4, IL-5, and IL-13 and chemokines such as CCL5 and the eotaxins (47). Eosinophils 
play a major role in antimicrobial response to parasitic helminths and RNA viruses and are also a 
hallmark cell of allergy (47, 48). Eosinophils produce a number of proinflammatory cytokines, 
chemokines, and lipid mediators (such as leukotrienes) and contain granules that harbor 
cytotoxic cationic proteins such as major basic protein (MBP), eosinophil cationic protein (ECP), 
eosinophil peroxidase (EPO), and eosinophil-derived neurotoxin (EDN) that can damage both 
pathogens and tissue (47). Eosinophils are hallmark of allergic diseases and contribute to asthma 
by inducing mast cell and basophil degranulation, smooth muscle contraction that contributes to 
airway hyperresponsiveness (AHR), and mucus production (49, 50). 
Basophils. Basophils account for less than 1% of granulocytes in the spleen and blood 
(51, 52). Like eosinophils, basophils are thought to be involved in the response to parasitic 
helminthes and promote allergy (52, 53). As indicated by their name, basophils contain 
basophilic granules in their cytoplasm that are released upon activation. Basophils are activated 
upon stimulation by cytokines such as IL-3 and antibodies such as IgE in allergic diseases and 
once activated produce Th2 cytokines (IL-4, IL-5, IL-13, and TSLP), chemokines, histamine, 
leukotrienes, and antimicrobial peptides (51). In the lung, the production of leukotrienes and 
histamine act on airway smooth muscle cells to induce bronchoconstriction, whereas Th2-family 
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cytokines promote Th2 lymphocyte differentiation and responses (51). Due to their 
responsiveness to IgE and migration to sites of ongoing allergic inflammation, basophils are 
considered late phase effector cells of allergic diseases, including asthma (53).  Additionally, 
basophils may also play a role in the induction of allergic inflammation, as they have been 
shown to migrate to lymphoid tissue and produce mediators such as TSLP and IL-4 that promote 
CD4+ T cell differentiation (54, 55). 
Mast cells. Mast cells are long-lived cells that reside near epithelial tissue, airway smooth 
muscle, blood vessels, nerves, and in mucus-producing glands (56). Like eosinophils and 
basophils, mast cells harbor granules that contain cytokines, histamine, proteoglycans, 
leukotrienes, and proteases such as chymase and β-tryptase (56). Mast cell degranulation is 
activated by FcεRI receptor binding of antigen-specific IgE, as well as activation of innate 
immune pattern recognition receptors such as the TLRs (57). The release of these mediators have 
important effects on the lung: mediators such as histamine and leukotrienes act on airway smooth 
muscle cells to induce bronchoconstriction whereas proteases play a key role in host defense by 
cleaving proinflammatory mediators, extracellular matrix proteins, and cell surface proteins (53, 
57, 58). Since mast cells are resident in the lung, they are important mediators of the early phase 
of allergic responses (53).  
Natural killer (NK) cells. NK cells compose approximately 10% of resident lymphocytes 
in the lung, though this number increases greatly with an inflammatory stimulus such as an 
infection (59). NK cells are important for host defense against infections and tumor cells, in part 
due to their cytotoxic capabilities. Cytotoxic NK cells release perforin, which pokes holes in the 
target cell membrane and allows entry of granzyme B to induce apoptosis or necrosis of the 
target cell (60). NK cells also have non-cytotoxic functions, which include the production of 
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inflammatory mediators, such as IFNγ, Th2 cytokines (IL-5 and IL-13), or regulatory cytokines 
such as IL-10 (61). Activation of NK cells is based both on interaction with receptors and 
cytokines. NK cell activating receptors include the natural cytotoxicity receptor NKp46, the Fc 
receptor CD16, and NKG2D, which recognizes ligands on “stressed” cells, such as UL16 
Binding Protein 3 (ULBP3) (62). NK cells are also activated by cytokines, in particular type 1 
interferons, IL-12, and IL-18 (60). In addition to antiviral and anti-tumor activity, NK cells are 
involved in allergy and asthma pathogenesis in the lung. NK cells can be activated by IgE and 
may release of a number of cytokines that contribute to the allergen sensitization, such as IL-4, 
IL-5 and IL-13 (63). 
1.1.2 Adaptive immunity in the lung 
Adaptive immunity is a specific, cell- and antibody-mediated immune response to an 
antigen that is mediated by T and B lymphocytes and typically results in memory (64). T 
lymphocytes mediate cellular immunity, whereas B lymphocytes recognize antigens and 
differentiate into antibody producing cells called plasma cells (64). T lymphocytes can be further 
broken down into CD4+ helper, CD4+ regulatory, and CD8+ cytotoxic lymphocytes, all of 
which express the αβ antigen receptor (65). Another type of T lymphocyte, called γδ T 
lymphocytes based on the antigen receptor, are also found in the airway and are considered to be 
more part of the innate immune response, but these cells will not be discussed here  (66).  
Furthermore,  lymphocytes may be broken down into “effector” or “memory” cells, with effector 
cells preforming functions such as cell-mediated cytotoxicity (CD8+ T lymphocytes), cytokine 
secretion and B cell activation (CD4+ helper T lymphocytes), suppression of inflammation 
(regulatory T lymphocytes), or antibody production (plasma cells) (64, 65). Memory cells are 
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conversely quiescent and may exist for years after encountering an antigen. Upon a second 
stimulus, memory cells quickly proliferate and mount strong immune responses (67).   
 In the absence of airway inflammation, the number of T and B lymphocytes in the 
airway is relatively low (1). Resident T lymphocytes may lie under the epithelium in the lamina 
propria or within the epithelial cell layer (1, 5, 68). Also within the lamina propria are plasma 
cells that produce mainly mucosal IgA antibodies (1, 69, 70). The adaptive immune response is 
closely tied to innate immune responses in the lung, thus with activation of innate immunity, an 
increased number of T and B lymphocytes migrate to the airway (3, 21). Innate antigen 
presentation cells, particularly DC, are important linkers of the two systems. DC present 
processed antigen to naïve T lymphocytes via a major histocompatibility (MHC) complexes (6, 
38). Based on the type of MHC complex, the naïve T lymphocyte will differentiate to a CD4+ 
(MHC class II) or CD8+ (MHC Class I) T lymphocyte (64, 65). MHC Class I stimuli represent 
active intracellular infections, which require destruction of the cell by a cytotoxic T lymphocyte, 
whereas MHC class II mediators represent extracellular mediators that may cleared by immune 
cells. Based on the microenvironment, CD4+ helper T lymphocytes differentiate into subtypes 
such as type 1, 2, and 17 helper cells (6, 65). Type 1 helper (Th1) cells are induced by cytokines 
such as IFNγ and IL-12, Th2 by IL-4, and Th17 by TGFβ with IL-6 or IL-1 (6, 71, 72). Each 
helper cell subtype produces different sets of cytokines: Th1 produce IFNγ and IL-12, Th2 
produce IL-4, IL-5, and IL-13, and Th17 produce IL-17, and these mediators then attract 
appropriate immune cells to clear the stimuli (65, 71). B cells differentiate inlymphoid tissue 
upon recognition of an antigen and, in some cases, a second stimulus from a helper T 
lymphocyte (64). Helper T lymphocyte co-stimulatory molecules and cytokines contribute to 
naive B cell class switching from IgM- or IgD- antibody production, to other mature classes, 
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such as IgG, IgE, or IgA isotypes (4). For example, IL-4, which is secreted by Th2 helper cells, 
induces a switch to the IgE isotype, which is an important mediator of allergy and asthma (6).  
Increased numbers Th2 and Th17 cells, as well as Th2- or Th17-skewed cytokines 
produced by innate cells have been implicated in the development and pathogenesis of allergy 
and asthma (6). Th2 cytokines are associated with B lymphocyte isotype switching to IgE and 
mast cell, eosinophil, and basophil recruitment and degranulation (72). Th17 cytokines are 
associated with neutrophilic asthma (71). 
1.1.3 Cell-cell communication underlies immunologic homeostasis 
 Immunologic homeostasis requires a complex interaction between cells of the innate and 
adaptive immune systems. Resident immune cells in the lung are constantly interacting with 
inhaled stimuli and must distinguish between innocuous and pathogenic agents. At baseline 
conditions, Mac and EC are two of the most populous cells in the airway, suggesting that they 
coordinate the immune response in tandem (1) (Figure 1.1). The lung lining fluid secreted by EC 
provides a number of regulatory molecules that are vital to host defense, and the mucociliary 
escalator provides a mechanism to remove pathogens and particles from the airway (17). Mac 
phagocytose antigens to prevent the development of specific immune responses and exist in a 
subdued phenotype with poor antigen presentation capabilities to prevent acquired immune 
responses unless truly necessary (23, 26, 27). The interaction between Mac and EC at baseline, 
and how signals from EC may modify Mac phenotype will be explored later in this dissertation 
(Chapter 5). Additionally, underlying the epithelium is a population of DC that constantly 
sample the airway for injurious stimuli (21). The interaction between these resident immune cells 
underlies host defense and is crucial for immunologic homeostasis. 
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 Upon activation of innate immune receptors, resident immune cells produce a number of 
mediators to recruit inflammatory cells in the airway and activate other resident cells in the lung 
(Figure 1.2). Resident DC travel to the draining lymph node to present antigens to T and B cells 
and initiate adaptive immune responses (38). The onslaught of cytokines and chemokines 
produced by resident cells in the lung recruit circulating immune cells from the blood to the 
airway, including neutrophils, eosinophils, and basophils (6). The molecular and cellular events 
that follow limit the infection or injury, but in the process can damage the surrounding tissue. 
Resolution is another highly coordinated process that involves clearance of damaged tissue and 
reactive inflammatory cells by apoptosis and phagocytosis, the release of pre-resolving mediators 
(e.g. lipoxins, resolvins, protectins, and maresins), and reconstitution of the epithelial barrier (41, 
73). Failure to resolve inflammation in the airway can lead chronic inflammatory diseases such 
as asthma, which will be discussed in more detail below (section 1.3) (7, 42, 73, 74). In the next 
section, the molecular mechanisms that initiate the innate immune response will be explored.  
1.2 Initiation of the innate immune response by pattern recognition receptors1 
Recognition of an injurious stimulus is the first step of innate immunity, and requires 
activation of pattern recognition receptors (PRRs) (75).  PRRs recognize conserved microbial 
ligands, termed pathogen associated molecular patterns (PAMPs), and endogenous ligands 
derived from stressed cells and damaged tissues, termed damage associated molecular patterns 
(DAMPs). (76). Examples of PAMPs include double-stranded RNA (dsRNA) derived from 
viruses and bacterial components, such as lipopolysaccharides (LPS, also known as endotoxin). 
DAMPs are endogenous mediators derived from damaged cells and tissue, and can include 
damaged extracellular matrix components (such as hyaluronic acid, HA) and intracellular 
components (such as ATP). DAMPs are important mediators of sterile inflammation, as caused 
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by inhalation of oxidant gases such as ozone (O3) (77). Stimulation of PRRs by PAMPs and 
DAMPs activates downstream signaling pathways that culminate in the production of cytokines 
and chemokines to attract leukocytes and antigen presenting cells (78).  In the case of antigen 
presentation cells such as DCs, activation of PRRs may provide a necessary maturation signal 
that leads to activation of naïve T lymphocytes in the draining lymph nodes (38).  
There are several classes of PRRs, including the Toll-like receptors (TLRs), C-type lectin 
receptors (CLRs), Retinoic acid-inducible gene (RIGI)-I-like receptors (RLRs), AIM2-like 
receptors (ALRs) and NOD-like receptors (NLRs) (79, 80). TLRs and CLRs are transmembrane 
associated receptors, whereas RLRs, ALRs, NLRs are cytoplasmic proteins. A number of studies 
have demonstrated the role of TLR signaling in both pathogen- and pollutant-induced 
inflammation. More recently, NLRs and the subset that assemble and oligomerize to form the 
complex known as the inflammasome have been implicated in both pathogenic and sterile 
inflammatory responses (81). RLRs play an important role in the innate immune response to 
RNA viruses, such as influenza, and can also form inflammasome complexes (82). CLRs, such 
as the Dectins and Mannose Receptor (CD206), though important for the recognition of 
carbohydrates on microorganisms, will not be discussed here (83). [Adapted from (84)] 
1.2.1 Toll-like receptors (TLRs) 
The TLR family is responsible for sensing PAMPs and DAMPs at membranes and 
disseminating the signal to intracellular transcription factors, which regulate cytokine and 
chemokine gene expression. There are currently 13 identified mammalian TLRs (10 in humans 
and 12 in mice), which are classified as type 1 transmembrane receptors containing an N-
terminal, leucine-rich repeat domain, a transmembrane region, and a C-terminal cytoplasmic 
domain (85).  TLRs are expressed by a wide variety of hematopoietic cells (e.g. Mac and DC) as 
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well as EC (86). Each TLR is associated with specific recognition patterns: extracellular TLRs 1, 
2, 4, and 5 sense bacterial components such as lipoproteins and the bacterial wall component 
LPS, whereas endosomal TLRs 3, 7, 8, and 9 recognize nucleic acids (Figure 1.3). (80) Notably, 
TLRs have been implicated in the response to a variety of pathogens, pollutants, and DAMPs, 
indicating that these receptors are not limited to one specific ligand. For example, TLR4 plays a 
key role in the innate immune response to the air pollutant O3, an oxidant gas that cannot be 
directly bound by a receptor, suggesting that DAMPs from O3-inudced damage of the airway 
mediate TLR4 activation (87).  
Interaction of the TLR with its specific ligand results in the activation of a signaling 
cascade leading to the production of innate effector molecules and the initiation of the adaptive 
immune response (88, 89) (Figure1.3). TLRs signal to the cytoplasm through adaptor proteins, 
such as myeloid differentiation primary response gene (MyD88),  toll-interleukin 1 receptor 
(TIR) domain containing adaptor protein (TIRAP), TIR-domain-containing adapter-inducing 
interferon-β (TRIF), and translocation associated membrane protein (TRAM), all of which 
harbor a Toll-Interleukin-1 Receptor (TIR) domain for the recruitment of the adaptor protein to 
the TLR cytoplasmic domain via a TIR-TIR interaction (85). MyD88 is an adaptor protein 
shared by all TLRs except TLR3, which instead utilizes TRIF to signal to the cytoplasm. The 
TLR signaling cascades result in the activation of transcription factors in the cytoplasm, such as 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), interferon regulatory 
Factors (IRFs), and activation protein 1 (AP-1), which then induce or inhibit the transcription of 
genes involved in  inflammatory and immune responses (78, 90).  
Dysfunction of the innate immune system and TLR signaling has been associated with 
the pathogenesis of several airway diseases, including acute respiratory distress syndrome 
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(ARDS), asthma, and chronic obstructive pulmonary disease (COPD) (78). For example, ARDS 
may be triggered by bacterial or viral infections and non-infectious insults such as environmental 
exposures or trauma, which may stimulate TLR signaling and initiate an inflammatory response 
and tissue damage (78, 91, 92). Additionally, TLR4, the endotoxin receptor, has been shown to 
play a role in the induction of Th2 biased immune response in the lung and the development of 
asthma (81). Consequently, mutations in several TLRs, including TLR4, have been associated 
with asthma (78, 93, 94). Clearly, the TLR signaling pathways play an important role in 
initiating the immune response to PAMPs and DAMPs which, when left unchecked, can lead to 
tissue injury and airway disease. [Adapted from (84)] 
1.2.2 RIG-I like Receptors (RLRs) 
 The RLR family consists of three receptors: RIG-I (retinoic acid-inducible gene I), 
MDA5 (melanoma differentiation associated factor 5), and LGP2 (laboratory of genetics and 
physiology 2 and a homolog of mouse D11lgp2) (82). The receptors of this family share a 
similar structure with three domains: 1) a N-terminal caspase activation and recruitment domain 
(CARD); 2) a central DExD/H box RNA helicase domain that recognizes RNA; and 3) a C-
terminal repressor domain involved in auto-regulation. Notably, LGP2 does not contain a N-
terminal CARD domain and is thought to regulate RIG-I and MDA5 activity (95). These 
receptors are found in myeloid and epithelial cells in the airway. RIG-I and MDA5 serve as 
cytoplasmic sensors of RNA from viruses such as influenza, and activation of RLRs results in 
downstream signaling through the adaptor protein IPS-1/MAVS/VISA/CARDIF leading to 
transcription factors that regulate antiviral gene expression and production of type 1 interferons 
(IFN) (82). Notably, RIG-I may also form inflammasome complexes with an adaptor protein, 
ASC (apoptosis speck-like protein containing a CARD domain) and caspase-1 via the CARD 
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domain and activate processing of IL-1β and IL-18 (96). Inflammasome signaling will be 
discussed in detail below (section 1.2.4). 
1.2.3 Nod-like Receptors (NLRs) 
Nucleotide-binding oligomerization domain receptors (NLRs) are a family of 
cytoplasmic PRRs that that are characterized by the presence of three domains: a C-terminal 
leucine-rich repeat domain that binds ligands, a central NATCH nucleotide binding domain that 
is important for oligomerization, and N-terminal effector domain that may be a pyrin, CARD, or 
BIR domain (97). The N-terminal effector domain determines the subfamily of the NLR: NLRB 
has a BIR domain and contains one member NAIP; the NLRC family has a CARD domain and 
contains NOD1, NOD2, NLRC3, NLRC4, NLRC5, and NLRX1; and the NLRP family has a 
pyrin domain and includes NLR1 through NLRP14 (98). Notably, the members of these 
subfamilies may differ in mice (99). The ligands recognized by these receptors are highly varied. 
For example, NLRC4 recognizes microbial bacterial flagellin and type III secretion machinery, 
NLRP1 recognizes muramyl dipeptide (a bacterial peptidoglycan), and NLRP3 recognizes a 
wide range of stimuli from influenza to uric acid crystals (100). Engagement of these receptors 
results in a cascade of intracellular signaling leading in the production of innate immune 
mediators, and the specific intracellular signaling pathways differ depending on the receptor. For 
example, NOD1 and NOD2 signal to transcription factors such as NF-kB, NLRC5 serves as a 
regulator of NF-kB signaling, and several other NLRs (namely NLRP1, NLRP3, NLRC4) form 
inflammasome complexes (97, 101, 102). A number of diseases are associated with mutations in 
NLRs, highlighting the importance of NLRs in immunity. For example, activating mutations in 
NLRP3 are associated with Familial Cold Autoinflammatory Syndrome and Muckle-Wells 
Syndrome (98). [Adapted from (84)] 
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1.2.4 Inflammasome signaling 
Upon recognition of a PAMP or DAMP, several NLRs, RIG-I, and the DNA-binding 
IFI200 family member absent in melanoma 2 (AIM2) may form a multi-protein complex termed 
the inflammasome. The inflammasome is composed of a PRR, pro-caspase-1, and the adaptor 
protein Pyd and card domain containing (PYCARD) (103). This complex has been best studied 
in myeloid cells, particularly Mac and monocytes, though recently there has been increased 
interest in inflammasome signaling in non-myeloid cells (104).   
Upon formation of the inflammasome complex, caspase-1 is autoactivated from the pro- 
form to the cleaved active form, which can then catalyze the proteolytic processing and release 
of IL-1β and IL-18. Caspase-1 mediated processing and the release of mature cytokines requires 
two distinct stimuli (100, 105). First, an inflammatory stimulus activates the transcription of pro-
cytokines, such as pro-IL1β and pro-IL18. This signal may be triggered by TLR activation and 
downstream signaling through the NF-κB or MAPK pathways. The second signal induces 
formation of the inflammasome complex, cleavage of caspase-1, and then pro-cytokine 
maturation and release (Figure 1.4). Active caspase-1 may also participate in one of several other 
effector mechanisms, including induction of a caspase-1 dependent form of programmed cell 
death termed pyroptosis, activation of NF-kB, and cleavage of proteins involved in glycolysis, 
apoptosis, and cytoskeleton functions (106, 107). 
The exact mechanism of inflammasome activation is not clear. Only AIM2 has been 
shown to directly bind to its ligand, DNA, prior to inflammasome formation (108). Conversely, 
NLRC4 and NLRP3 are not thought to directly bind to ligands. NLRC4 has been shown to 
require co-receptors from NAIP family to recognize the flagella, rod, or needle proteins of 
bacteria (109). Because NLRP3 senses a variety of PAMPs, DAMPs, and pollutants, NLRP3 is 
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generally thought to sense general changes in cellular homeostasis rather than directly binding to 
a ligand (Figure1.4) (100, 110). Activation of the NLRP3-mediated IL-1β/IL-18 processing 
actually requires three steps: pro-IL-1β and pro-IL-18 transcription, up-regulation of NLRP3 
transcription, and NLRP3-PYCARD-caspase-1 association to form the inflammasome complex 
(105). Mitochondria are thought to play a key role in NLRP3 inflammasome assembly and 
activation. Mitochondria may serve as an activation platform for the NLRP3 inflammasome and 
a source of reactive oxygen species and DNA, both of which have been shown to either directly 
activate NLRP3 or up-regulate its expression (111-114). Alterations in ion concentrations in the 
cell have also been associated with NLRP3 inflammasome activation, as low levels of 
intracellular potassium (K
+
) and high levels of intracellular calcium (Ca
+
) can activate 
inflammasome formation (110, 115, 116). Finally, the NLRP3 inflammasome may also be 
activated by lysosamal damage, as caused by phagocytosis of large crystals or fibers (e.g. 
asbesotos or silica). Rupture and release of lysosomal contents, such as cathepsin B, may trigger 
NLRP3 inflammasome activation (117). Thus, a number of questions remain regarding 
inflammasome activation, and inflammasome activation likely involves a combination of 
mechanisms that is tailored for specific PRRs and stimuli. [Adapted from (84)] 
1.2.5 PRRs in the response to pathogens versus pollutants 
Pattern recognition is typically associated with the response to microbial stimuli that may 
be directly recognized by PRRs via a PAMP, yet PRRs are also implicated in the inflammatory 
response to a number of pollutants. Neutrophilic influx is a shared characteristic of exposure to 
both pollutants and the bacterial cell component LPS, leading to the hypothesis that the 
inflammatory response to these different stimuli may be mediated by a common innate immune 
mechanism (81). Indeed, studies have shown that the prototypical endotoxin receptor, TLR4, is 
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important for the inflammatory response to air pollutants (75, 87). Exactly how pollutants 
activate PRRs such as TLR4 is not as clear. For particulates such as particulate matter or 
biomass, endotoxin is a common contaminate that can activate TLR4 signaling (118, 119). Yet, 
other pollutants, such as O3, induce sterile inflammation and cannot directly bind a PRR, 
suggesting that pollutant-induced injury may generate DAMPs that activate PRRs (87).  For 
example, O3 is associated with fragmentation of the extracellular matrix component hyaluronic 
acid (HA), and these fragments can be recognized by PRRs including TLR2 and TLR4 to induce 
innate immune responses (91, 120, 121).  
Inflammasome signaling has received increased attention as an innate immune pathway 
induced by a wide array of stimuli, including pathogens, DAMPs, and pollutants. Whereas 
infection with a virus or bacteria may directly activate AIM2, RIG-I, and other receptors in the 
cytoplasm and induce inflammasome signaling, the mechanism by which pollutants activate 
inflammasome signaling is less clear. Some pollutants, such as asbestos fibers and silica crystals, 
have been shown to induce phagosomal destabilization, lysosomal damage, and the generation of 
reactive oxygen species in Mac that induce NLRP3 inflammasome formation (117). Other 
pollutants, such as O3, more likely activate inflammasome signaling through a secondary 
mediator or DAMP. Indeed, in murine studies the NLRP3 inflammasome be activated by HA 
fragments, which may contribute to O3-induced airway hyperresponsiveness in mice (122, 123). 
Thus, the inflammasome may be a common pathway by which pollutants and pathogens 
stimulate similar inflammatory responses.  
As indicated above, signaling through PRRs is the first step of the innate immunity to the 
inhaled environment, be it viruses or pollutants, and the response dictates subsequent adaptive 
immune responses (3, 80). A number of studies indicate that PRR signaling may be important 
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mechanism contributing to the pathogenesis of immune diseases, such as allergy and asthma (6). 
Indeed, viral infection and inhalation of air pollutants are known causes of asthma exacerbation, 
suggesting innate immunity contributes to asthma pathogenesis. The role of innate immunity in 
asthma will be discussed below. 
1.3 Asthma overview 
Over 20 million Americans suffer from asthma, a chronic lung disease characterized by 
airway inflammation and variable and reversible obstruction of the airway (7).
 
The rates of 
asthma incidence have continued to increase over the past 50 years, which is thought to be due to 
a combination of changes in lifestyle and urbanization (124). Asthma is an extremely 
heterogeneous disease with a diverse etiology and pathophysiology (7). Asthma is thought to be 
caused by a combination of genetic and environmental factors. A number of susceptibility genes 
for asthma have been identified that are involved in pattern recognition, T lymphocyte 
differentiation and function, epithelial cell function, and lung function (125). Yet, not all 
individuals with familial history or susceptibility genes have asthma, suggesting that interaction 
with additional environmental factors is necessary (125, 126). Environmental factors that are 
associated with asthma susceptibility include prenatal maternal smoking, early life viral 
infection, lack of exposure to infectious agents (known as the “hygiene hypothesis”), and 
inhalation of air pollutants (124, 127).  
The most common form of asthma is allergic asthma, which is induced by allergy to an 
antigen such as house dust mite (HDM), pollen, or mold and is dependent on the presence of IgE 
antibodies specific for the allergen. Non-allergic asthma is exacerbated by stimuli such as 
exercise, cold air, medications (e.g. aspirin), and stress (128). Both forms of asthma are 
associated with the accumulation of Th2 lymphocytes that secrete the cytokines IL-4, IL-5, and 
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IL-13. These cytokines induce B cell isotype switching to IgE synthesis, the recruitment of 
eosinophils, basophils, and mast cells to airway, goblet cell metaplasia, and bronchial reactivity 
(21).  Notably, other helper T lymphocytes can also contribute the pathogenesis of asthma, such 
as Th17 lymphocytes, which produce IL-17 and attract neutrophils to the airway (71). Chronic 
inflammation of the airways leads to airway remodeling, obstruction, and airway 
hyperresponsiveness (AHR) that mediate the asthma symptoms of wheezing and difficulty 
breathing (7). 
 Though adaptive immunity, mediated by B and T lymphocytes, is clearly central to 
asthma pathophysiology, the innate immune system is essential for the initiation and propagation 
of these adaptive responses and of particular significance during asthma exacerbation (3, 6, 129). 
The role of innate immunity in asthma development and asthma exacerbation will be briefly 
introduced below. Primarily allergic asthma development will be discussed here as it is the most 
common type of asthma.  
1.3.1 Innate immunity in asthma development 
Both structural airway epithelial cells and innate immune cells, such a DC, are important 
contributors to the induction and maintenance of Th2-mediated immune responses (21). 
Increases in airway permeability caused by damage to tight junctions as caused by inhalation of 
viruses, pollutants, or allergens that contain proteases (e.g. certain HDM species) can lead to 
increased access of antigen to the underlying tissue or intraepithelial DCs (21, 74). DC that have 
recognized an antigen then migrate to the draining lymph node, where they present the processed 
antigen to naïve T lymphocytes (21).  
Innate immune PRRs play a key role in priming DC and the airway for the development 
of Th2 responses.  Without the appropriate co-stimulatory molecules to fully activate DC, 
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presentation of a harmless antigen leads to the induction of tolerance, or unresponsiveness of the 
adaptive immune system to an antigen (6, 21). In order to be fully active, DCs must be 
stimulated by PAMP or DAMP activation of innate pattern recognition receptors (TLRs and 
CLRs) or through proteolytic activity of the allergen (e.g. proteases found in some HDM) that 
can induce protease activated receptors (PARs) (21, 130). Activation of PRRs induces the 
production of pro-Th2 cytokines and the expression of co-stimulatory molecules by DCs. 
Additionally, activation of PRRs on EC induces the release of cytokines, including granulocyte-
macrophage colony stimulating factor (GM-CSF), IL-33, and thymic stromal lymphoprotein 
(TLSP), that prime DC and promote Th2 cell differentiation (131). For example, TSLP produced 
by EC induces expression of the co-stimulatory molecule OX40L by DCs (132). Thus, there is a 
clear role for innate immune receptors in the development of asthma, and previous studies have 
indicated that mice deficient in PRRs such as TLR4 are protected against the development of 
allergic inflammation (133).  
With appropriate activation of DC and the presence of Th2-polarized cytokines in the 
draining lymph node, particularly IL-4, naïve T cells will differentiate to Th2 lymphocytes (6). 
Th2 lymphocytes produce cytokines such as IL-4, IL-5, IL-13 that drive allergic inflammation, 
including B cell isotype switching to IgE synthesis and recruitment or activation of mast cells, 
eosinophils, and basophils to the airway (6). Degranulation of mast cells, eosinophils, and 
basophils induces airway smooth muscle contraction and goblet cell metaplasia that are 
associated with airway obstruction (7). Chronic Th2-skewed airway inflammation causes airway 
remodeling and permanent changes to the lung structure, such as increased airway smooth 
muscle mass (6). Thus, the innate immune system is crucial not only for allergen sensitization, 
but also maintenance of chronic airway inflammation. 
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Despite the important link between PRRs and asthma development, the contribution of 
the inflammasome signaling pathway to asthma remains unclear. Due to the involvement of 
NLRP3 inflammasome in the response to many PAMPs and DAMPs associated with allergic 
diseases, such as alum and several bacterial and viral species, the  NLRP3 inflammasome has 
been best investigated for a a role in asthma development (134-138).  Results from these studies 
are conflicting and have not identified a clear role for NLRP3 or caspase-1 in the development of 
allergic inflammation (131, 135,136). Likewise, studies investigating the role of IL-1 receptor 
(IL-1R) and IL-1 axis signaling in murine models of allergic inflammation are also unclear (131, 
133, 134, 137). These studies suggest contribution of inflammasome signaling to asthma 
development is complex, and may differ depending on the iniator of asthma pathogenesis.  
1.3.2 Innate immunity in asthma exacerbation: 
 Exacerbations of asthma symptoms can lead to emergency department visits, 
hospitalization, and even fatality in very severe cases (129, 139). There are many causes of 
asthma exacerbation, including viral infections, allergens, occupational exposures, exercise, 
stress, and air pollutants (129). In response to these stimuli, structural cells of the airway, such as 
EC and airway smooth muscle, as well as inflammatory cells, including macrophages, mast cells, 
eosinophils, and neutrophils initiate an innate immune response, including production of 
proinflammatory and cytotoxic mediators that lead to acute asthma symptoms (140). Here we 
will explore two common causes of exacerbation,respiratory viral infections and air pollution, 
and the innate immune responses that mediate these effects.  
Virus-induced asthma exacerbation. The leading cause of an asthma exacerbation is 
respiratory viral infection. Viruses have been associated with approximately 80% of wheezing 
episodes in children, and up to three-fourths of wheezing episodes in adults (141-143). 
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Rhinovirus (RV) is the most frequent cause of virus-induced asthma exacerbation, though other 
viruses including influenza A virus (IAV) and respiratory syncytial virus (RSV) are also 
common (142). IAV infection frequently reaches seasonal epidemic and, at times, pandemic 
proportions and thus is a serious concern for patients with asthma (144).  
 Airway ECs are the primary target for respiratory viruses such as RV and IAV. In vitro 
and in vivo studies have found that the barrier function of EC in asthmatics is impaired due to 
disruptions in tight junctions (22).  Additionally, EC repair and proliferation of basal cells is 
reduced in the airways of asthmatics (74, 145).  Finally, genome-wide expression comparisons of 
ECs from asthmatics to non-asthmatics found that a number of genes involved in repair and 
immune responses are differentially expressed by EC from asthmatics (146). Thus, it is not 
surprising that EC from asthmatics respond differently to viral infection. Upon infection with a 
virus, pattern recognition receptors such as TLR3 and RIG-I recognize the virus and induce 
downstream cytokine, chemokine, and antiviral mediators (20). Previous studies have found that 
EC from asthmatics have deficient interferon (IFN) production after  infection and increased 
production of the inflammatory cytokines IL-1, IL-6, IL-8, and GM-CSF with RV or RSV 
infection, correlating with the increased pro-inflammatory response to viral infections observed 
in vivo (146-150). Virus-induced damage of EC may increase airway permeability to allergens. 
Indeed, previous studies have shown a synergistic effect of virus infection and allergen exposure 
on hospital admissions for asthma (151). 
Increased production of cytokines and chemokines by virus-infected EC from asthmatics 
contributes to the recruitment of inflammatory cells, such as neutrophils, eosinophils and T 
lymphocytes, to the airways (152, 153). As indicated above, eosinophils are important mediators 
of allergic asthma, but neutrophilia of the airway is also observed in patients with severe asthma 
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or during an exacerbation (49). Neutrophils are very reactive and secrete a variety of cytokines 
and proteases such as neutrophil derived elastase and matrix metalloproteinase 9 that damage the 
airway and contribute to AHR and increased mucus production (154, 155, 156). Virus-induced 
asthma exacerbations may also be related to an imbalance of Th1/Th2 responses to the virus. In 
patients with RV infection, reduced CD4+ T cell production of IFNγ and increased IL-4, IL-5, 
and IL-13 were associated with more severe RV-induced asthma symptoms (152).  
In summary, alterations in EC response, increased airway inflammation, and altered 
Th1/Th2 response to virus infection are key mediators of virus-induced asthma exacerbation. 
The specific molecular signaling pathways contribute to altered response to virus must be further 
investigated.Specifically, the function of inflammasome signaling in virus-induced asthma 
exacerbations has not been studied despite clear involvement of the inflammasome in the innate 
immune response to several respiratory infections. such as IAV (157). Moreover, epithelial cells 
from asthmatics have been shown to have enhanced IL-1 expression after RV infection, 
suggesting the inflammasome signaling may be altered in airway epithelial cells from asthmatics 
and thereby contribute to asthma pathogenesis (146). Results shown in Chapter 2 will elucidate 
the role of inflammasome signaling in the airway epithelial cell innate immune to IAV infection, 
and how asthma may modified this signaling pathway.  
 Pollutant-induced asthma exacerbation. Exposure to air pollutants such as particulate 
matter (PM), diesel exhaust (DE), and ozone (O3) are associated with increased rates of 
hospitalization for asthma exacerbation (158-160). Pollutants induce oxidative stress that 
damages the airway and activates redox-reactive transcription factors, such as NF-kB and AP-1, 
to enhance inflammatory gene expression (161). Components of damaged cells and tissue serve 
as DAMPs that can activate innate immune pathways through PRR signaling. Particulate air 
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pollutants may also serve as carriers for allergens and endotoxin, and thus induce synergistic 
inflammatory responses (118, 119, 140). Finally, air pollutants may directly affect lung function 
by activating nocicepetive receptors (162). Though air pollutants may have direct effects on the 
airway, air pollutants have an even greater adjuvant effect, whereby the inflammation and 
damage caused by air pollutants may prime for more severe response to a subsequent 
environmental allergen (163-165).  
The effects of DE on asthma and allergy have been best characterized. DE particles 
(DEP) consist of a carbon core with a large surface area to absorb heavy metals and organic 
compounds, including allergens (140, 166). DEP has effects on both innate and adaptive immune 
responses that may contribute to asthma exacerbation. Both in vitro and in vivo studies suggest 
that DEP simulates B lymphocyte production of IgE, which then bind to receptors on mast cells 
and basophils to induce degranulation (167, 168). DEP also enhances Th2-cytokine production, 
particularly IL-4 and IL-5, as well as induction of IL-8 (a potent neutrophil chemoattractant) and 
GM-CSF among other mediators (169, 170). The effects of DEP on airway inflammation are 
even greater in combination with exposure to an allergen, suggesting that DEP may serve as an 
adjuvant for allergic inflammation and Th2-skewed responses (163, 171) .  
Epidemiological studies suggest a clear association between exposure to O3 and asthma 
exacerbations (81, 160). O3 induces both a nociceptive response that affects lung function and an 
inflammatory response in the airway, and these effects may be more severe in individuals with 
asthma (81). The effects of O3 on lung function are observed immediately after exposure and are 
likely mediated by stimulation of nociceptive receptors and/or by stimulation of C fibers in the 
lung that induce smooth muscle contraction and increased airway resistance (172, 173). 
Interestingly, the lung function effects of O3 seem to be independent of airway inflammation, 
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suggesting separate mechanisms mediate these effects (81, 174). O3-induced airway 
inflammation is thought to be mediated by oxidative stress and damage of the airway epithelium 
and resident cells. O3 may directly damage cells of the airway, but due to its high reactivity O3 
likely does not penetrate beyond the epithelial layer or deep into the lung (77). O3 also reacts 
with lipid or protein components of the lung lining fluid and induces reactive intermediates such 
as oxidized lipids and proteins that can travel further into the lung (175-177). Oxidized lipids as 
well as damaged tissue and cellular debris can serve as DAMPs for PRRs (178, 179). For 
example, fragments of the extracellular matrix component hyaluronic acid (HA) found in the 
airway after exposure to O3 activate TLR4 and the NLRP3 inflammasome to induce 
inflammation and AHR (121, 123, 179, 180). O3-induced airway damage is greater in asthmatics 
compared to healthy volunteers and asthmatics have  enhanced O3-induced inflammatory 
cytokine levels in the airway, such as IL-1β and IL-6 that correlates with increased neutrophilia 
in the airway with O3 (181-183). Additionally, an increase in eosinophils has been observed in 
the airway of allergic asthmatics after O3 exposure (182, 184).  
 Epidemiological studies indicate that there may be a 24-48 hour lag period between O3 
exposure and asthma-related exacerbation, suggesting that increased airway sensitivity and 
inflammation may prime individuals for enhanced response to an inhaled allergen (81, 185). 
Indeed, previous controlled exposure studies have found that allergic asthmatics have heightened 
airway reactivity to allergens after exposure (165, 185, 186). These effects may be due to 
alterations in inflammatory cell phenotype. Previous studies have shown that Mac and 
monocytes have altered expression of PRRs, co-stimulatory/antigen presentation molecules, and 
immunoglobulin receptors after exposure to O3, and that expression of CD23, FceRI, and TLR4 
were further increased in asthmatic subjects (81, 182, 187). Furthermore, a murine study found 
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that O3 served as an adjuvant for OVA-induced airway inflammation and activated expression of 
the co-stimulatory molecule CD86 on DCs (188).  
In summary, inhalation of O3 or other pollutants induce inflammation that may 
exacerbate the chronic airway inflammation associated with asthma and prime the airway for an 
enhanced response to a subsequent inhaled stimulus, such as an allergen. As air pollutants are 
associated with oxidative damage in the airway, DAMPs likely play a particularly important role 
in the initiation of inflammation in the airway and the chronically inflammed asthmatic airway 
may be more susceptible to this damage. Many DAMPs found in the airway after exposure to air 
pollutants, such as HA, may activate inflammasome signaling. Interestingly, asthmatics subjects 
exposed to O3 in vivo have been shown to have enhanced HA in the airway after exposure to O3, 
which was correlated with elevated IL-1β (181, 182). Thus inflammasomem signaling and 
DAMPs may be important contributors to pollutant-induced asthma exacerbation. In chapters 4 
and 5, the contribution of DAMPs to the innate immune response to O3 will be investigated. 
1.4 Summary  
 The respiratory mucosal host defense system is composed of a complex network of innate 
and adaptive cells that together must distinguish between innocuous and injurious inhaled 
stimuli. Resident immune cells, such as EC and Mac, are crucial for determining the very initial 
responses to inhaled stimuli and recruiting the appropriate inflammatory cells to the airway. The 
innate immune response informs the development of adaptive immunity. Failure to respond to a 
pathogenic stimulus may result in susceptibility to infection, whereas excessive response to a 
harmless stimulus may lead to diseases such asthma.  
 In this dissertation, we explored the role of inflammasome signaling in the innate 
respiratory mucosal host defense system and how these pathways may contribute to asthma 
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pathogenesis. Given that the inflammasome may be a common signaling pathway shared by 
pathogens and pollutants, we chose to investigate this pathway in the context of two known 
causes of asthma exacerbation: viral infection and inhalation of the oxidant air pollutant O3. 
Viral components serve as PAMPs and can be directly recognized by PRRs, whereas O3 is a 
model of sterile inflammation that activates PRRs via DAMPs. In chapters 2 and 3, the role of 
the inflammasome in virus-induced asthma exacerbation and the development of allergic 
inflammation will be discussed. In chapters 4 and 5, we investigated the role of DAMPs and the 
inflammasome in the innate immune response to O3, and how the interaction between resident 
EC and Mac influence the response to O3. Our results uncover new insights on the innate 
immune response to viruses and pollutants in humans that may contribute to asthma 
pathogenesis, and suggest that inflammasome signaling may have diverging functions depending 
on the stimulus and the cell type.  
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Figure 1.1 Respiratory epithelium at homeostasis. The respiratory epithelium of the bronchial 
mucosa is composed of four main types of airway epithelial cells: 1) ciliated epithelial cells; 2) 
goblet (mucus-producing) cells; 3) club (secretory) cells; and 4) basal (precursor) cells. 
Epithelial cells secrete a number of mediators that make up the lung lining fluid, including 
mucins, antioxidants, proteases, and anti-proteases, and transport secretory immunoglobulin A 
(sIgA) from plasma cells to the lumen. Macrophages patrol the airway and clear debris, 
particulates, and pathogens. Dendritic cells lie under the epithelium, and extend processes to 
“sample” the airway. Finally, T lymphocytes may be found within the epithelium, though the 
role of these cells in host defense is unclear. 
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Figure 1.2. Respiratory mucosal host defense to an antigen. Damage to epithelial cells by an 
injurious stimulus causes the release of damage associated molecular patterns (DAMPs), 
cytokines, and chemokines to alert immune cells of the injury. The stimulus is recognized by DC 
as an antigen, leading to DC migration to a draining lymph node where antigen is presented to 
naïve T lymphocytes. Mature T lymphocytes travel to the site of injury to preform effector 
functions. Innate immune cells (neutrophils, basophils, eosinophils, mast cells, NK cells) respond 
to cytokines and chemokines and travel from the blood stream to the airway. B lymphocytes 
proliferate and differentiate to plasma cells that produce antibody specific for the antigen. 
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Figure 1.3. Toll-like receptor (TLR) signaling. TLRs are membrane-associated pattern 
recognition receptors. TLRs may reside on the cell membrane or the endosomal membrane. Each 
TLR recognizes specific pathogen-associated molecular patterns or damage-associated molecular 
patterns. Examples of prototypical stimuli are indicated. Active TLRs signal through adaptor 
proteins such as TRAM, TRIF, TIRAP, and MYD88 to activate MAPK, NF-kB, IRF3, or IRF7 
signaling and transcription of inflammatory cytokines and IFN-inducible genes. Image adapted 
from Bauer, RN; Diaz-Sanchez, D; Jaspers I. Effects of air pollutants on innate immunity: the 
role of toll-like receptors and nucleotide-binding oligomerization domain–like receptors. J 
Allergy Clin Immunol. 2012 Jan; 129(1):14-24 with permission from Elsevier.  
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Figure 1.4. Activation of the NLRP3 inflammasome. The NLRP3 inflammasome can respond 
to a  wide range of stimuli, including silica and uric acid crystals, asbestos fibers, bacteria, 
viruses, particulates, and a number of DAMPs. NLRP3 likely does not bind to these stimuli, but 
rather senses changes in cellular homeostasis (free mitochondrial DNA, reactive oxygen species 
(ROS), lysosomal damage, and changes in ion concentration). The NLRP3 inflammasome 
consists of an adaptor protein (ASC) and pro-caspase-1. Upon formation of the inflammasome, 
caspase-1 becomes active and can then cleave pro-IL-1β and pro-IL-18 to an active form that can 
be secreted from the cell or can perform several alternative functions, including initiation of 
pyroptosis. Image adapted from Bauer, RN; Diaz-Sanchez, D; Jaspers I. Effects of air pollutants 
on innate immunity: the role of toll-like receptors and nucleotide-binding oligomerization 
domain–like receptors. J Allergy Clin Immunol. 2012 Jan; 129(1):14-24. 
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Chapter 2: Influenza enhances caspase-1 in bronchial epithelial cells from asthmatics and 
is associated with pathogenesis
12
 
2.1 Introduction 
Most acute asthma exacerbations are caused by respiratory viral infections and the 
resulting innate immune response (1-6).  Epidemiological studies of the 2009 H1N1 influenza A 
virus (IAV) pandemic revealed an association between  asthma diagnosis and increased 
morbidity and mortality from infection, yet the mechanisms by which underlying asthma 
enhances IAV-induced responses are poorly understood (7-10). 
The primary sites for IAV infections are airway epithelial cells (AECs). The first step in 
the AEC response to viral infections is recognition of the virus by pattern recognition receptors 
(PRRs), such as NOD-like receptors (NLRs) and RIG-I- like receptors (RLRs), which activate 
downstream signaling cascades to initiate expression of cytokines and chemokines (11, 12). 
Several NLRs and RIG-I that oligomerize with caspase-1 and PYCARD to form the 
inflammasome complex have been implicated in the innate immune response to viruses, 
including IAV (12, 13). Formation of the inflammasome complex induces auto-activation of 
caspase-1, which catalyzes the proteolytic processing of pro-IL-1β and pro-IL-18. Active 
caspase-1 may also participate in several alternative mechanisms, including a pro-inflammatory 
form of programmed cell death termed pyroptosis (14). Alterations in inflammasome signaling 
are associated with inflammatory diseases including Crohns’ disease, gout, and atopic dermatitis 
                                                 
1
This article was previously published in the Journal of Allergy and Clinical Immuulogy as Bauer RN, Brighton LE, 
Mueller L, Xiang Z, Rager JE, Fry RC, et al. Influenza enhances caspase-1 in bronchial epithelial cells from 
asthmatic volunteers and is associated with pathogenesis. J Allergy Clin Immunol. 2012 Oct;130(4):958,967.e14 and 
is used here with permission from Elsevier.  
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(15); however, involvement of the inflammasome in virus-induced asthma exacerbation is 
unknown. 
Human bronchial epithelial cells (HBEC) from asthmatics have modified innate immune 
responses to viral infection. A genome-wide expression study comparing rhinovirus (RV)-
infected HBEC from asthmatics and non-asthmatics demonstrated that HBEC from asthmatics 
had altered RV-induced expression of immune response genes, including IL1B (16). In addition, 
HBEC from asthmatics have been shown to have deficient RV-induced interferon (IFN) 
production (17, 18) and increased production of the inflammatory cytokines IL-6, IL-8, and GM-
CSF with RSV infection (19), correlating with the increased pro-inflammatory response to viral 
infections seen in vivo (20).  
Since inflammasome signaling is important for antiviral response to IAV in AECs (21), 
and virus-induced IL-1β expression differs in HBEC from asthmatics and non-asthmatics (16), 
we hypothesized that in the asthmatic epithelium, altered expression of inflammasome and innate 
immune signaling components contributes to virus-induced asthma pathogenesis. Using 
differentiated primary HBEC, we compared IAV-induced activation of inflammasome and innate 
immune responses in HBEC from asthmatics and non-asthmatics. Our data show that IAV-
induced expression of inflammasome and innate immune signaling components is enhanced in 
HBEC from asthmatics. Specifically, caspase-1 expression and localization differed in IAV-
infected HBEC from asthmatics and associated with enhanced, albeit low levels, of IAV-induced 
IL-1β production. Using tracheal epithelial cells (MTEC) from caspase-1 deficient (Casp1 -/-) 
mice, we found that caspase-1 affects expression of several innate immunity genes and viral 
replication. Our results demonstrate an important role for caspase-1 in the response to IAV 
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infection at the level of the epithelium, which may be independent of IL-1β production and is 
enhanced in HBEC from asthmatics.  
2.2 Materials and Methods 
Subject characterization. Refer to Tables 2.1-2.3 for subject information and a list of 
allergens included in the allergy skin prick test.  All asthmatics had positive skin prick test 
results or history of allergic rhinitis. 54.5% of the non-asthmatic volunteers had positive skin 
prick test results or history of allergic rhinitis. Mild asthma status was characterized by history of 
asthma symptoms (e.g. cough or wheeze) two times or less a week and no current use of inhaled 
steroids. All asthmatics were considered “mild” except for subject 4, who was considered 
“moderately asthmatic” due to use of an oral steroid. Subject 4 first entered the human subjects 
database in 2003 and during this initial screening visit was characterized as “moderately 
asthmatic” due to the frequency of symptoms (3-4 times a week). The subject went on oral 
steroids and albuterol in 2003. When the subject enrolled in this study (2009), the subject had not 
used the oral steroid or albuterol medications in over two months.  This subject did not appear to 
be an outlier in any endpoints.  Non-asthmatics had no history of asthma symptoms.  
Human bronchial epithelial cell (HBEC) culture. Primary HBEC were obtained from 
non-asthmatic (n=11) and asthmatic (n=13) adult volunteers by cytologic brushing during 
bronchoscopy using a protocol approved by the UNC-Chapel Hill School of Medicine 
Institutional Review Board. HBEC were expanded to passage two in bronchial epithelial growth 
medium (BEGM; Cambrex Bioscience Walkersville, Inc., Walkersville, MD) and differentiated 
as described before (22).  
Animals and murine tracheal epithelial cell (MTEC) isolation. C57BL/6 Casp1 -/- mice 
were purchased from Jackson Laboratories (Bar Harbor, ME). Female Casp1 -/- or wild type 
 72 
 
matched littermates were used throughout the study. All experimental procedures were approved 
by the University of North Carolina Institutional Animal Care and Use Committee. MTEC 
isolation and culture was performed as described by You et al. (23).  MTEC were expanded to 
passage one in Ham’s F-12 medium (Invitrogen, Carlsbad, CA) before use.   
Influenza infection. HBEC were infected with Influenza A/Bangkok/1/79 (H3N2) (24-25) 
diluted in Hank’s Buffered Saline Solution (HBSS, Invitrogen). MTEC were infected with 
mouse-adapted Influenza A/PR/8/34 (H1N1) (26-27) diluted in culture medium. Both viruses 
were obtained from Dr. Melinda Beck (Department of Nutrition, University of North Carolina, 
Chapel Hill), propagated in 10-day-old embryonated hens’ eggs, and collected from the allantoic 
fluid. For infection of HBEC and MTEC, 500,000 cells were infected with approximately 50 
hemagglutination units (HAU). Control treated HBEC received HBSS alone, and MTEC 
received media alone.  
Quantitative real-time PCR (qRT-PCR). Total RNA was isolated from HBEC from 
asthmatics (n=7) and non-asthmatics (n=8) using TRizol (Invitrogen) according to manufacturer 
instructions. First-strand cDNA synthesis and qRT-PCR were performed as previously described 
(28, 29). Primers and probes for caspase-1, PYCARD, capase-4, NOD2, RIG-I, IP-10, and β-
actin were commercially available (Applied Biosystems, Foster City, CA). Sequences for 
primers and probes designed “in-house” are as follows: Human: IFN-β: 5'-FAM-
AGCAGCAATTTTCAGTGTCAGAAGCTCCTG-TAMRA-3' (probe), 5'- 
CAACTTGCTTGGATTCCTACAAAG-3' (sense), and 5'-AGCCTCCCATTCAATTGCC-3' 
(antisense); Hemagglutinin (HA) of influenza A/Bangkok/79/1: probe, 5′-FAM 
TGATGGGAAAAACTGCACACTGATAGATGC-TAMRA-3′; sense, 5′-
CGACAGTCCTCACCGAATCC-3′; antisense, 5′-TCACAATGAGGGTCTCCCAATAG-3′. 
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Mouse: Matrix 1 (M1) gene of influenza A/PR/8/34: 5’-FAM-TTT GTG TTC ACG CTC ACC 
GT-TAMRA-3’(probe), and (sense) 5′-AAGACCAATCCTGTCACCTCTGA-3′, and (antisense) 
5′-CAAAGCGTCTACGCTGCAGTCC-3′; IL-6: 5’-FAM-
CCAGCATCAGTCCCAAGAAGGCAACT-TAMRA-3’(probe), and sense 5’-
TATGAAGTTCCTCTCTGCAAGAGA-3’ (sense), and 5’-TAGGGAAGGCCGTGGTT-3’ 
(antisense); IFNβ: 5’-FAMAGGGCGGACTTCAAGATCCCTATGGA-TAMRA-3’ (probe), and 
5’-TGAATGGAAAGATCAACCTCACCTA-3’ (sense), and 5’-
CTCTTCTGCATCTTCTCCGTCA-3’ (antisense). Differences in expression were determined 
using the ΔΔCt method and B-actin for normalization. 
qRT-PCR array. Total RNA isolated from a subset of HBEC from asthmatics (n=3) and 
non-asthmatics (n=3) was purified using an RNeasy Mini Kit (Qiagen, Valencia, CA). cDNA 
was prepared using a RT First Strand Kit (SABiosciences, Frederick, MD) and analyzed  using 
the human inflammasome RT2 Profiler PCR Array System (SABiosciences). Gene expression 
results were normalized to GAPDH, analyzed using the ∆∆Ct method, and probed for genes with 
≤1.5-fold difference in expression.  
Cytokine quantification. The apical surface of HBEC were washed with HBSS and 
analyzed for concentrations of IL-6, IL-1β, and TNFα using a commercially available ELISA kit 
(Meso Scale Discovery, Gaithersburg, MD). Lower limits of detection were: IL-1β= 0.5 pg/ml; 
IL-6= 0.22 pg/ml; TNFα= 0.49 pg/ml. 
Immunofluorescence microscopy. HBEC from asthmatics (n=3) and non-asthmatics (n=3) 
were fixed with 4% paraformaldehyde (Sigma-Aldrich) and prepared for immunofluorescence as 
described previously (30). Primary antibodies for Caspase-1 (1:200, Cell Signaling, Danvers, 
MA) and PYCARD (1:200, Santa Cruz Biotechnology, Santa Cruz, CA) were incubated 
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overnight at 4ᵒC. Secondary antibodies were goat anti-mouse-Alexa 488 (for PYCARD) or 
donkey anti-rabbit- Alexa 568 (for CASP1) (Molecular Probes , Invitrogen). Vectashield plus 
DAPI (Vector H-1200; Vector Laboratories, Burlingame, CA) was added to mount the transwell 
membrane. A Nikon C1si confocal microscope with a 60x oil lens and Nikon EZ-C1 3.8 
software were used to acquire z-stack images (Nikon Instruments, Melville, NY), which were 
processed using the NIS-Elements software (Nikon). Images shown are composites of all z-stack 
slices. Equal adjustments were performed on all images. 
Lactate dehydrogenase (LDH) assay. To assess cytotoxicity, the basolateral supernatents 
from HBEC were analyzed for concentrations of LDH using a commercially available kit 
(Takara Bio Inc., Otsu, Shiga, Japan). 
UV-inactivation of influenza A virus. UV inactivated, replication deficient Influenza 
A/PR/8/24 was generated by exposing the virus inoculum on ice to 120mJ UV light for 20 
minutes using a Stratlinker 1800 (Stratagene, La Jolla, CA). Humaggultination assay was 
performed to ensure the virions remained intact and M1 gene expression was used to verify 
replication deficient virus. 
Influenza virus titer. Influenza virus titers in apical washes (HBEC) or supernatants 
(MTEC) were determined by 50% tissue culture infections dose (TCID50) in Madin-Darby 
canine kidney cells (MDCK) and by hemagglutination as previously described (31). 
Array Analysis. Array results were analyzed using the Comparative Marker Selection tool 
in GenePattern (www.broadinstitute.org/cancer/software/genepattern/) (32). Differences in gene 
expression between HBEC from asthmatics and HBEC from non-asthmatics were determined 
using the ΔΔCt method. Briefly, threshold cycle (Ct) value for the housekeeping gene (GAPDH) 
were subtracted from the Ct value for the gene of interest to determine the ΔCt value. Ct values 
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that were "undetermined" were replaced with Ct=40 for calculation purposes. For each pair-wise 
set of samples to be compared, the difference in ΔCt values between the two samples were 
calculated for the genes of interest to determine the ΔΔCt value. The fold change in gene 
expression was calculated as 2-ΔΔCt.The fold difference in expression between HBEC from 
asthmatics and HBEC from non-asthmatics was determined by dividing the average asthmatic 2-
ΔΔCt by the average non-asthmatic  2-ΔΔCt. For the array analysis, the p-value was determined 
by GenePattern comparative marker selection tool with a p-value cut-off of 0.05. 1000 
permutation tests were carried out using the signal-to-noise (SNR) ratio analysis and smoothed 
p-values were determined for each gene. SNR is defined by the equation SNR = (μA – μB) / (σA 
+ σB), where μ represents average sample intensity and σ represents standard deviation. 
Statistical analysis. For other non-array gene expression, cytokine analysis, and viral titer 
data, individual differences between asthmatics and non-asthmatics or Casp1-/- and wild type 
mice were assessed by analysis of variance (ANOVA) with a Tukey post-hoc test (*p < 0.05 , ** 
p< 0.01, ***p < 0.001). Factorial ANOVA was used to determine the interaction between IAV 
infection and asthma status or mouse genotype (# p<0.05,  ## p< 0.01, and ### p<0.001). 
Endpoints with no detection at baseline (MTEC IL-6 and M1 expression and viral titer) were 
assessed using unpaired T-test for individual differences between Casp1 -/- and wild type MTEC 
24 hours post-IAV infection (@ p<0.05). All graphs show mean ± SEM. 
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2.3 Results 
HBEC from asthmatics have enhanced IAV-induced production of cytokines 
 To determine whether HBEC from asthmatics have altered IAV-induced cytokine 
production, HBEC from asthmatics and non-asthmatics were infected with IAV for 6 or 24 hours 
and assessed for cytokine secretion (Figure 2.1A-C; Table 2.4-2.5). HBEC from asthmatics 
secreted significantly more IAV-induced IL-6, TNFα, and IL-1β, with the greatest increase 
observed 24 hours post-infection. Notably, the subject characterized as “moderately asthmatic” 
(Table 2.1) had neither an ablated nor a particularly heightened response to IAV infection.   
HBEC from asthmatics have differential expression of inflammasome- and innate immunity-
related genes 
Based on the elevated production of IL-1β by HBEC from asthmatics (Figure 2.1A), we 
investigated alterations in inflammasome signaling. Using an inflammasome-specific qRT-PCR 
array, encompassing 84 genes involved in innate immunity and inflammasome signaling, we 
compared baseline and IAV-induced gene expression between HBEC from asthmatics and non-
asthmatics (Table 2.6 and Table 2.7). The expression of eight genes was significantly altered at 
baseline in HBEC from asthmatics (Table 2.6). Of these genes, all but CCL5 were down-
regulated in HBEC from asthmatics. 24 hours post-IAV infection, HBEC from asthmatics had 
altered expression of seventeen genes, all of which were enhanced (Table 2.6).  
To confirm and expand upon the array results, we performed gene-specific qRT-PCR 
analysis of several genes with significant differences in HBEC from asthmatics using an 
increased number of subjects and expanded time course. Similar to the array results, HBEC from 
asthmatics had significantly increased expression of CASP1, CASP4, RIPK2, NLRC5, and NOD2 
after IAV infection (Figure 2.2A, C-F). The greatest increase was observed 24 hours post-IAV 
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infection, correlating with the highest production of cytokines. In both HBEC from asthmatics 
and non-asthmatics, the expression of PYCARD, an adaptor protein which links caspase-1 to one 
of several inflammasome receptors, was initially reduced with IAV infection, and then returned 
to baseline levels by 24 hours post-infection (Figure 2.2B). The expression of PYCARD was 
slightly decreased in HBEC from asthmatics throughout the time course, correlating with the 
array results.  
Caspase-1 and PYCARD immunofluorescence microscopy 
 Inflammasome signaling involves the oligomerization of caspase-1, PYCARD, and a 
PRR to form the inflammasome complex. To determine whether IAV- induced expression of 
caspase-1 translates to caspase-1/PYCARD co-localization, we used immunofluorescence 
microscopy to qualitatively assess the localization of PYCARD and caspase-1 in HBEC from 
asthmatics and non-asthmatics 6 or 24 hours post-IAV infection (Figure 2.3-2.5). In both groups 
at baseline, caspase-1 and PYCARD were located diffusely throughout the cell (Figure 2.3A-B 
1st and 3rd rows, 2.4A-B 1st row). With IAV infection, we observed the formation of co-
localized caspase-1/PYCARD foci, especially in the asthmatics, and particularly at 24 hours 
post-IAV infection (Figure 2.3A-B 2nd and 4th rows, 2.4A-B 2nd row). The HBEC from 
asthmatics had large, intense foci of co-localized PYCARD and caspase-1 at 24 hours post-IAV 
infection, (Figure 2.3A 4th row, 2.4A 2nd row), correlating with the enhanced caspase-1 
expression 24 hours post-IAV infection (Figure 2.2A). The co-localization of caspase-1 and 
PYCARD did not correlate with cytotoxicity, as we did not detect any differences in cytotoxicity 
throughout the infection time course (Figure 2.6). Our data show that PYCARD and caspase-1 
co-localized in response to IAV infection in HBEC, and suggests that the intensity of co-
localization appears to differ in HBEC from asthmatics. 
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HBEC from asthmatics have increased expression of antiviral genes, which correlates with 
enhanced IAV replication 
We next investigated whether HBEC from asthmatics also had enhanced expression of 
known antiviral genes, particularly interferon-γ induced protein 10 (IP-10), interferon β (IFNβ) 
and retinoic acid inducible-gene I (RIG-I).  Our data show that HBEC from asthmatics had 
elevated expression of these genes 24 hours post- IAV infection (Figure 2.7A-C).  
To determine whether the enhanced innate immune response was due to increased viral 
replication, we assessed influenza hemagglutinin (HA) transcripts and TCID50 viral titers of 
HBEC from asthmatics and non-asthmatics(24, 33). Though HBEC from asthmatics had no 
significant overall differences compared to non-asthmatics (Figure 2.8), there was significant 
correlation between the expression of IP-10, IFNβ, and RIG-I and influenza HA transcript 
number, suggesting that the enhanced innate immune response in the HBEC from asthmatics was 
correlated with greater viral replication (Figure 2.9A-C). Likewise, caspase-1 expression was 
correlated with influenza HA mRNA levels, suggesting that caspase-1 is involved in the antiviral 
response (Figure 2.9D). 
MTEC from Casp1-/- mice have diminished antiviral response to IAV infection and reduced viral 
replication 
 Our findings in HBEC from asthmatics indicated the enhanced expression of caspase-1 
was associated with heightened innate immune response to IAV. To further assess whether 
caspase-1 was causally linked to  antiviral defense against IAV infection, we examined the 
expression of innate immune genes by MTEC from Casp1 -/- and wild type mice, which were 
cultured and infected with IAV ex vivo. Our results show that Casp1 -/- MTEC had reduced 
IAV-induced expression of IFNα, IFNβ, IL-6, and IP-10 compared to wild type (Figure 2.10), 
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suggesting that the presence of caspase-1 is necessary for optimal expression of these genes. The 
baseline and IAV-induced expression of RIG-I was decreased to a similar extent  in Casp1 -/- 
MTEC, suggesting that caspase-1 expression may regulate baseline expression of RIG-I, and that 
these effects persist during IAV infection.  
To determine whether decreased viral replication was associated with the diminished 
innate immune gene expression response in Casp1-/- MTEC, we assessed viral replication 24 
hours post-IAV infection. Compared to wild type, the Casp1 -/- MTEC had reduced levels of 
influenza matrix 1 (M1) RNA and lower viral titers (Figure 2.11). To determine if viral 
replication was necessary for the diminished innate immune gene expression response in Casp1 -
/- MTEC, wild type and Casp1 -/- MTEC were infected with UV-inactivated (replication 
deficient) IAV, wild type IAV, or media control and assessed for expression of IP-10, which had 
the most robust IAV-induced expression (Figure 2.10), and influenza M1 RNA (Figure 2.12). No 
M1 transcripts were detected from cells infected with UV-inactivated IAV. As observed in 
Figure 2.10, wild type-IAV infected Casp1 -/- MTEC had significantly lower IP-10 expression 
compared to wild type MTEC. When infected with UV-inactivated virus, the Casp1 -/- and wild 
type MTEC had similar expression levels of IP-10, suggesting that viral replication was 
necessary for the diminished innate immune gene expression in Casp1 -/- MTEC. 
2.4 Discussion 
Respiratory viral infections are the leading cause of asthma exacerbations. Innate 
antiviral defense pathways are altered in the asthmatic epithelium, yet involvement of the 
inflammasome in virus-induced asthma exacerbations is unknown. We compared IAV-induced 
activation of inflammasome and innate immune signaling between differentiated HBEC from 
asthmatics and non-asthmatics, and found that HBEC from asthmatics had modified baseline and 
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IAV-induced expression of genes involved in innate immune and inflammasome signaling. In 
particular, we showed that caspase-1 expression was enhanced in HBEC from asthmatics, 
correlating with enhanced, albeit low levels, of IAV-induced IL-1 production. Using MTEC 
from Casp1 -/- and wild type mice, we found that IAV-infected Casp1 -/- MTEC had decreased 
expression of innate immunity genes and viral replication compared to wild type. These results 
establish an important role for caspase-1 in the AEC response to IAV, which may involve 
inflammasome-independent functions and is enhanced in the asthmatic epithelium.  
AEC-derived cytokines and chemokines contribute to the inflammatory cell influx and 
airway hyperresponsiveness associated with asthma exacerbation. AECs from asthmatics have 
altered production of cytokines and chemokines in response to RV and RSV (16, 17, 19). 
Consistent with these observations, we found that baseline and/or IAV-induced levels of innate 
immune cytokines and chemokines (IL-1β, TNF, IL-6, CCL5, IP-10, and IFNβ) were enhanced 
in HBEC from asthmatics. Previous studies have shown that these cytokines are increased in 
asthmatic airways in vivo either at baseline or following challenge and contribute to virus-
induced asthma exacerbation (34-39). Our findings add to the literature suggesting that baseline 
differences in HBEC from asthmatics may prime the epithelium for an exaggerated innate 
immune response to viral infection. 
Many of the cytokines and chemokines with enhanced expression in HBEC from 
asthmatics are under NF-kB regulation. NF-kB activity has previously been shown to be 
enhanced in AECs from asthmatics (40, 41).We found that expression of NFKBIB, an inhibitor 
of NF-kB signaling, was reduced in HBEC from asthmatics at baseline (Table 2.6), which may 
contribute to the enhanced innate immune response to IAV infection. Interestingly, caspase-1 has 
been shown to activate NF-kB via RIPK2, a CARD-containing kinase (42) that, similar to 
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caspase-1, had enhanced IAV-induced expression in HBEC from asthmatics (Table 2.6, Figure 
2.2E). Additionally, Nod2 activation of NF-kB signaling has been shown to induce CCL5 release 
in murine macrophages (43). Our findings indicate that IAV-induced expression of Nod2 was 
enhanced in HBEC from asthmatics (Table 2.6, Figure 2.2D), suggesting that Nod2 may be a 
regulator of IAV-induced CCL5 release that is enhanced in HBEC from asthmatics.  
The enhanced IAV-induced production of IL-1β suggested that HBEC from asthmatics 
may have modified inflammasome activity. Other studies have demonstrated involvement of the 
inflammasome and, more specifically, NOD-like receptor protein 3 (NLRP3), in defense against 
IAV infection (21, 44, 45). Allen et al. found that AECs secrete IL-1β, albeit at much lower 
concentrations than monocytes (21). We similarly observed low levels of IL-1β secretion, 
suggesting that AECs are not a major source of this cytokine. Though the canonical function of 
the inflammasome is activation of caspase-1 for the proteolytic processing of pro-IL-1β and pro-
IL-18, caspase-1 has alternative functions involved in the activation of NF-kB signaling, cell 
death, cellular metabolism, and cell repair (14). Therefore, caspase-1 may play alternative roles 
in non-myeloid cells, such as AECs, which do not produce high levels of IL-1β. 
 Based on this knowledge, we used a less biased approach to identify inflammasome-
related pathways activated by IAV infection. The most consistent differences in IAV-induced 
gene expression were the increased expression of CASP1 and CASP4 in HBEC from asthmatics. 
Caspase-4, a member of the caspase-1 subfamily, is involved in inflammatory responses to IAV 
infection (46-48). The murine homolog of caspase-4, caspase-11, may be involved in caspase-1 
activation and inflammasome-mediated cell death (49, 50). 
Activation of the inflammasome pathway involves oligomerization of caspase-1 and 
PYCARD with a PRR to form the inflammasome complex. The formation of large caspase-
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1/PYCARD foci has previously been shown in macrophages and monocytes (51-53). In resting 
monocytes and macrophages, PYCARD and caspase-1 exist diffusely throughout the cell (50, 
52). When stimulated by an agonist, PYCARD forms large cytosolic foci, which are often 
associated with NLRs and caspase-1 (50). Using immunofluorescence microscopy, we 
demonstrated IAV-induced co-localization of caspase-1 and PYCARD in HBEC. In agreement 
with the gene expression and cytokine data, we observed large and intense caspase-1 and 
PYCARD co-localization with IAV infection especially in asthmatics at 24 hours post-IAV 
infection.  
Our findings in HBEC indicate that caspase-1 is involved in the innate immune response 
to IAV infection. To further define the role of caspase-1 in antiviral defense, we infected MTEC 
from Casp1 -/- and wild type mice with IAV. Notably, the mouse-adapted influenza virus 
influenza A/PR/8/34 strain was used to infect MTEC and may differ in infectivity compared the 
human influenza A/Bangkok/1/79 strain. Our results indicate that IAV-infected MTEC and 
HBEC had similar patterns of innate immune gene expression. We found that 24 hours post-IAV 
infection, Casp1 -/- MTEC had decreased viral replication, correlating with reduced expression 
of several innate immune genes. Interestingly, enhanced caspase-1 expression in HBEC was 
correlated with increased influenza HA transcript quantity, suggesting that caspase-1 may be a 
determinate of viral replication. Previous studies have shown that Casp1-/- mice infected in vivo 
with IAV had reduced quantities of innate immune cytokines and chemokines in the 
bronchoalveolar lavage, which correlated with increased severity of pneumonia and mortality 
(44). In contrast to our study, this study did not detect a difference in lung viral titers measured at 
3 or 6 days post-IAV infection. Thus, though caspase-1 appears important for IAV-induced 
expression and secretion of cytokines and chemokines, caspase-1 involvement in viral replication 
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remains unclear. Notably, the Casp-1 -/- mouse model also harbors a mutation in the Casp11 
gene, rendering the mice Casp1/Casp11 double knockouts (48). Our findings in HBEC show that 
expression of caspase-4 (the human homolog of caspase-11) is up-regulated following IAV 
infection. Future studies are necessary to delineate the functions of caspase-1 and caspase-4 in 
antiviral response. 
Though our results suggest that caspase-1 is important for the innate immune response to 
IAV, whether caspase-1 activity is related to inflammasome complex formation remains unclear.  
We were unable to detect expression of many NOD-like receptors by the qRT-PCR array, 
including NLRP3, which was previously shown to be expressed in AECs following IAV 
infection (21, 44). While protein expression cannot be excluded, these results indicate that, in 
AECs, the NLRP3 inflammasome may play a less prominent role than caspase-1 and other 
complexes in the response to IAV. 
Our findings suggest that HBEC from asthmatics have an enhanced innate immune 
response to IAV infection. We found that HBEC from asthmatics had baseline and virus-induced 
differences in gene expression, and that enhanced innate immune gene expression correlated 
with viral replication. However, we found no overall differences in viral replication. These 
findings are consistent with a recent genome-wide expression study demonstrating that HBEC 
from asthmatics have many baseline differences in gene expression also present in cells with RV 
infection (16).  Yet, this study and others using HBEC have shown either enhanced or no 
difference in RV replication in asthmatics compared to non-asthmatics (16, 17, 54). Therefore, 
HBEC from asthmatics may not necessarily have a more severe viral load, but rather a more 
sensitive and severe innate immune response, contributing to airway inflammation and 
pathogenesis. 
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Collectively, our results demonstrate that caspase-1 is important for the AEC innate 
immune response to IAV infection, which is enhanced in HBEC from asthmatics. Similar to 
other studies, our findings suggest that caspase-1 regulates the expression and secretion of 
cytokines besides IL-1β and IL-18, and thus may have other non-inflammasome related 
functions contributing to innate immunity (44). Since viral infections are the leading cause of 
asthma exacerbations, understanding the contribution of modified innate immune mechanisms to 
asthma pathogenesis is essential for the development of relevant therapies.  
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Table 2.1 Subject Characteristics 
  
SUBJECT 
NUMBER 
AGE SEX RACE SKIN TEST HISTORY 
OF 
ASTHMA 
HISTORY OF 
ALLERGIES 
1 25 F W POSITIVE-+7 Y-MILD Y 
2 27 F W POSITIVE-+5 Y-MILD Y 
3 26 F B POSITIVE-+4 Y-MILD Y 
4 32 F H POSITIVE-+2 Y-MOD Y 
5 22 M W POSITIVE-+9 Y-MILD Y 
6 30 M W NOT DONE Y-MILD Y 
7 22 F H POSITIVE-+3 Y-MILD NO 
8 20 M B POSITIVE-+4 Y-MILD Y 
9 23 M W POSITIVE-+5 Y-MILD Y 
10 26 F MULTI POSITIVE-+2 Y-MILD NO 
11 23 M W NOT DONE Y-MILD Y 
12 22 F W POSITIVE-+4 Y-MILD Y 
13 21 M H POSITIVE-+3 Y-MILD Y 
14 24 M W POSITIVE-+3 NO NO 
15 20 M W POSITIVE-+8 NO NO 
16 22 F W NEGATIVE NO NO 
17 20 F W NOT DONE NO Y 
18 38 M W NOT DONE NO Y 
19 21 F B NEGATIVE NO NO 
20 31 M B POSITIVE-+9 NO Y 
21 24 M W POSITIVE-+2 NO Y 
22 22 F W NEGATIVE NO NO 
23 19 M B NOT DONE NO NO 
24 23 M W NOT DONE NO NO 
Sex: F= female; M= male 
Race: W=white; B= black; H=Hispanic; MULTI= multiple races 
Skin test: If positive, the number of antigens the subject was sensitive to is listed. 
History of asthma symptoms; Y= yes; MILD= history of mild symptoms; MOD= history of 
moderate symptoms 
History of allergy symptoms; Y=yes 
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Table 2.2 Summary of subject characteristics 
 
 
Parameter Non-asthmatic Asthmatic 
Age (years) 24.54 24.77 
Sex (n; female/male) 4/7 7/6 
Race (n; black (B)/white (W)/Hispanic (H)/multi 
(M)) 3B/9W/0H/0M 2B/7W/3H/1M 
Postive Allergy skin prick test or history of allergic 
rhinitis (% yes) 54.5% 100% 
History of asthma symptoms (% yes) 0 % 100%* 
*All subjects were considered "mild asthmatics" except for one, which was 
characterized as "moderate asthmatic" due to use of oral steroids. 
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Table 2.3 Antigens for allergy skin test 
 
Antigens for allergy skin test 
Mite Pteronyssinus 
Mite Farinae 
Cockroach 
Tree Mix (GS) 10 
Grass Mis (GS) 7 
Weed 
Mold #1 
Mold#2 
Cat 
Guinea Pig 
Rabbit 
Dog 
Rat 
Mouse 
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Table 2.4 Cytokine levels and Influenza HA mRNA 6 hours post-IAV infection 
 
Cytokine levels and Influenza HA mRNA 6 hours post-IAV infection 
Subject # Asthma IL-1β pg/ml IL-6 pg/ml TNFα pg/ml HA mRNA (2^
-ΔΔCt
) 
1 Y 0.5 276.8 6.1 15.8 
2 Y 0.6 572.6 11.5 9.6 
3 Y 0.8 190.0 7.1 3.1 
4 Y 0.9 417.7 3.8 0.3 
5 Y 1.9 394.5 5.1 0.7 
6 Y 1.3 224.8 10.6 0.3 
8 Y 1.3 81.5 2.9 1.1 
14 N 0.0 19.4 0.4 1.2 
15 N 0.0 13.2 0.2 0.4 
16 N 0.0 19.3 0.2 0.3 
17 N 0.2 69.7 2.0 1.1 
18 N 0.0 1.0 0.1 1.0 
19 N 0.0 4.2 0.1 2.1 
20 N 0.0 0.4 0.2 0.4 
21 N 0.1 15.5 0.3 0.8 
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Table 2.5 Cytokine levels and Influenza HA mRNA 24 hours post-IAV infection 
  
Cytokine levels and Influenza HA mRNA 24 hours post-IAV infection 
Subject # Asthma IL-1β pg/ml IL-6 pg/ml TNFα pg/ml HA mRNA (2^
-ΔΔCt
) 
1 Y 5.8 5732.7 354.6 2824.9 
2 Y 12.8 7325.3 435.0 2115.8 
3 Y 2.5 1316.9 17.7 434.4 
4 Y 5.0 1684.7 6.7 60.4 
5 Y 11.7 3858.4 24.9 322.5 
6 Y 2.3 1126.6 8.6 109.2 
8 Y 1.1 193.6 20.6 282.5 
14 N 0.2 135.4 2.0 124.9 
15 N 0.2 24.4 0.3 55.6 
16 N 0.5 150.1 1.7 20.5 
17 N 0.9 677.3 14.7 250.4 
18 N 0.1 32.0 0.5 92.2 
19 N 0.9 385.3 2.5 1169.0 
20 N 0.4 15.0 1.6 41.2 
21 N 2.3 71.1 1.0 90.6 
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Table 2.6 Genes with significantly different expression in HBEC from asthmatics vs. non-
asthmatics at baseline (control treatment) and 24 hours post-IAV infection 
Gene 
Symbol Gene Name 
Average 
Non-
Asthmati
c 
2
-ΔΔCt 1 
Average 
Asthmatic 
2
-ΔΔCt 1
 
Averag
e FD
3
 
p-
value
2
 
Baseline (control treatment)    
BCL2 B-cell CLL/lymphoma 2 0.89 0.33 0.39 0.050 
CCL5 Chemokine (C-C motif) ligand 5 0.68 3.04 4.50 0.002 
IRAK1 Interleukin-1 receptor-associated 
kinase 1 
1.23 0.60 0.49 0.050 
MAP3K7IP
1 
Mitogen-activated protein kinase 
kinase kinase 7 interacting protein 
1 
0.96 0.63 0.66 0.050 
MAPK13 Mitogen-activated protein kinase 
13 
1.12 0.54 0.48 0.050 
NFKBIB Nuclear factor of kappa light 
polypeptide gene enhancer in B-
cells inhibitor, β 
1.14 0.61 0.54 0.050 
NLRP1 NLR family, pyrin domain 
containing 1 
1.49 0.67 0.45 0.050 
PYCARD PYD and CARD domain 
containing 
1.15 0.65 0.57 0.050 
24 hours post- IAV infection    
BIRC2 Baculoviral IAP repeat-containing 
2 
0.88 2.41 2.75 0.002 
BIRC3 Baculoviral IAP repeat-containing 
3 
0.56 4.89 8.72 0.002 
CASP1 Caspase 1, apoptosis-related 
cysteine peptidase (interlekin 1β, 
convertase) 
0.75 2.16 2.86 0.002 
CASP4 Caspase 4, apoptosis-relted 
cysteine peptidase 
0.73 1.85 2.54 0.002 
CASP5 Caspase 5, apoptosis-related 
cysteine peptidase 
0.60 10.90 18.13 0.002 
CCL5 Chemokine (C-C motif) ligand 5 0.38 5.56 14.80 0.002 
CFLAR CASP8 and FADD-like apoptosis 
regulator 
1.19 3.11 2.61 0.002 
IL12A Interleukin 12A  0.42 3.44 8.29 0.002 
IRF1 Interferon regulatory factor 1 0.74 1.51 2.04 0.002 
IRF2 Interferon regulatory factor 2 1.04 1.84 1.77 0.002 
MYD88 Myeloid differentiation primary 0.84 1.67 1.99 0.002 
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response gene (88) 
NLRC5 NLR family, CARD domain 
containing 5 
0.65 1.49 2.30 0.002 
NOD2 Nucleotide-binding 
oligomerization domain containing 
2 
0.92 2.48 2.71 0.002 
PANX1 Pannexin 1 0.95 2.92 3.07 0.002 
RIPK2 Receptor-interacting serine-
threonine kinase 2 
0.71 3.14 4.44 0.002 
TNF Tumor necrosis factor (TNF 
superfamily, member 2) 
0.55 7.67 13.86 0.002 
TXNIP Thioredoxin interacting protein 0.94 1.62 1.73 0.002 
IAV, influenza A virus; HBEC, human bronchial epithelial cell; FD, fold difference 
1. Differences in gene expression between HBEC from asthmatics (n=3) and non-
asthmatics (n=3) were determined using the ΔΔCt method. 2
-ΔΔCt
 represents the fold 
change in gene expression. 
2. Significantly different gene expression (p ≤ 0.05) was determined using signal-to-
noise ratio (SNR) analysis.  
3. The fold difference (FD) in expression between HBEC from asthmatics and non-
asthmatics was determined by dividing the average asthmatic 2
-ΔΔCt
 by the average 
non-asthmatic 2
-ΔΔCt 
. Only genes with greater than 1.5 times higher or lower 
expression were considered “significantly different.”  
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Table 2.7. Full inflammasome array results at baseline (A) and 24 hours after IAV infection (B) 
Table 2.7.A. Baseline (2
-ΔΔCt
) Differences between HBEC from asthmatics  vs. 
Non-asthmatics 
Gene 
Symbol 
Average  2
-ΔΔCt
 
Non-Asthmatic 
baseline
1
 
Average  2
-ΔΔCt 
Asthmatic 
baseline 
1
 
Fold Difference 
(Asthmatic/Non-
Asthmatic)
2
 p-value
3
  
AIM2 0.401 0.057 0.142 0.096 
BCL2 0.885 0.326 0.368 0.050 
BCL2L1 0.946 1.022 1.081 0.703 
BIRC2 0.878 0.995 1.134 0.373 
BIRC3 0.588 1.220 2.076 0.060 
CARD18 8.844 8.041 0.909 0.902 
CARD6 1.118 1.164 1.041 0.699 
CASP1 1.084 1.026 0.946 0.920 
CASP4 0.964 1.063 1.102 0.435 
CASP5 0.409 1.607 3.926 0.190 
CASP8 1.446 1.187 0.821 0.633 
CCL2 0.546 1.538 2.815 0.513 
CCL5 0.675 3.040 4.503 0.002 
CCL7 ND ND N/A N/A 
CD40LG ND ND N/A N/A 
CFLAR 1.141 1.453 1.274 0.174 
CHUK 1.033 0.866 0.838 0.607 
CIITA 0.767 0.597 0.779 0.401 
CTSB 0.748 0.801 1.071 0.856 
CXCL1 0.588 0.917 1.560 0.427 
CXCL2 1.322 1.558 1.179 0.687 
FADD 1.116 0.801 0.718 0.341 
HSP90AA1 1.080 1.242 1.150 0.463 
HSP90AB1 1.086 0.987 0.908 0.216 
HSP90B1 0.855 1.011 1.183 0.174 
IFNB1 28.402 25.254 0.889 0.962 
IFNG ND ND N/A N/A 
IKBKB 0.872 0.668 0.765 0.250 
IKBKG 1.212 0.815 0.673 0.148 
IL12A 0.565 1.672 2.959 0.060 
IL12B 5.088 0.697 0.137 0.709 
IL18 0.905 0.760 0.840 0.250 
IL1B 1.699 3.003 1.767 0.148 
IL33 2.004 3.417 1.705 0.391 
IL6 47.578 858.135 18.036 0.070 
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IRAK1 1.227 0.602 0.491 0.050 
IRF1 0.762 0.724 0.950 0.872 
IRF2 0.940 0.768 0.817 0.216 
MAP3K7 0.862 0.986 1.144 0.649 
MAP3K7IP1 0.955 0.628 0.657 0.050 
MAP3K7IP2 0.933 0.825 0.884 0.721 
MAPK1 1.051 0.774 0.737 0.204 
MAPK11 0.864 0.668 0.773 0.250 
MAPK12 0.861 0.954 1.108 0.782 
MAPK13 1.123 0.538 0.479 0.050 
MAPK3 0.999 0.728 0.729 0.050 
MAPK8 0.940 1.081 1.151 0.449 
MAPK9 0.826 0.691 0.836 0.479 
MEFV ND ND N/A N/A 
MYD88 1.459 1.010 0.693 0.162 
NAIP 0.963 1.272 1.320 0.387 
NFKB1 0.821 0.603 0.734 0.216 
NFKBIA 0.924 0.773 0.836 0.152 
NFKBIB 1.141 0.614 0.538 0.050 
NLRC4 0.811 0.404 0.499 0.176 
NLRC5 0.942 1.146 1.217 0.683 
NLRP1 1.491 0.673 0.451 0.050 
NLRP12 ND ND N/A N/A 
NLRP3 ND ND N/A N/A 
NLRP4 ND ND N/A N/A 
NLRP5 ND ND N/A N/A 
NLRP6 1.276 2.103 1.648 0.230 
NLRP9 1.134 1.064 0.938 0.958 
NLRX1 1.179 0.830 0.704 0.150 
NOD2 1.859 1.052 0.566 0.172 
P2RX7 7.281 3.149 0.432 0.405 
PANX1 0.904 0.845 0.936 0.733 
PEA15 1.474 0.930 0.631 0.108 
PSTPIP1 0.907 0.597 0.659 0.192 
PTGS2 0.710 1.970 2.775 0.269 
PYCARD 1.150 0.651 0.566 0.050 
PYDC1 0.902 1.369 1.517 0.228 
RAGE 0.949 0.897 0.945 0.954 
RELA 1.036 0.711 0.686 0.050 
RIPK2 0.790 0.784 0.993 0.924 
SUGT1 1.178 1.104 0.937 0.856 
TIRAP 0.820 0.471 0.574 0.150 
TNF 29.599 97.748 3.302 0.297 
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TNFSF11 1.107 1.587 1.434 0.667 
TNFSF14 0.624 1.667 2.673 0.202 
TNFSF4 0.570 0.337 0.591 0.323 
TRAF6 0.959 0.664 0.692 0.257 
TXNIP 0.895 0.709 0.792 0.303 
XIAP 0.946 0.799 0.844 0.411 
ND= not detectable, all subjects had Ct>35 or "undetermined" 
N/A=  not applicable because gene expression was not detectable 
IAV, influenza A virus; HBEC, human bronchial epithelial cells 
     Table 2.7.B 24 hours post-IAV infection differences  (2
-ΔΔCt
) HBEC from 
asthmatics vs. non-asthmatics 
Gene 
Symbol 
Average  2
-ΔΔCt
 
Non-Asthmatic 
IAV 24hr
1
 
Average  2
-ΔΔCt 
Asthmatic IAV 
24hr 
1
 
Fold Difference 
(Asthmatic/Non-
Asthmatic)
2
 p-value
3
  
AIM2 0.45 2.25 5.01 0.162 
BCL2 1.09 0.94 0.86 0.978 
BCL2L1 1.07 0.92 0.86 0.994 
BIRC2 0.88 2.41 2.75 0.002 
BIRC3 0.56 4.89 8.72 0.002 
CARD18 13.91 13.87 1.00 0.643 
CARD6 0.91 0.90 0.99 0.886 
CASP1 0.75 2.16 2.86 0.002 
CASP4 0.73 1.85 2.54 0.002 
CASP5 0.60 10.90 18.13 0.002 
CASP8 0.54 0.94 1.75 0.707 
CCL2 0.50 8.48 17.08 0.527 
CCL5 0.38 5.56 14.80 0.002 
CCL7 ND ND N/A N/A 
CD40LG ND ND N/A N/A 
CFLAR 1.19 3.11 2.61 0.002 
CHUK 0.76 0.49 0.65 0.655 
CIITA 0.98 1.24 1.26 0.601 
CTSB 0.76 0.63 0.83 0.667 
CXCL1 0.67 1.11 1.67 0.343 
CXCL2 1.06 2.55 2.40 0.343 
FADD 0.94 0.72 0.77 0.421 
HSP90AA1 1.09 1.09 1.00 0.601 
HSP90AB1 1.41 1.05 0.74 0.581 
HSP90B1 1.07 1.39 1.30 0.198 
IFNB1 0.37 4.56 12.25 0.162 
IFNG ND ND N/A N/A 
IKBKB 0.73 0.51 0.70 0.655 
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IKBKG 1.72 1.01 0.59 0.397 
IL12A 0.42 3.44 8.29 0.002 
IL12B 0.36 2.02 5.69 0.162 
IL18 0.83 0.72 0.87 0.794 
IL1B 0.88 2.38 2.69 0.184 
IL33 8.21 19.97 2.43 0.184 
IL6 0.41 12.01 29.47 0.162 
IRAK1 1.44 0.49 0.34 0.238 
IRF1 0.74 1.51 2.04 0.002 
IRF2 1.04 1.84 1.77 0.002 
MAP3K7 1.24 1.31 1.06 0.379 
MAP3K7IP1 1.86 1.00 0.54 0.397 
MAP3K7IP2 0.96 1.23 1.28 0.379 
MAPK1 1.23 1.08 0.88 0.812 
MAPK11 1.80 1.08 0.60 0.567 
MAPK12 1.19 0.81 0.68 0.603 
MAPK13 1.08 0.56 0.52 0.421 
MAPK3 0.96 0.68 0.71 0.581 
MAPK8 1.17 1.17 1.00 0.812 
MAPK9 0.84 0.63 0.75 0.655 
MEFV ND ND N/A N/A 
MYD88 0.84 1.67 1.99 0.002 
NAIP 1.31 1.46 1.12 0.944 
NFKB1 0.73 0.96 1.32 0.537 
NFKBIA 0.74 1.72 2.34 0.343 
NFKBIB 1.93 1.60 0.83 0.812 
NLRC4 0.93 1.67 1.79 0.343 
NLRC5 0.65 1.49 2.30 0.002 
NLRP1 1.45 1.05 0.72 0.567 
NLRP12 ND ND N/A N/A 
NLRP3 ND ND N/A N/A 
NLRP4 ND ND N/A N/A 
NLRP5 ND ND N/A N/A 
NLRP6 0.71 3.65 5.18 0.345 
NLRP9 1.02 1.27 1.25 0.343 
NLRX1 1.38 0.83 0.60 0.581 
NOD2 0.92 2.48 2.71 0.002 
P2RX7 0.75 0.57 0.76 0.974 
PANX1 0.95 2.92 3.07 0.002 
PEA15 1.44 0.90 0.63 0.397 
PSTPIP1 3.81 3.69 0.97 0.643 
PTGS2 0.71 3.28 4.59 0.343 
PYCARD 0.95 0.84 0.88 0.994 
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PYDC1 0.93 1.02 1.09 0.002 
RAGE 1.27 1.16 0.91 0.956 
RELA 1.13 1.51 1.34 0.002 
RIPK2 0.71 3.14 4.44 0.002 
SUGT1 1.42 1.13 0.80 0.812 
TIRAP 1.14 0.74 0.65 0.812 
TNF 0.55 7.67 13.86 0.002 
TNFSF11 0.85 3.53 4.14 0.527 
TNFSF14 0.91 3.43 3.78 0.345 
TNFSF4 5.29 2.93 0.55 0.784 
TRAF6 0.76 0.72 0.94 0.902 
TXNIP 0.94 1.62 1.73 0.002 
XIAP 1.02 1.58 1.54 0.184 
ND= not detectable, all subjects had Ct>35 or "undetermined" 
N/A=  not applicable because gene expression was not detectable 
IAV, influenza A virus; HBEC, human bronchial epithelial cells 
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Figure 2.1. HBEC from asthmatics have enhanced production of pro-inflammatory 
cytokines in response to IAV infection.  Apical washes from HBEC from asthmatics (n=7) and 
non-asthmatics (n=8) were collected 6 or 24 hours post-IAV infection or 24 hours HBSS control 
treatment and analyzed for (A) IL-1β; (B) IL-6; and (C) TNFα concentrations by ELISA.  
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Figure 2.2. Gene- specific qRT-PCR confirmation of inflammasome-related gene 
expression. Total RNA from HBEC from asthmatics (n=7) and non-asthmatics (n=8) at 6 or 24 
hours post-IAV infection or 24 hours HBSS control treatment was analyzed for expression of (A) 
CASP1; (B) PYCARD; (C) CASP4; (D) NOD2; (E) NLRC5; and (F) RIPK2 by qRT-PCR. Ct 
values were normalized to β-actin.  
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Figure 2.3. Caspase-1 and PYCARD co-localize with IAV-infection. HBEC from (A) 
asthmatics and (B) non-asthmatics 6 or 24 hours post-IAV infection or HBSS control treatment 
were probed for Caspase-1 (red) and PYCARD (green). DAPI stain identified nucleic acid 
(blue). Images are representative of 3 asthmatic and 3 non-asthmatic isolates. White bars=10μm. 
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Figure 2.4. Additional immunofluorescence images of caspase-1 and PYCARD localization. 
HBEC from (A) asthmatic and (B) non-asthmatic 24 hours post-IAV infection or HBSS control 
treatment were probed for Caspase-1 (red) and PYCARD (green). DAPI stain identified nucleic 
acid (blue).  
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Figure 2.5. 3-dimensional and side view of caspase-1 and PYCARD localization. HBEC 
from an (A) asthmatic and (B) non-asthmatic  24 hours post-IAV infection were probed for 
Caspase-1 (red) and PYCARD (green). DAPI stain identified nucleic acid (blue). Images show 
3-dimensional and side views of the z-stacks that were used to create the compressed images 
corresponding with images from Figure 2.3. 
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Figure 2.6. HBEC from asthmatics and non-asthmatics have similar levels of cytotoxicity. 
Supernatants from HBEC from asthmatics (n=4-5) and non-asthmatics (n=6) were assessed for 
LDH quantities as a measure of cytotoxicity. No statistical differences were detected. 
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Figure 2.7. HBEC from asthmatics have enhanced expression of antiviral genes. Total RNA 
from HBEC from asthmatics ( n=7) and non-asthmatics ( n=8) at 6 or 24 hours post-IAV 
infection or 24 hours HBSS control treatment was analyzed for expression of (A) IFNβ; (B) IP-
10; and (C) RIG-I by qRT-PCR. Ct values were normalized to β-actin. 
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Figure 2.8. Viral replication is not significantly increased in HBEC from asthmatics. (A) 
Total RNA from IAV-infected HBEC from asthmatics (n=7) and non-asthmatics (n=8) were 
analyzed for IAV hemagglutinin (HA) RNA by qRT-PCR. Ct values were normalized to β-actin. 
(B) Vial titer of apical washes from HBEC from asthmatics (n=4-5) and non-asthmatics (n=6) at 
6 and 24 hours post-IAV infection. 
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Figure 2.9. Correlation between expression of innate immune genes and quantity of 
influenza HA transcripts. Total RNA was isolated from HBEC from asthmatics  (n=7) and 
non-asthmatics (n=8). Data were analyzed for correlation between influenza HA and (A) IP-10, 
(B) RIG-I(C) IFNβ, and (D) CASP1 using Pearson’s correlation test (p-value, **p<0.01, 
***p<0.001) and linear regression (r
2
 value). 
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Figure 2.10. Casp1
-/-  
MTEC have diminished antiviral gene expression in response to IAV 
infection. RNA from wild type (n=8) and Casp1 -/- (n=9) MTEC 24 hours post-IAV infection or 
control were analyzed for expression of (A) IFNα; (B) IFNβ; (C) RIG-I; (D) IL-6; (E) IP-10 by 
qRT-PCR. Ct values were normalized to β-actin. @  p<0.05 Student’s T-test Casp1 -/- vs. wild 
type, 24hrs post-IAV infection only; * p<0.05, **p<0.01; ***p<0.001 ANOVA and Tukey post-
hoc test, Casp1 -/-  vs. wild type 24hrs post-IAV and control infection; ##p<0.01, ### p<0.001 
Factorial ANOVA, interaction between genotype and infection.  
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Figure 2.11. Casp1
-/-
 MTEC have diminished viral replication. (A) Total RNA from Casp1 -/- 
(n=9) and wild type (n=8) MTEC 24 hours post-IAV infection or media control treatment were 
analyzed for IAV matrix 1 (M1) RNA by qRT-PCR. Ct values were normalized to β-actin. (B) 
Vial titer was assessed using media supernatents from Casp1 -/- (n=9) and wild type (n=8) 
MTEC 24 hours post-IAV infection. 
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Figure 2.12 Viral replication is necessary for the reduced innate immune response in Casp1
-
/-
 MTEC. MTEC were infected with wild type IAV (wt IAV) or   UV-inactivated IAV (UV20 
IAV) for 24 hours. Total RNA was isolated from Casp1 -/- (n=6) and WT (n=6) MTEC and 
probed for (A) M1 and (B) IP-10 expression by qRT-PCR. 
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Chapter 3: Caspase-1 deficiency modifies in vivo development of house dust mite-induced 
allergic airway disease
1,23
 
3.1 Introduction 
Asthma is a chronic inflammatory disorder of the conducting airways that is associated 
with airflow obstruction and airway hyperresponsiveness (AHR) (1). The incidence of asthma 
has increased significantly over the past 50 years, which may be attributed to changes in 
urbanization, diet, and lifestyle (1, 2). Despite the increasing prevalence of asthma, the genetic 
and environmental factors that contribute to the development asthma remain unclear (3). Since 
allergic asthma is the most prevalent form of the disease, several murine models of allergic 
asthma have been developed to investigate the specific mechanisms contributing to the 
development and pathophysiology of asthma (4). The most common approaches to mimic 
allergen-induced lung inflammation in mice consist of sensitization with ovalbumin (OVA) 
with/or without an adjuvant such as Alum or sensitization to house dust mite (HDM) antigen (4).  
Airway inflammation and type 2 helper (Th2) T lymphocyte-mediated adaptive immunity 
to an innocuous antigen are key characteristics of atopic asthma (5). More recently, the role of 
the innate immune system in the initiation and propagation of Th2 responses has received 
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increased attention (1). Both innate structural cells, including airway epithelial cells, and 
inflammatory cells, such as mast cells and dendritic cells (DC), are now considered important 
contributors to the induction and maintenance of Th2 lymphocyte-mediated immune responses 
(6, 7). Initiation of atopic asthma is thought to begin with sensitization of the airway to allergens 
such as HDM, animal dander, or pollen, through enzymatic activity of the allergen (e.g. 
proteases found in some HDM) that activate protease-activated receptors and/or though 
recognition by innate pattern recognition receptors (PRRs) such as the toll-like receptors (TLRs) 
(7, 8). DC in the airway recognize, process, and present the antigen to T lymphocytes in the 
lymph node (7). Additionally, activation of PRRs on epithelial cells and other innate immune 
cells in the airway causes the release of cytokines, including granulocyte-macrophage colony 
stimulating factor (GM-CSF), interleukin (IL)-33 and thymic stromal lymphoprotein (TLSP), 
that prime DC and promote Th2 cell differentiation (9). Th2 lymphocytes produce cytokines 
such as IL-4, IL-5, and IL-13 that drive allergic inflammation, including B cell isotype switching 
to IgE synthesis and recruitment or activation of mast cells, eosinophils, and basophils (1).  
Considering the important role of innate immune receptors in allergen sensitization, a 
number of studies have investigated the specific contribution of PRRs to the initiation of allergic 
airway inflammation. Previous studies have indicated that mice deficient in TLR4 or its adaptor 
molecule MyD88 have reduced HDM-induced allergic inflammation (9-11). Yet, further 
analyses indicate the necessity for MyD88 in asthma development may be dependent on HDM 
sensitization, as some studies that sensitized mice using OVA with an adjuvant via 
intraperitoneal injection did not observe MyD88-dependent allergic inflammation (12, 13).  
Additionally, the nucleotide-binding domain leucine-rich repeat-containing receptor (NLR) 
family of PRRs may also contribute to the development of asthma. Several NLRs can form 
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inflammatory signaling complexes called inflammasomes that consist of an adaptor protein 
(PYCARD) and the protease caspase-1 (14). Upon formation of the inflammasome, caspase-1 
becomes active and then cleaves pro-IL-1β and pro-IL-18 to their active forms. IL-1β has been 
proposed to promote Th2 cell proliferation (15), and IL-18, though typically associated with Th1 
responses, may also enhance IgE production (16).  Of all of the NLRs, the NLRP3 
inflammasome has been most investigated as a mediator of asthma development due to its ability 
to respond to many PAMPs and DAMPs associated with allergic inflammation, such as uric acid, 
alum, ATP, and several bacterial and viral species (12, 13, 17, 18). However, involvement of 
NLRP3 in asthma pathogenesis is controversial. A recent exhaustive study of several murine 
models of asthma in Nlrp3
-/- 
mice could not confirm a role for NLRP3 in the development of 
allergic inflammation (17). Similar to NLRP3 and MyD88, studies investigating IL-1 receptor 
(IL-1R) signaling in murine models of allergic inflammation have also yielded conflicting 
results, suggesting an unclear role for IL-1 axis signaling in the development of allergic 
inflammation  (9, 10, 12, 19). 
 Caspase-1 is a cysteine protease that is activated upon formation of the inflammasome 
complex and thus plays a key role in the innate immune response to a number of viruses, 
bacteria, and DAMPs that can trigger asthma symptoms (20). Beyond IL-1β and IL-18 
processing, caspase-1 has several other functions, including activation of NF-kB (21) , induction 
of a pro-inflammatory form of programmed cell death termed pyroptosis (22), and cleavage of 
several proteins involved in cell death (e.g. caspase-7), glycolysis (e.g. GAPDH and α-enolase), 
and cytoskeletal function (23, 24). Despite the ability of caspase-1 to regulate the innate immune 
response to many sources of asthma exacerbation, the involvement of caspase-1 in asthma 
development is unclear.  Two previous studies have investigated caspase-1 in asthma 
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development: one study used an OVA model with alum adjuvant and found that Casp1
-/- 
mice 
had significantly reduced airway inflammation and OVA- specific IgG1 and IgG2c (13); 
conversely, a second study used a low-level HDM sensitization model and found that Casp1
-/-
 
mice sensitized had similar levels of airway inflammation to wild type mice (9). With these 
studies in mind, we sought to elucidate the role of caspase-1 in the development allergic 
inflammation using a well characterized model of high dose acute HDM sensitization (17, 25, 
26). We found that caspase-1 deficiency reduced AHR in response to methacholine challenge, 
but enhanced neutrophilic airway inflammation, therefor suggesting that caspase-1 may play 
divergent roles in the development of allergic inflammation.  
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3.2 Materials and Methods 
Experimental animals. Adult female C57BL/6  wildtye (WT) and Caspase 1-deficient 
(Casp1
−/−
) mice were purchased from Jackson Laboratories (Bar Harbor, ME) and used at 3 to 4 
months of age. All experiments were conducted on age and sex matched mice. The Casp1
-/-
 
mouse strain has been previously described (27). All experimental procedures were approved by 
the University of North Carolina Institutional Animal Care and Use Committee. Genotypes were 
confirmed by PCR as previously described using the primers: 5’- GCGCCTCCCCTACCCGG-3’ 
(mutant), 5’-GAAGAGATGTTACAGAAGCC-3’ (common), 5’-
CATGCCTGAATAATGATCACC-3’ (wild type).  
Induction of Allergic Airway Inflammation with house dust mite (HDM). Mice were 
anesthesized with isoflurane and treated intranasally to 25μg of HDM (Dermatophagoides 
pteronyssinus 1, Greer Laboratories, Lenoir, NC) in 20μl of sterile PBS (Life Technologies, 
Carlsbad, CA) or 20μl PBS control once a day for 14 consecutive days similar to previous 
studies (17, 25, 26). Mice were harvested 72 hours after the last HDM challenge. Notably, the 
HDM contained 23.01 EU/mg of HDM. See schematic figure 3.1. 
Lung function assessment. Lung function was assessed by the forced oscillation technique 
as previously described (17, 28-30). Briefly, mice anesthetized with pentobarbital sodium were 
tracheostomized and mechanically ventilated using a computer-controlled small animal 
ventilator (flexiVent, Scireq, Montreal, Canada). Mice were treated with aerosolized sterile 
saline or methacholine (Sigma, St. Louis, MO) at increasing doses (10 mg/mL, 20 mg/mL, and 
40 mg/mL) and lung resistance (RL), central airway resistance (Raw), and alveolar tissue 
dampening (G) was measured every 10 seconds. Max values for each methacholine dose were 
graphed.  
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Serum and bronchoalveolar lavage collection. Mice were euthanized and blood was 
collected by cardiac puncture. Serum was separated by centrifugation and stored at -80ᵒC. The 
left mainstem bronchus was clamped and the right lung lobes were lavaged 5 times with 1 mL of 
PBS each time. The right lobe was then removed, flash frozen in liquid nitrogen, and stored for 
protein or RNA isolation. Total cell counts in the lavage fluid of each mouse were obtained using 
a hemacytometer. A 200ul of broncoalveolar lavage (BAL) fluid was centrifuged onto slides 
using a Cytospin (Shandon, Pittsburgh, PA) and stained with Diff -Quik® solution (American 
Scientific, McGraw Park, PA) for cell differential assessment. At least 200 cells were counted 
from each slide and cell counts were adjusted for total cell number. The lavage fluid was 
centrifuged and cell-free BAL fluid was stored at -80°C. 
Immunohistochemistry. The left lung was unclamped and fixed by inflation and 
submersion in 10% formalin (Sigma). The whole lungs were embedded in paraffin and three 5 
μm sections were taken every 100 μm. Histopathology was evaluated using hematoxylin and 
eosin (H&E; Richard Allan, Richland, MI) stained lung sections and scored on a scale of 1 
(none) to 5 (severe) for the following parameters: large airway inflammation, alveolar 
inflammation, perivascular inflammation, and overall impression of severity of disease. Three 
slides from each mouse lung was read by two independent scorers while blinded to genotype and 
treatment. Scores were averaged to generate a semi-quantitative histology score. Mucin 
production and goblet cell metaplasia was assessed by Alcian Blue and Periodic Acid Schiff 
(AB-PAS) staining. For each slide (representing one animal), eight representative images of the 
large airway were acquired at 10x magnification. The percentage of positive PAS stained cells 
within the area of the airway was measured by ImageJ (National Institutes of Health) and a 
computer-based color deconvolution module as previously described (31).  
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Enzyme linked immunosorbent assay (ELISA). Total levels of IgE in the serum were 
assessed using a commercially available kit (Total IgE, BD Biosciences, Franklin Lakes, NJ). 
Lung homogenates were prepared from approximately 100mg snap-frozen lung tissue 
homogenized in HBSS using the Lysing Matrix D tubes (Millipore, Billerica, MA) and the 
Bio101
 
FastPrep system (MP Biomedicals, Santa Ana, CA). Homogenates were centrifuged and 
supernatants were assessed for protein levels. Protein levels of IL-12, KC, IL-1β, IL-5, and IL-10 
were assessed in serum, cell-free BAL fluid supernatants and lung homogenates using 
commercially available ELISAs (Mesoscale Discovery, Rockville, MD). Cytokine levels were 
normalized to mg tissue used for the homogenate. If the majority of samples were below the 
lower limit of detection (LLOD) as indicated in table 3.1, the cytokine was deemed non-
detectable (ND). Otherwise, readings with zero values or that were below LLOD were 
substituted with  
    
√ 
 (32). 
RNA isolation and quantitative real time PCR (qRT-PCR). 100mg of harvested lungs 
were homogenized in Trizol for RNA extraction using Lysing Matrix D tubes (Millipore) and the 
Bio101
® 
FastPrep
® 
system (MP Biomedicals). RNA isolation, first-strand cDNA synthesis, and 
qRT-PCR were performed as previously described (33, 34). Taqman primers for Elane, Ctsg, 
Il1b, and B-actin were commercially available (Applied Biosystems, Life Technologies, 
Carlsbad, CA). Differences in expression were determined using the ∆∆Ct method and B-actin 
for normalization. 
Western Blot. Lung homogenates were assessed for total protein concentrations using a 
Bradford Protein Assay (Bio-Rad Laboratories, Hercules, CA). 50 μg of protein per sample were 
separated by a 15% SDS-PAGE gel and transferred to nitrocellulose membranes (Bio-Rad). 
Proteins were detected with specific antibodies for IL-1β (1:1000) and anti-rabbit horseradish 
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peroxidase (HRP)-conjugated secondary antibody (1:2000) (Santa Cruz Biotechnology, Dallas, 
TX) in 5% milk in 1XTBS-0.05%Tween buffer (Sigma). For loading control, nitrocellulose 
membranes were stripped with Blot Restore (Millipore) and probed for β-Actin (1:5000) and 
anti-mouse HRP-conjugated secondary antibody (1:10,000) (Santa Cruz Biotechnology). 
Proteins were detected using SuperSignal West Pico Chemiluminescent Substrate (Pierce, 
Rockford, IL) and images were acquired with a Fujifilm LAS-3000 imager (Fuji Film Global 
Tokyo, Japan). 
Statistical Analysis. Each experimental group had at 5 to 12 animals. One HDM-
sensitized Casp1
-/-
 mouse was removed from analysis because of low IgE levels, low cytokine 
levels, and low cell counts that suggested the animal was not successfully sensitized to HDM. 
Data was analyzed by factorial ANOVA, followed by Bonferroni post-hoc test to determine 
significant differences among the experimental groups for cell counts, cell differentials, serum 
IgE, lung function, and gene expression analyses. Student’s T-test was used to assess differences 
between HDM-sensitized Casp1
-/-
 and WT mice for histopathology scores and cytokine 
assessment. p < 0.05 was considered statistically significant. Data are shown as mean ± SEM. 
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3.3 Results 
Casp1
-/-
 mice have enhanced airway inflammation with HDM sensitization 
Casp1
-/-
 or wild type (WT) C57Bl/6 mice were sensitized to Dermatophagoides 
pteronyssinus 1(Der p1) HDM or PBS control intranasally once a day for 14 days. 72 hours after 
the last HDM sensitization, the mice were challenged with methacholine for lung function 
assessment and harvested for samples (Figure 3.1). We measured total serum IgE as an indicator 
of allergic inflammation. Our results revealed that HDM-sensitization induced increased serum 
IgE in both Casp1
-/-
 and WT mice, and that there was no significant differences in serum IgE 
between the genotypes (Figure 3.2). 
 In line with previous characterization of the Casp1
-/-
 mouse model, we found that PBS-
treated Casp1
-/- 
and WT mice have similar levels of cellularity in the lung (Figure 3.3) (27, 35). 
With HDM-sensitization, Casp1
-/-
 mice had significantly enhanced inflammatory cell influx in 
the airway compared to WT mice (Figure 3.3A). Further differential analysis revealed that 
Casp1
-/-
 mice had increased airway neutrophils (PMN) with HDM sensitization compared to WT 
(Figure 3.3B). Histological assessment of the lungs indicated that HDM sensitization severely 
increased allergic inflammation in both genotypes. We observed increased inflammation around 
the large airways, alveoli, and blood vessels and damage to the airway in both WT and Casp1
-/-
 
mice (Figure 3.4). Upon further evaluation, histopathology scoring of the lungs revealed that 
HDM-sensitized Casp1
-/-
 mice had a trend for overall increased severity of inflammation in the 
lung compared to HDM-sensitized WT mice (p=0.0525) and significant increases in perivascular 
and alveolar inflammation (Figure 3.5). In summary, our results indicate that the severity of 
HDM-induced inflammation, particularly neutrophilia, was increased in the lungs from Casp1
-/-
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mice, suggesting that caspase-1 is protective against the development of HDM-induced airway 
inflammation.  
Casp1
-/-
 and WT mice have similar levels of HDM-induced goblet cell metaplasia 
Goblet cell metaplasia and increased mucin production are characteristic features of 
allergic airway disease progression in mice that contribute to airway obstruction (36). We 
assessed mucin production and goblet cell numbers by Alcian Blue and Periodic Acid Schiff 
(AB-PAS) staining of the lungs from HDM and PBS-treated WT or Casp1
-/-
 mice. Both Casp1
-/-
 
and WT mice had increased mucin production and goblet cell numbers with HDM sensitization 
(Figure 3.6A). We used a computer-based color deconvolution module to score the average 
percentage of goblet cells (%PAS+ cells) per airway area and found a non-significant trend 
(p=0.108) for increased goblet cell number in the lungs of HDM-sensitized Casp1
-/-
 mice 
compared to WT (Figure 3.6B). These data suggest that caspase-1 does not play a major role in 
determining HDM-induced goblet cell metaplasia. 
HDM-sensitized Casp1
-/-
 mice have increased IL-1β in lung homogenates 
Allergic asthma is often associated with a shift in the balance of Th1 toTh2 cell 
immunity, with increased levels of Th2 cytokines such as IL-4 and IL-5 contributing to a shift 
towards Th2 lymphocyte differentiation (1). We compared levels of several Th1 (IL-1β, 
keratinocyte chemoattractant (KC), total IL-12) and Th2 (IL-4, IL-5, and IL-10) cytokines in 
BAL fluid, lung homogenates, and serum from HDM-sensitized Casp1
-/-
 and WT mice. Our 
results indicate that there were no differences between the genotypes in HDM-induced Th1 and 
Th2 cytokine levels in the BAL fluid or serum (Table 3.1). In the lung homogenate, lungs from 
HDM-sensitized Casp1
-/-
 mice surprisingly had significantly increased levels of IL-1β, but a 
trend for reduced total IL-12 (p=0.07) and no difference in KC levels. IL-1β is produced in a pro- 
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form that must be cleaved by proteases such as caspase-1 or neutrophil elastase before release 
from the cell. We assessed pro-IL-1β (Il1b) gene expression in lung homogenates and found no 
effect of HDM or caspase-1 deficiency Il1b mRNA (Figure 3.7A). We then measured IL-1β 
cleavage in the lung homogenates by western blot and found that Casp1
-/-
 and WT had similar 
levels of pro- and cleaved IL-1β in both PBS and HDM-treated lung homogenates (Figure 3.7B). 
Notably, the lung homogenates used for this analysis had signs of degradation, as evidenced by 
multiple bands detected for the β-actin loading control. Moreover, we assessed gene expression 
of neutrophil elastase (Elane) and cathepsin G (Ctsg), two neutrophil-derived proteases that have 
been previously shown to cleave IL-1β, in the lung homogenates and found no differences in 
expression between HDM-sensitized Casp1
-/-
 or WT mice (Figure 3.8A-B). In summary, we 
found that HDM-sensitized Casp1
-/-
 mice have increased IL-1β in the lung tissue compared to 
WT, but no evidence of increased IL-1β production or processing.  
Casp1
-/-
 mice have reduced HDM-induced airway hyperresponsiveness 
A common characteristic of asthma is increased airway hyperresponsiveness (AHR) to 
inhaled stimuli, which is thought to be related to airway narrowing caused by both inflammation 
and structural changes in the lung (37, 38). Narrowing of the airway is associated with increased 
airway resistance, and can be measured using forced oscillation techniques in mice (30). Using a 
computer-controlled small animal ventilator (flexiVent®), we compared changes in total lung 
resistance (RL), large airway resistance (Raw), and alveolar tissue damping (G, closely related to 
alveolar tissue resistance) in response to the bronchoconstricting agent methacholine between 
PBS or HDM-treated Casp1
-/-
 and WT mice. Our results indicate that Casp1
-/-
 and WT mice have 
similar levels of basal airway resistance in both PBS and HDM-treated groups (Figure 3.9A-C). 
With increasing doses of methacholine, RL, Raw, and G increased in the HDM-sensitized mice, 
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but not in PBS-treated, demonstrating the development of AHR in response to HDM.  At the 
highest does of methacholine (40 mg/mL), HDM-sensitized Casp1
-/-
 had significantly reduced 
RL and Raw compared to HDM-sensitized WT mice. Together these results suggest that caspase-1 
may contribute to development of AHR, despite playing a protective role in HDM-induced 
airway inflammation.  
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3.4 Discussion 
 Given the many functions that caspase-1 plays in innate immunity and the increasing 
appreciation for the role of innate immune pathways in asthma development, we sought to 
determine how caspase-1 contributes to the development of allergic inflammation. We compared 
the development of allergic asthma in caspase-1 deficient (Casp1
-/-
) and wild type (WT) mice 
using an acute model of house dust mite (HDM)-induced allergic inflammation. Our results 
indicate that Casp1
-/-
 mice have enhanced HDM-induced inflammation in the lung, which 
primarily affects perivascular and alveolar tissue and may be mediated by enhanced neutrophilia. 
Surprisingly, we found that Casp1
-/-
 mice have elevated IL-1β in the lung tissue, but we could 
not detect a corresponding increase in Il1b gene expression nor pro-IL-1β cleavage. Finally, our 
results indicate that HDM-sensitized Casp1
-/-
 mice have reduced airway hyperresponsiveness 
(AHR) in response to methacholine challenge compared to WT mice. Together, our results 
indicate that caspase-1 may play a dual role in HDM-induced allergic inflammation, whereby 
caspase-1 is protective against airway inflammation, but contributes to AHR.  
Based on the role of caspase-1 in IL-1β and IL-18 processing and release, and the 
implications for IL-1 signaling in the development of allergic inflammation, we hypothesized 
that caspase-1 deficiency would reduce allergic inflammation in response to HDM-sensitization 
(15). Surprisingly, we observed enhanced airway inflammation and increased levels of IL-1β in 
the lung tissue from HDM-sensitized Casp1
-/-
 mice (Figure 3.3 and Table 3.1). Subsequent 
analysis revealed that there was no effect of HDM-treatment on Il1b gene transcription in either 
genotype (Figure 3.7A). Western blot analysis indicated that HDM and PBS-treated mice of both 
genotypes had similar levels of pro- and cleaved IL-1β, though the lung homogenates used for 
this analysis had signs of degradation (Figure 3.7B). The increased IL-1β may be due to release 
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of intracellular stores from dying or damaged cells, which can then be cleaved by other proteases 
such as neutrophil-derived elastase, cathepsin g, and proteinase-3 and mast cell-derived chymase 
(39-42). Despite elevated levels of neutrophils in the airways of HDM-sensitized Casp1
-/-
 mice, 
we did not detect an associated increase in gene expression of neutrophil elastase (Elane) or 
cathepsin g (Ctsg) (Figure 3.8). Thus, our results indicate that the elevated IL-1β in the lung 
tissue from Casp1
-/-
 mice is likely not due to increased production nor is there is increased 
processing. Future studies will be necessary to determine if the increased IL-1β may be derived 
from pre-existing intracellular stores and how this mechanism contributes to the allergic 
inflammation. 
Beyond the processing of IL-1β and IL-18, proteomic analysis of caspase-1 substrates 
have indicated that caspase-1 regulates activity of a number of proteins necessary for cell 
survival, including proteins involved in metabolism (e.g. GAPDH, α-enolase), cytoskeleton 
function (e.g. γ-actin), and cell death (e.g. caspase-7, Bid) (23, 24). Caspase-1 activity is directly 
linked to induction of a pro-inflammatory form of programmed cell death termed pyroptosis. 
Pyroptotic cell death has been shown in macrophages (and not in neutrophils) and is thought to 
eliminate the intracellular environment necessary for pathogen replication (43). Pyroptosis shares 
several features of apoptosis, including DNA fragmentation, but differs in that the process results 
in lytic release of intracellular contents that must then be cleared by immune cells (22). In 
addition to pyroptosis, caspase-1 has been shown to regulate a number of other forms of cell 
death, including apoptosis (44). For example, caspase-1 inhibition or deficiency is protective 
against septic shock and B cell apoptosis, an effect which was not evident in IL-1β/IL-18 double 
knockout mice (45). Thus, caspase-1 mediated cell death may be a pathway necessary for 
inflammatory cell clearance, and loss of this function could contribute to enhanced inflammatory 
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cell accumulation in response to HDM sensitization. Additionally, caspase-1 is an activator of 
NF-kB, a transcription factor of many genes involved with inflammation and innate immunity 
(23, 24, 46). The loss of caspase-1 mediated NF-kB activation could contribute to an altered 
inflammatory response to HDM. Clearly, future studies are necessary to confirm and delineate 
the mechanisms contributing to caspase-1 protection against HDM-induced allergic 
inflammation. 
Differential analysis of immune cells in the lung revealed that HDM-sensitized Casp1
-/-
 
mice increased numbers of neutrophils in the airway (Figure 3.2). Though airway eosinophilia is 
considered a pathological hallmark of asthma, neutrophils are increasingly recognized as drivers 
of asthma pathogenesis (47). Airway neutrophilia is most commonly observed in patients with 
severe or steroid-resistant asthma or undergoing acute asthma exacerbations (48, 49). 
Neutrophils secrete a variety of cytokines and proteases such as neutrophil derived elastase, 
cathepsin g, and matrix metalloproteinase 9, which are elevated in the airways of asthmatics and 
may contribute to airway remodeling, AHR, and increased mucus production (50, 51, 51, 52). 
Our studies indicate that gene expression of neutrophil elastase and cathepsin G, though 
enhanced by HDM sensitization, were not significantly altered by caspase-1 deficiency (Figure 
3.8). Though it is possible that protein levels or the expression of other proteases, such as matrix 
metalloproteinases, may differ with caspase-1 deficiency, these results suggest that the elevated 
neutrophils in the airways of Casp1
-/-
 mice were not correlated with increased expression of 
certain neutrophil-derived proteases.  
Several studies suggest that neutrophilic and eosinophilic asthma may be driven by 
different subsets of CD4+ T helper lymphocytes. Eosinophilic allergic inflammation is thought 
to be primarily driven by Th2 lymphocytes that produce cytokines such as IL-3, IL-5, and IL-13 
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to promote eosinophil maturation, recruitment, and survival, whereas Th17 lymphocytes produce 
IL-17A that attracts neutrophils to the airway (1, 53, 54). In our study, the levels of Th2 
cytokines IL-4 and IL-5 were very low or non-detectable in the BAL fluid, lung homogenates, 
and serum samples of both genotypes (Table 3.1). Though we did not investigate other Th2-
promoting cytokines, such as IL-13, these results suggest that the acute HDM sensitization did 
not induce Th2-skewed immune responses. The poor Th2 response to HDM sensitization may be 
related to the C57BL/6 mouse strain used for these studies. C57BL/6 mice have been previously 
shown to have Th1-prone inflammatory response and poor development of airway 
hyperresponsiveness, whereas other mouse strains, such as the BALB/c, are Th2-skewed (55-
57). We were able to detect significant levels of KC and IL-12 in the BAL fluid, serum, and lung 
homogenates, and IL-1β in the lung homogenates only. IL-1β in concert with IL-6 has been 
shown to enhance Th17 lymphocyte differentiation, whereas IL-12 inhibits Th17 polarization 
(58). Lung tissue from Casp1
-/-
 mice had significantly elevated IL-1β and a trend for reduced 
total IL-12 (p=0.07), indicating a pro-Th17 milieu in the airways (Table 3.1). Future studies will 
be necessary to assess development of Th17-mediated allergic inflammation in the airways of 
Casp1
-/-
 mice and how this may correlate with airway neutrophilia.  
In opposition to the protective role for caspase-1 in HDM-induced allergic inflammation, 
our results indicate that caspase-1 may promote HDM-induced AHR. Both airway inflammation 
and structural changes of the airway are important contributors to AHR. Th2 lymphocyte 
production of IL-4, IL-5, and IL-13 induce eosinophil and mast cell migration. These cells 
produce pro-inflammatory mediators such as eosinophil granule proteins, chymase, histamine, 
leukotrienes, and cytokines that damage the airway, prime airway smooth muscle (ASM), and 
induce neural pathways leading to bronchoconstriction (59, 60). In addition, structural increases 
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in ASM mass and altered ASM mechanics, as well as extracellular matrix deposition, are 
associated with AHR in asthmatics (38, 61). To determine the effects of caspase-1 deficiency on 
AHR, we used a methacholine challenge to induce bronchonstriction and measured airway 
resistance as an indicator of AHR. Methacholine acts directly on histamine H1 receptors on 
ASM to induce bronchoconstriction, and thus is a better measure of structural ASM changes in 
the lung compared to other agents of provocation such as adenosine monophosphate that act 
indirectly by stimulating inflammatory cells to produce mediators that induce AHR (62). We 
observed that in response to methacholine challenge, HDM-sensitized Casp1
-/-
 mice have 
reduced RL, or total resistance of the lung, suggesting that caspase-1 may contribute to structural 
changes in the lung. Total resistance of the lung (RL) can be partitioned into resistance of the 
large airways (Raw) and resistance from alveolar tissue (G). HDM sensitized Casp1
-/-
 mice had 
reduced Raw, but not G. These results suggest that increased inflammation in the perivascular and 
alveolar tissue of HDM-sensitized Casp1
-/-
 mice was not associated with increased G. We did not 
detect significant differences in inflammation of the larger airways in HDM-sensitized Casp1
-/-
 
mice, indicating that the reduced RL and Raw may be due to structural effects in the large airways. 
A recent study found that caspase-1 was not expressed in tracheal ASM from human donors, 
suggesting that caspase-1 may have an indirect effect on ASM, possibly by altered ASM 
microenvironment, or may contribute to airway remodeling that leads to AHR (63). Future 
studies using chronic HDM sensitization to induce airway remodeling will be necessary to assess 
the contribution of caspase-1 to structural changes of the lung and AHR. 
In this study, we present findings that caspase-1 may play divergent roles in the 
development of high level HDM-induced allergic inflammation, with caspase-1 potentially 
protecting against allergic inflammation, but conversely contributing to AHR. Two previous 
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reports indicate that caspase-1 deficiency either protected against OVA-induced allergic 
inflammation (Eisenbarth et al.) or had no effect on low-level HDM sensitization (Willart et al.). 
Each of these studies used different models of allergen sensitization: Eisenbarth et al. sensitized 
mice with intraperitoneal OVA and an alum adjuvant on day 0 and day 10, intranasally with 
OVA on days 21, 22, and 23, and collected samples on day 25; Willart et al.sensitized mice to 1 
µg intranasal HDM (unspecified type), challenged with 10 µg HDM on days 7-12, and collected 
samples 3 days after the last challenge. In the study presented here, we sensitized mice to 25 μg 
intranasal Der p1 HDM for 14 days, and collected samples 3 days after the last challenge. OVA 
sensitization with an adjuvant has been criticized because OVA is not a natural trigger of asthma 
in humans. Moreover, chronic OVA administration in mice leads to tolerance (4). Conversely, 
HDM is a common allergen that induces asthma symptoms in humans, meaning it is a more 
relevant model allergen for sensitization (64). Additionally, long-term administration of HDM 
can mimic some aspects of chronic asthma and airway remodeling (4). However, commercial 
HDM extracts can vary considerably in preparation and composition, including marked 
differences in endotoxin content (65). Thus, the differences between OVA and HDM, 
sensitization protocols, and HDM preparation may significantly contribute to the variable 
findings of Casp1
-/-
 allergic sensitization in different studies. 
A shortcoming of this and most previous Casp1
-/-
  studies is the recent revelation that the 
commonly used Casp1
-/-
 mouse model also harbors a deficiency in caspase-11 (Casp11), the 
ortholog of human caspase-4 and caspase-5, due to a mutation in 129 mice that was backcrossed 
into the C57BL/6 Casp1
-/-
 mouse strain (66, 67). A recent study showed that most of the known 
inflammasome agonists, such as ATP, dsDNA, flagellin, and monosodium urate, activate 
inflammasome signaling and caspase-1-mediated IL-1β secretion independently of caspase-11 
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(66). However, caspase-11 deficiency, but not caspase-1 deficiency, was protective against 
endotoxic shock, suggesting that early reports that Casp1
-/-
 mice were protected from endotoxic 
shock were due to an unidentified deficiency in caspase-11 (66, 68). Moreover, caspase-11 can 
signal independently of NLRP3 and caspase-1 to induce a form of cell death similar to 
pyroptosis (69). Thus, caspase-11 and caspase-1 have non-redundant functions, and future 
studies will be necessary to delineate the true effects of caspase-1 deficiency on the development 
of allergic inflammation.  
In summary, the data presented here indicates that caspase-1 protects against the 
development of allergic inflammation, but contributes to AHR with high dose HDM-
sensitization. However, these findings are preliminary and future studies will be necessary to 
better characterize the inflammatory cells and T cell subtypes, assess inflammatory cell death 
and clearance, and determine the contribution of caspase-1 to structural changes in the lung. 
Though we believe that this data may indicate a role for caspase-1 in the development of allergic 
sensitization, this effect may be of even greater significance during asthma exacerbation. We 
have previously shown that caspase-1 expression is enhanced in bronchial epithelial cells from 
asthmatic volunteers following influenza infection, suggesting that caspase-1 may contribute to 
virus-induced asthma exacerbation (70). Moreover, viral infections early in life have been 
previously associated with the development of asthma (71, 72). Given the important role of 
caspase-1 in the response to a number of viruses, bacteria, pollutants, and DAMPs that can 
induce and exacerbate asthma, understanding the contribution of caspase-1 to asthma 
development and exacerbation will ultimately better our understanding of asthma pathogenesis.   
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Table 3.1. Summary of cytokine levels in bronchoalveolar lavage fluid (BAL) fluid, lung 
homogenate, and serum.  
 
 Total IL-12 KC IL-1β IL-5 IL-10 
BAL fluid (pg/mL) 
WT HDM 298.9 ± 106.3 
(n=10) 
16.30 ± 4.554 
(n=10) ND ND ND 
Casp1 -/- 
HDM 
275.8  ± 79.07 
(n=6)  
17.43 ± 4.537 
(n=6) ND ND ND 
P-value 
0.8810 0.5662 N/A N/A N/A 
Lung homogenate (pg/100mg tissue) 
WT HDM 572.0 ± 183.9  
(n=10) 
38.98 ± 8.780  
(n=10) 
3.550 ± 1.437  
(n=10) ND ND 
Casp1 -/- 
HDM 
100.6 ± 38.58  
(n=6) 
53.08 ± 22.81  
(n=6) 
17.80 ± 7.856  
(n=6) ND ND 
P-value 
0.0723 0.5073 0.0382* N/A N/A 
Serum (pg/mL) 
WT HDM 853.4 ± 187.4  
(n=10) 
47.16 ± 7.612  
(n=10) ND 
4.390 ± 1.506  
(n=10) 
28.56 ± 11.99 
(n=10) 
Casp1 -/- 
HDM 
851.1 ± 214.9  
(n=6)  
62.68 ± 6.931  
(n=6)  ND 
2.940 ± 0.9622 
 (n=6)  
9.997 ± 1.645 
(n=6)  
P-value 
0.9940 0.1897 N/A 0.5018 0.2333 
LLOD 
(pg/ml) 5.3 2.9 2.1 0.7 11 
Lower limit of detection (LLOD), Bronchoalveolar lavage (BAL) fluid, Not-detectable (ND), Not 
applicable (N/A).  
P-value determined by Student’s T-test. *p<0.05.  
Unless all samples of a group were below LLOD, zero values were substituted with 
    
√ 
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Figure 3.1. Schematic of house dust mite (HDM) sensitization protocol. Casp1
-/-
 or wild type 
(WT) C57BL/6 mice were exposed intranasally (i.n.) to 25μg of HDM (Dermatophagoides 
pteronyssinus 1) in 20μl of sterile PBS or 20μl PBS control for 14 consecutive days. Mice were 
challenged with methacholine for lung function assessment and harvested 72 hours after the last 
HDM challenge.  
  
1 14 
 
Daily i.n. HDM or PBS control 
Methacholine challenge 
and lung function test, 
Sacrifice 
day 
Casp1
 -/- 
and Wild type 
C57BL/6 
17 
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Figure 3.2. No differences between Casp1
-/-
 and WT mice in HDM sensitization-induced 
serum IgE levels. Total serum IgE was measured by ELISA. n=8 WT PBS, 11 WT HDM, 7  
Casp1
-/-
 PBS, 9  Casp1
-/-
 HDM. 
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Figure 3.3. Casp1
-/-
 mice have enhanced neutrophil influx with HDM sensitization. A) Total 
cell count from bronchoalveolar lavage fluid of HDM-sensitized or PBS treated Casp1
-/-
 and WT 
mice. n= 9 WT PBS, 11 WT HDM, 6 Casp1
-/-
 PBS, 6 Casp1
-/-
 HDM. B) Cells in the 
bronchoalveolar lavage fluid were assessed for number of eosinophils (EOS), neutrophils 
(PMN), monocytes/macrophages (MONO/MAC) and lymphocytes (LYMPH) from HDM-
sensitized Casp1
-/-
 and WT mice. Counts were adjusted for total cell number. n= 9 WT HDM, 5 
Casp1
-/-
 HDM. P-value determined by factorial ANOVA with Bonferroni post-hoc test. *p<0.05, 
**p<0.01. 
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Figure 3.4. Histopathology assessment of lung inflammation and damage. H&E stained lung 
slices from PBS-treated and HDM-sensitized Casp1
-/-
 and WT mice. Images were acquired at 
20x magnification. A) Large airway inflammation; B) Large airway inflammation; C) 
Perivascular Inflammation. Bars represent 100 micron (μm). 
  
Casp1
-/-
 WT 
PBS HDM 
WT Casp1
-/-
 
  
A 
B 
C 
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Figure 3.5. Lungs from HDM-sensitized Casp1
-/-
 mice have enhanced inflammation. H&E 
stained lung slices  from HDM-sensitized Casp1
-/-
 and WT mice were assessed for A) large 
airway inflammation, B) alveolar inflammation, C) perivascular inflammation, and D) overall 
severity of inflammation on a scale of 1 (none) to 5 (severe). n=12 WT HDM, 8 Casp1
-/-
 HDM. 
P-value determined by Student’s T-test. *p<0.05. 
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Figure 3.6. Assessment of goblet cell metaplasia. A) Alcian Blue and Periodic acid Schiff 
(AB-PAS) stained lung sections from PBS-treated and HDM-sensitized Casp1
-/-
 and WT mice. 
Images were acquired at 20x magnification. Bars represent 100 micron (μm). B) Comparison of 
the quantification of the average percentage of PAS+ cells within an airway in lungs from HDM-
sensitized WT and Casp1
-/-
 mice. n=12 WT HDM, 8 Casp1
-/-
 HDM. P-value determined by 
Student’s T-test. *p<0.05. 
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A 
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Figure 3.7. HDM-sensitization and caspase-1 deficiency do not affect Il1b gene expression 
or pro-IL-1Β cleavage. A) Il1b gene expression was assessed in lung homogenates by qRT-
PCR. n=6 WT PBS, 10 WT HDM, 6 Casp1
-/- 
PBS, 8 Casp1
-/-
 HDM. B) IL-1β protein in lung 
homogenates was assessed by western blot. Line indicates that the HDM and PBS samples were 
run on different gels.  
Casp1
-/-
 WT Casp1
-/-
 WT 
HDM PBS 
Full length 
IL-1β 
(31kDa) 
Cleaved IL-1β  
(17kDa) 
Β-Actin 
B 
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Figure 3.8. WT and Casp1
-/- 
have similar expression of Neutrophil elastase and Cathepsin G 
in lung tissue. A) Cathepsin G
 
(Ctsg) and B) Neutrophil elestase (Elane) mRNA expression in 
lung tissue homogenate from PBS-treated and HDM-sensitized Casp1
-/-
 and WT mice. n=5 WT 
PBS, 9 WT HDM, 6 Casp1
-/-
 PBS, 8 Casp1
-/-
 HDM.  
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Figure 3.9. HDM-sensitized Casp1
-/-
 mice have reduced airway resistance with 
methacholine challenge. A) Total lung resistance (RL), B) tissue dampening (G), and C) large 
airway resistance (Raw) was assessed by forced oscillation technique in PBS-treated or HDM-
sensitized Casp1
-/-
 and WT mice. n= 9 WT PBS, 11 WT HDM, 7 Casp1
-/-
 PBS, 8 Casp1
-/-
 HDM. 
P-value determined by factorial ANOVA with Bonferroni post-hoc test. *p<0.05, **p<0.01. 
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Chapter 4: Investigation of damage associated molecular patterns and activation of the 
inflammasome in the airway of healthy volunteers after in vivo ozone exposure
1,24
 
4.1 Introduction 
Inhalation of ozone (O3) causes airway inflammation that can exacerbate preexisting 
diseases, such as asthma and chronic obstructive pulmonary disease, and increases susceptibility 
to respiratory infections (1-3). The inflammatory response to O3 suggests an active innate 
immune response to O3 in the lung. Previous studies have implicated the pattern recognition 
receptors (PRRs) toll-like receptor (TLR) 2, TLR4, CD14, NOD-like receptor protein 3 
(NLRP3), and CD44 in the innate immune response to O3 (4-9). These receptors recognize 
pathogen associated molecular patterns (PAMPs), such as the bacterial cell wall component 
lipopolysaccharide (LPS), and damage associated molecular patterns (DAMPs), which are 
endogenously-derived molecules produced by damaged cells or tissue, such as adenosine 
triphosphate (ATP) or damaged extracellular matrix components (10-12). Since O3 is an oxidant 
gas that induces sterile inflammation, activation of PRRs is likely mediated indirectly by a 
DAMP (13). O3 induces oxidative stress that can directly damage the airway and react with the 
lung lining fluid to create reactive intermediates such as oxidized lipids, causing the release of 
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pro-inflammatory cytokines and chemokines that enhance migration of inflammatory cells, such 
as neutrophils, to the airways (14). In the process of responding to the injury, neutrophils 
generate more reactivate mediators, such as proteases and reactive oxygen species,that can cause 
further airway damage (15). Damage of the airway caused either directly by O3 or indirectly by 
immune-mediated damage is associated with the presence of DAMPs in the airway, including 
ATP and hyaluronic acid (HA) fragments (6, 16, 17).  
The inflammasome is an innate signaling complex composed of a PRR [often a NOD-like 
receptor (NLR)], pro-caspase-1, and, in some cases, the adaptor protein PYCARD that has been 
implicated in the innate immune response to a number of DAMPs and pollutants (18). Formation 
of the complex leads to cleavage of pro-caspase-1 to an active form, which can then preform one 
of several functions, including the processing and release of IL-1β and IL-18 and a pro-
inflammatory form of programmed cell death termed pyroptosis (19). Caspase-1–mediated 
processing of IL-1β and IL-18 requires two distinct signals (20). First, TLR activation induces 
downstream signaling through NF-kB to enhance transcription of pro–IL-1β and pro–IL-18. The 
second signal induces formation of an inflammasome complex and activation of caspase-1 that 
then cleaves the pro-cytokines to an active form. The NLRP3 inflammasome has been shown to 
mediate O3-induced airway inflammation and airway hyperresponsiveness in mice (8). 
Additionally, several murine studies have found a key role for IL-1-dependent signaling in the 
response to O3 (21-23). Though these findings suggest that O3-induced oxidative damage may 
activate inflammasome signaling, contribution of the inflammasome to the human innate 
immune response to O3 has not been shown.  
Inflammasome signaling has been primarily characterized in macrophages and 
monocytes (24). Pulmonary macrophages (Mac) compose the majority of resident innate immune 
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cells in the lung at baseline conditions, suggesting that Mac are key initiators of the innate 
immune response to O3 (25). Ablation of Mac in the lung with gadolinium chloride prevents O3-
induced inflammation and lung injury, demonstrating Mac are key mediators of the innate 
immune response to O3 (26). In this study, we assessed the innate immune response of healthy 
volunteers exposed to O3 in vivo and tested the hypothesize that DAMPs are early mediators of 
the innate immune response to O3 that activate innate pattern recognition and inflammasome 
responses in Mac to initiate the inflammatory response to O3.  
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4.2 Materials and methods 
In vivo O3 exposure. Subjects for this study were healthy adults with no history of 
smoking within two years of the study. See table 4.1 for subject characteristics. Subjects were 
recruited by Westat Corporation and underwent a screening procedure with complete medical 
history, physical exam, and pregnancy test for females. Subjects were excluded if they 
experienced respiratory illness or symptoms within 6 weeks of bronchoscopy and if they had a 
positive pregnancy test. Informed consent was obtained from all study participants. The study 
protocol was approved by the U.S. Environmental Protection Agency and the University of 
North Carolina at Chapel Hill institutional review board. The study design was a randomized, 
double-blinded, crossover study of the response of healthy volunteers to inhaled O3. Subjects 
were randomly exposed to clean air and, in a separate exposure, 0.3 parts per million (ppm) O3 
for 2 hours with exercise and a minimum of 2 weeks separation between each exposure. The 
exposures took place in stainless steel chambers at the EPA Human Studies Facility on the 
campus of the University of North Carolina at Chapel Hill. The generation of O3 and the 
exposure chambers were as previously described (27). Minute ventilation was maintained at 25 
L/min/m
2
 body surface area by adjusting the exercise level. Ventilatory parameters, 
electrocardiac signals, heart rate, and blood oxygen saturation were monitored throughout the 
exposure and spirometric lung function and symptom scores were assessed immediately before 
and after the exposure period for subject safety.  The subjects underwent bronchoscopy with 
bronchoalveolar lavage (BAL) using sterile saline 1 or 24 hours after exposure as previously 
described (28). BAL samples were kept on ice immediately after aspiration and the cells were 
pelleted by centrifugation (300 x g for 10 minutes at 4° C). Cell-free BAL fluid was stored at -
80ᵒC until analysis. 
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Measurement of glutathione and purine metabolites in BAL fluid. Mass spectrometric 
(MS) analysis for purine metabolites (AMP, adenosine, and uric acid) and glutathione (GSH) 
was performed using a previously described method modified to include detection of GSH and 
reduced glutathione disulfide (GSSG) (17).  Briefly, an internal standard solution of isotopically 
labeled urea, AMP, adenosine, and amino acids was added to the BAL fluid samples and the 
mixture was filtered through a 10k Da size selection filter (EMD Millipore, Billerica, MA) to 
remove macromolecules.  Compounds were separated by liquid chromatography using 0.1% 
formic acid and methanol gradients on a C-18 column (Acquity UPLC HSS T3, Waters, Milford, 
MA), with positive mode MS detection performed in multiple-reaction monitoring mode 
scanning for transitions in mass-to-charge ratio (m/z) from parent to product ions for AMP, 
adenosine, and uric acid as described (17). The method was modified to add the transitions 
308.1→179.1 for GSH and 307.1→355.1 for glutathione disulfide (GSSG).  Metabolite 
concentrations were defined as ratio of the peak area from the metabolite to that of the internal 
standard with the closest column run time, and concentrations quantified by comparison to 
standard solutions run in parallel. 
Measurement of oxysterols in BAL fluid.  To 1 mL BAL fluid, 10 μl of alkynyl_secoB (50 
ng/μl), 1mL NaCl (0.9%), 10 μl of triphenylphosphine (TPP) and butylated hydroxytoluene 
(BHT) (25 mg TPP and 10 mg BHT in 10 mL MeOH), 2 mL of MeOH, and 3 mL of iso-octane 
were added. The mixture was vortexed vigorously for 2 minutes and separated by centrifugation. 
The collected organic layer was evaporated to dryness in a SpeedVac™ concentrator and 
resuspended in 100 μl MeOH. For liquid chromatography-multiple-reaction monitoring (LC-
MRM) analysis, the resuspended samples were chromatographed by RP-HPLC using a UPLC 
BEH C18 column (1.7 μm, 2.1 mm × 100 mm) in Waters Acquity UPLC system equipped with 
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an autosampler (Waters, Milford, MA). The oxysterols were separated by 95% solvent B in 
isocratic method with a flow rate of 200 μL/min, and the mobile phase solvents consisted of 2 
mM NH4OAc (solvent A) in water and 2 mM NH4OAc in MeOH (solvent B). The injection 
volume was 10 μl using a partial loop with needle overfill mode. MS detections were performed 
using a TSQ Quantum Ultra tandem mass spectrometer (ThermoFisher, Waltham, MA), and data 
was acquired and analyzed using a Thermo Xcalibur™ 2.2 software package. 
Alkynyl_secosterol B was used as an internal standard for the analysis. The cholesterol and 
oxysterols form [M+NH4]
+
 ions in positive ion mode (29). The transitions monitored were m/z 
436383 for secosterol A and B (SecoA and B), m/z 404369 for cholesterol, m/z 418365 
for alkynyl_secosterolB (a_secoB), m/z 420385 for cholesterol epoxide α and β (CholEp α and 
β). See Figure 4.1 for structures. 
Cytokine analysis. Levels of IL-8 and IL-1β in the BAL fluid were measured using a 
commercially available enzyme-linked immunosorbent assay (ELISA, BD Biosciences, San 
Jose, CA). IL-8 and IL-1β in the media supernatants from BAL cells with ex vivo ATP 
stimulation were measured using a commercially available ELISA kit (Meso Scale Discovery, 
Gaithersburg, MD). 
Hyaluronic Acid (HA) Analysis. Concentrations of hyaluronic acid (HA) in the BAL fluid 
were measured using a commercially available kit (Hyaluronan DuoSet;  R&D, Minneapolis, 
MN). 
LDH Assay. To assess cytotoxicity, the BAL fluid and media supernatants from BAL 
cells were analyzed for concentrations of LDH using a commercially available kit (Takara Bio 
Inc., Otsu, Shiga, Japan). 
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Ex vivo ATP stimulation. BAL cells were pelleted by centrifugation and washed twice 
with RPMI 1640 (Life Technologies, Carlsbad, CA). Cells were resuspended in RPMI 
supplemented with 10% FBS (Life Technologies) and 1% Penicillin-Streptomycin (Life 
Technologies) and were kept at 37ᵒC until use within 1 hour. 100,000 cells were aliquoted to 
sterile 5mL polystyrene culture tubes (Evergreen Scientific, Los Angeles, CA) and incubated 
with 1mM of ATP (Sigma Aldrich, St. Louis, MO) or PBS vehicle control (Life Technologies) 
for 30 minutes at 37ᵒC. The cells were centrifuged at 500g for 10 minutes and the media 
supernatants were stored at -20ᵒC until analysis. The cells were immediately used for flow 
cytometry assessment of caspase-1 activity. 
Flow Cytometry. For surface marker analysis, BAL cells were resuspended in staining 
buffer [PBS, 1% heat-inactivated FBS, and 0.09% Sodium azide (Sigma, St. Louis, MO, USA)] 
and stained with antibodies for CD14 (Beckman Coulter, Brea, CA), CD44 (BD Biosciences), 
TLR4 (eBioscience, San Diego, CA), and with Live/Dead® Violet Fixable cell stain (Life 
Technologies) for 20 minutes at room temperature in the dark. Cells were washed with staining 
buffer and resuspended in 0.5% paraformaldehyde (Sigma). Caspase-1 activity in BAL cells was 
assessed following ex vivo ATP stimulation using the FLICA
TM
 Caspase-1 Assay Kit 
(Immunohistochemistry Technologies, Bloomington, MN). Briefly, the cells were labeled using 
a carboxyfluorescein-YVAD-fluoromethyl ketone, which is bound by active caspase-1, for 1 
hour at 37ᵒC in the dark. During the final 20 minutes of incubation, the cells were stained with 
CD45 and Live/Dead® stain to assess viability. Cells were washed twice with flow cytometry 
staining buffer and resuspended in 0.5% PFA. Samples were stored at 4°C in the dark and 
acquired within 24 hours on a BD Biosciences LSRII flow cytometer. Live Mac were identified 
by forward and side scatter properties, positive CD45 staining, and negative LiveDead staining, 
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and analyzed for mean fluorescence instensity (MFI) of receptor expression or percentage of 
FLICA positive cells. Unstained and isotype-matched single color controls (BD Biosciences) 
were used to control for nonspecific staining and to set analysis gates. 
Statistical Analysis. Non-parametric, paired Wilcoxin Signed Rank Test was used to 
assess the effects of O3 on cytokines, purine metabolites, HA, oxysterols, GSSH and GSSG in 
the BAL fluid and surface marker expression by Mac. Two way ANOVA with Bonferroni post-
hoc analysis was to assess the effects of O3 and ATP on caspase-1 activity in ex vivo Mac and 
IL-1β, IL-8, and LDH release by ex vivo BAL cells. Linear regression and non-parametric 
Spearman correlation analysis was used to assess correlation between IL-1β and LDH produced 
by ex vivo BAL cells.  Significance was set at p<0.05. All graphs show mean ± SEM. 
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4.3 Results 
In vivo O3 exposure induces early signs of oxidative stress and cytotoxicity  
 Healthy volunteers were exposed to 0.3 ppm O3 and, in a separate exposure, clean air for 
2 hours with exercise. Though the concentration of O3 used here, 0.3ppm, is higher than the EPA 
standard of 0.075 ppm/hour, peak hourly levels of O3 close to this magnitude have been reported 
in highly polluted cities such as Mexico City (30).  Inhaled O3 induces oxidative stress that can 
damage the airway and is combatted by antioxidants in the lung lining fluid such as glutathione 
(GSH) (31). Oxidation of GSH to glutathione disulfide (GSSG) is a marker of oxidative stress. 
We measured the effect of O3 on GSH in the bronchoalveolar lavage (BAL) fluid using mass 
spectrometry and found enhanced levels of total glutathione (GSSH + GSH) with O3 exposure 
and a non-significant (p= 0.09 ) increase in the ratio of GSSG to GSH at 1 hour after O3 exposure 
(Figure 4.2 A-B). Next, we measured levels of lactate dehydrogenase (LDH) in the BAL fluid, a 
marker of cytotoxicity and airway damage. Our results indicate that there was trend for enhanced 
LDH in the BAL fluid 1 hour after O3 exposure (p=0.0504, Figure 4.2 C). Together, our results 
suggest that markers of oxidative stress and airway damage can be measured in the airway as 
early as 1 hour following O3 exposure. 
In vivo O3 exposure enhances DAMPs in the airway 
 Damaged cells and tissue release DAMPs such as hyaluronic acid (HA), oxidized lipids, 
ATP, and uric acid that activate PRR and inflammasome signaling (12, 32-35). Since O3 induces 
sterile inflammation, we hypothesize that DAMPs mediate the innate immune response to O3. 
We measured levels of total HA, several purine metabolites (adenosine monophosphate (AMP), 
adenosine, and uric acid), and several oxidized cholesterols (oxysterols) in BAL fluid from 
healthy volunteers exposed to air or O3. 1 hour after exposure, we found significantly increased 
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uric acid, cholesterol epoxide β, and secosterol A and a trend for increased cholesterol epoxide α 
in BAL fluid from O3-exposed individuals, but no difference in HA concentrations (Figures 4.3 
and 4.4). Conversely, we found only enhanced levels of HA in BAL at 24 hours after O3 
exposure (Figure 4.3 A). Notably, due to limited sample volume we were unable to assess purine 
metabolites in the 24 hour samples. These results suggest that exposure to O3 induces time-
dependent accumulation of DAMPs in the airway. 
In vivo O3 exposure enhances IL-8, but not IL-1β, in the airway. 
 Activation of PRR and inflammasome signaling by DAMPs leads to downstream 
cytokine and chemokine production. We assessed levels of the inflammasome cytokine IL-1β 
and the neutrophil chemokine IL-8 in the BAL fluid by ELISA. O3 significantly enhanced levels 
of IL-8 in airway at both 1 and 24 hours post-exposure (Figure 4.5), whereas IL-1β was 
undetectable in the BAL fluid in all samples (data not shown).  
In vivo O3 exposure does not alter macrophage expression of CD14, TLR4, and CD44 at 1 hour 
post-exposure 
 Pulmonary macrophages (Mac) compose the majority of innate immune cells in the 
airway at baseline conditions and express a broad range of PRRs to patrol the airway for 
injurious stimuli (24). Previous studies have implicated CD14, TLR4, and the HA receptor, 
CD44, as key PRRs involved in innate immune response to O3 (6, 13, 36, 37). We assessed 
surface receptor expression of CD14, TLR4, and CD44 by Mac at 1 hour after exposure to Air or 
O3 by flow cytometry and found no differences in surface expression (Figure 4.6). 
In vivo O3 exposure primes Mac for enhanced IL-8 production in response to ATP 
IL-1β and IL-1R signaling has been associated with many of the adverse health effects of 
O3 (22, 23). IL-1β release is dependent on processing by the proteases such as caspase-1, 
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neutrophil elastase, or mast cell chymase (38). Since the NLRP3 inflammasome has been 
implicated in the innate immune response to O3 in mice (8), we measured caspase-1 activity in 
Mac from air and O3-exposed volunteers by flow cytometry. Consistent with the undetectable 
levels of IL-β in the BAL fluid, we found no effect of O3 on caspase-1 activity in Mac at 1 hour 
post-exposure (Figure 4.7 C, control samples).  
Caspase-1 mediated processing of IL-1β requires two stimuli: induction of pro-IL-β and 
formation of an inflammasome complex to activate caspase-1. Pro-IL-1β expression is regulated 
by transcription factors such as NF-kB that can be activated by signaling through TLRs (39). O3 
has been previously shown to activate TLR signaling and NF-kB activation, suggesting that O3 
may prime Mac for subsequent inflammasome activation and IL-1β processing (40, 41). To 
determine whether O3 primes the airway for subsequent IL-1β processing by the inflammasome, 
we treated BAL cells from air and O3-exposed volunteers at 1 hour post-exposure with the 
known inflammasome activator ATP ex vivo (1mM ATP for 30 minutes) and measured IL-1β 
production by ELISA and caspase-1 activity in Mac by flow cytometry. We found that ATP 
significantly enhanced IL-1β only in O3-exposed BAL cells (Figure 4.7 A), though the level of 
IL-1β was barely above detection limits (< 4ng/mL) and caspase-1 activity was not altered by 
ATP stimulation in either Air or O3-exposed Mac (Figure 4.7 C). ATP stimulation also enhanced 
production of IL-8 only in O3 exposed BAL cells (Figure 4.7 B). Notably, ATP stimulation did 
not significantly enhance LDH release (Figure 4.7 D), but there was a significant positive 
correlation between enhanced IL-1β and LDH, suggesting that detected IL-1β may be pro-IL-1β 
released from lytic cells (Figure 4.7 E). In summary, our results indicate that at 1 hour post-
exposure, O3 did not activate or prime caspase-1 activity in Mac, but enhanced Mac IL-8 
response to subsequent stimulation with DAMPs such as ATP.  
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4.4 Discussion 
 In this study, we tested the hypothesis that airway damage induced by in vivo O3 
exposure causes the release of damage associated molecular patterns (DAMPs) that activate 
inflammasome signaling in Mac and initiate the inflammatory response to O3 in humans. Our 
results indicate that inhalation of O3 induced time-dependent increases in DAMPs, including 
hyaluronic acid (HA), oxidized cholesterols (oxysterols), and uric acid, that were associated with 
enhanced IL-8 in the airway. Additionally, we found that pulmonary Mac exposed to O3 had 
enhanced IL-8 production in response to ex vivo stimulation with the DAMP ATP. However, we 
found no evidence of O3- or ATP-induced caspase-1 activity in pulmonary macrophages (Mac) 
collected 1 hour after exposure and were unable to detect IL-1β in the BAL fluid at any time 
point, suggesting that in vivo O3 exposure does not activate inflammasome-mediated IL-1β 
production in humans. Together, our results uncovered novel mediators of the innate immune 
response to O3 in the lung that may induce inflammation independently of inflammasome 
signaling.  
Similar to previous studies, we detected signs of oxidative stress and cytotoxicity as early 
as 1 hour after O3 exposure, as indicated by increased oxidation of GSH to glutathione disulfide 
(GSSG) and enhanced lactate dehydrogrenase (LDH) in the BAL fluid (Figure 4.2) (42, 43). Due 
to technical limitations, we were unable to measure GSH oxidation or LDH release at 24 hours 
post-exposure, but previous studies in humans have shown increased LDH, increased antioxidant 
responses, and decreased activity of glutathione peroxidase, an enzyme that neutralizes hydrogen 
peroxide and lipid hydroperoxides in the presence of GSH, as late as 18 hours after exposure to 
O3 (31, 44, 45). Our results show that oxidative damage induced by O3 is associated with the 
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presence of DAMPs in the airway, including several oxysterols, HA, and uric acid, and that 
abundance of these DAMPs vary over time after exposure.  
Due to high reactivity, O3 is not thought to penetrate further than the lung lining fluid or 
apical surface of the airway epithelium (46). The reaction of O3 with lipids and proteins in cell 
membranes and the lung lining fluid generates more stable intermediates that travel deeper into 
the lung to damage cells and tissue (47, 48). Though primarily studied in the context of 
atherosclerosis, oxidized lipids, such oxysterols, oxidized phospholipids, and oxidized 
cholesteryl esters, have received increased attention as mediators of innate immune responses in 
the lung (33, 49, 50). Our results indicate that O3 exposure rapidly induces the presence of 
cholesterol epoxide α, cholesterol epoxide β, and secosterol A in the airway by 1 hour post-
exposure, suggesting that oxysterols may be early mediators of the inflammatory response to O3 
(Figure 4.4). Though other oxidized lipids have been identified in the human airway after in vivo 
O3 exposure, including the lipid peroxidation product 4-hydroxynonenal (51), to our knowledge 
this is the first study to identify oxysterols in BAL fluid from humans after in vivo exposure to 
O3. These findings are in agreement with previous studies that found increased oxysterols, 
including cholesterol epoxide β, in BAL fluid from mice or rats exposed to O3 in vivo that peak 6 
hours post-exposure (29, 52, 53). Oxysterols in the lung may be induced by direct interaction of 
cholesterol with O3, generation of free radicals that promote cholesterol peroxidation, or reaction 
oxidant species produced by immune cells such as neutrophils during normal immune responses 
with cholesterol (29, 52, 54, 55). Since neutrophil influx typically does not occur until 3 hours 
after exposure to O3 and remains elevated through 24 hours, the generation of oxysterols at 1 
hour post-exposure was not likely mediated by neutrophil-derived oxidants (42). 
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 In addition to oxysterols, we also found that O3 enhanced levels of the DAMP uric acid, 
a product of purine nucleoside catabolism, in the BAL fluid at 1 hour post-exposure (Figure 4.3 
B) (32). Whereas at low levels uric acid may serve an antioxidant function by scavenging singlet 
oxygen, peroxyl radicals and hydroxyl radicals, high levels of uric acid form monosodium urate 
crystals that act as DAMPs and stimulate PRRs such as TLR2, TLR4, and the NLRP3 
inflammasome (32, 56). Though we detected enhanced uric acid in the BAL fluid 1 hour post-O3 
exposure, there was no significant correlation between uric acid and markers of inflammation or 
oxidative damage in the airway, including oxidation of GSH, LDH, or IL-8 in the airway (data 
not shown). In addition, due to limited sample volume, we were unable to measure uric acid in 
the BAL fluid at 24 hours post-exposure to determine if the increase in uric acid accumulates 
over time after exposure. Thus, future studies will be necessary to determine whether uric acid 
serves as a DAMP or an antioxidant in the response to O3. 
In opposition to oxysterols and uric acid, which were elevated only 1 hour after O3 
exposure, increased hyaluronic acid (HA) was only detected in the BALF 24 hours post-exposure 
(Figure 4.3A). HA is a component of the extracellular matrix produced by airway epithelial cells 
and submucosal glands in the lung as long strands (high molecular weight) that have anti-
inflammatory effects (57, 58). With tissue injury or oxidative damage, the long strands become 
fragmented to low molecular weight HA that induces inflammation (58, 59). Low molecular 
weight HA has been shown to activate O3-induced TLR4, CD44, and the NLRP3 inflammasome 
signaling in mice (6, 8, 37). Similar to our findings, previous studies have found that HA does 
not accumulate until 12 to 24 hours after O3 exposure in mice, and a human O3 exposure study 
found increased HA in asthmatic subjects 6 hours after O3 exposure, suggesting that HA may be 
a late mediator of O3-induced airway inflammation (8, 60). We propose that accumulation of HA 
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is not caused by immediate O3-induced damage, but may rather be a consequence of immune-
mediated damage, as caused by neutrophil influx, or inflammatory cell dysfunction. For 
example, Macs have been shown to have altered immunophenotype and phagocytic function 
after O3 (3, 7, 36). As clearance of HA occurs via CD44-mediated endocytosis by Mac, Mac 
dysfunction could lead to accumulation of HA (61). We assessed Mac receptor expression 1 hour 
after exposure, and found no effects of O3 on TLR4, CD14, or CD44 expression (Figure 4.6); 
however, changes in Mac immunophenotype may not occur until later after O3 exposure when 
immune-mediated damage has occurred.  
The increased presence of DAMPs in the airway after O3 exposure was associated with 
enhanced levels of the neutrophil chemoattractant IL-8 at 1 and 24 hours post-exposure, 
suggesting an ongoing inflammatory response to O3 as early as 1 hour post-exposure (Figure 
4.5). Surprisingly, IL-1β was undetectable in all BAL fluid samples and O3 exposure had no 
effect on caspase-1 activity in Mac, suggesting that inflammasome signaling did not contribute to 
O3-induced inflammation (Figures 4.7 C). These results are in disagreement with a previous 
murine study by Feng et al. that showed NLRP3, caspase-1, and PYCARD contribute to O3-
induced airway hyperresponsiveness and inflammation and that inflammasome-mediated IL-1β 
production by Mac was activated by HA fragments at 24 hours post- O3 exposure (8). Unlike the 
Feng et al. study, we assessed caspase-1 activity only at1 hour post-exposure, when HA levels 
were not altered by O3 exposure (Figure 4.3 A). Thus, the inflammasome may not be activated 
until later after exposure to O3 when DAMPs such as HA accumulate. However, we also could 
not detect IL-1β in BAL fluid at either 1 or 24 hours post-exposure. Though it possible that the 
BAL fluid was too dilute, or that IL-18 or pyroptotic cell death may be a more important 
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endpoint of O3-induced inflammasome signaling in humans, our data does not suggest a strong 
role for the inflammasome in the innate immune response to O3. 
Caspase-1 mediated IL-1β processing requires two steps: 1) activation of TLR and NF-
kB mediated pro-IL1β transcription and 2) inflammasome assembly to induce caspase-1 activity. 
Previous studies have shown O3 activates TLR4 and TLR2 signaling and NF-kB activity, 
suggesting that O3 may prime the cell for inflammasome activation by a subsequent DAMP such 
as HA or ATP (9, 13, 40). To test this hypothesis, we treated BAL cells from Air and O3-exposed 
individuals at 1 hour post-exposure with the known inflammasome stimulator ATP. We found 
that BAL cells from O3-exposed individuals produced IL-8 and IL-1β in response to ATP, 
whereas ATP had no effect on Air-exposed cells (Figure 4.7 A-B). Notably, the levels of IL-1β 
were very low (< 4ng/mL) and correlated with LDH, suggesting that IL-1β may be released from 
lytic cells rather than via caspase-1 activity (Figure 4.7 E). Moreover, we did not detect ATP-
induced caspase-1 activity in either Air or O3-exposed Mac, suggesting that ATP may not induce 
caspase-1 activity in resident pulmonary Mac (Figure 4.7 C). Many studies of human 
inflammasome signaling have been performed in vitro using blood monocytes and the human 
THP-1 monocyte cell line (20). Whereas monocytes have constitutively activate caspase-1 and 
rapidly produce IL-1β in response to a single stimulus, macrophages express low levels of 
caspase-1, require multiple stimuli to secrete IL-1β, and produce IL-1β more slowly than 
monocytes (20, 62). Thus, additional stimuli or longer incubation with ATP may be necessary to 
activate caspase-1 and detect IL-1β production by human pulmonary Mac. Together, our results 
suggest that O3 primes Mac for an enhanced inflammatory response to a subsequent DAMP, 
such as ATP, but that this effect is likely not mediated by inflammasome signaling.  
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In summary, we show here that in vivo O3 exposure of healthy volunteers induces 
oxidative damage that is associated with enhanced levels of several DAMPs and IL-8 in the 
airway, but that O3-induced airway inflammation in humans is likely not mediated by activation 
of inflammasome-induced IL-1β. Our results indicate that different DAMPs mediate the early 
and late immune responses to O3 in the lung. Oxysterols may serve as early initiators 
inflammation, and are thus likely induced directly by O3-induced airway damage. Oxysterols 
have been primarily studied in the context of atherosclerosis, where overload of macrophages 
with oxidized lipids induces the formation of pro-inflammatory foam cells that contribute to 
atherogenesis (63, 64). Our results suggest that oxysterols are also important immune mediators 
in the lung, and future studies should investigate the downstream effects of O3-induced 
oxysterols on airway innate immune responses. As the oxysterols subside, HA accumulates late 
in the response to O3, suggesting that increased HA is a consequence of immune-mediated 
inflammation rather than direct O3-induced damage. Increased knowledge of the function of 
these mediators in innate immunity will improve our understanding of O3-induced lung injury 
and better inform the design of therapeutics to combat oxidant-related lung pathology.  
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Table 4.1 Subject Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
  
Total 
Subject # 
Sex Race 
Average 
Age (± SD) 
Average 
BMI (± SD) 
11 1F/10M 
9 Caucasian, 
1 Hispanic, 
 1 African 
American 
24.27 
(3.069) 
25.24 
(2.847) 
SD= standard deviation; BMI= body max index; F=female; M=male;  
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Figure 4.1. Oxysterols analyzed by LC-MRM analysis. A) Cholesterol epoxide α (CholEp-
alpha); B) cholesterol epoxide β (CholEp-beta); C) secosterol A (SecoA), and D) secosterol B 
(SecoB). E) Alkynyl secosterol B (a_SecoB) was used an internal standard for LC-MRM 
analysis. 
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Figure 4.2. Trend for increased gutathione (GSH) oxidation and lactate dehyrodrogenase 
(LDH) the airway at 1 hour post-O3 exposure.(A) Levels of oxidized glutathione (GSSG) and 
GSH in the BAL fluid collected 1 hour after exposure  0.3ppm O3 or air for 2 hours were 
measured by mass spectrometry and (B) the ratio of GSSG to GSH was assessed as a marker of 
oxidative stress. (C) BAL fluid collected 1 hour after exposure to O3 or Air was assessed for 
LDH quantities as a measure of cytotoxicity. n=9 subjects. P-value determined by Wilcoxin 
Signed Rank Test. 
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Figure 4.3. O3 exposure enhances hyaluronic acid and uric acid in the airway. (A) 
Hyaluronic acid in the BAL fluid at 1 and 24 hours after exposure to 0.3ppm O3 or air for 2 
hours was measured by ELISA. (B) Concentration of the ATP metabolites adenosine, AMP, and 
uric acid in the BAL fluid 1 hour after exposure to O3 or air were assessed by mass spectrometry. 
n=9-11 subjects. P-value determined by Wilcoxin Signed Rank Test.  
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Figure 4.4. O3 exposure enhances levels of oxysterols in the airway. Quantities of A) 
cholesterol epoxide α, B) cholesterol epoxide β, C) secosterol A; and D) secosterol B in the 
BALF were measured by liquid chromatography-multiple-reaction monitoring. BALF was 
obtained by bronchoscopy at 1 or 24 hours after exposure to air or 0.3ppm O3 for 2 hours.  n=9 
(1 hour) or 10 (24 hour)  subjects. P-value determined by Wilcoxin Signed Rank Test. *p<0.05. 
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Figure 4.5. O3 enhances IL-8 in the bronchoalveolar lavage fluid. Quantities of IL-8 in the 
BAL fluid collected at 1 and 24 hours after exposure to 0.3ppm O3 or air for 2 hours were 
measured by ELISA. n=9-11 subjects. P-value determined by Wilcoxin Signed Rank Test. 
*p<0.05. 
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Figure 4.6. O3 exposure did not modify surface expression of CD14, TLR4, and CD44 by 
Mac at 1 hour post-exposure. Surface expression of (A) TLR4, (B) CD14, and (C) CD44 by 
live Mac collected 1 hour after exposure from volunteers exposed 0.3ppm O3 or Air for 2 hours  
was assessed by flow cytometry and expressed as mean fluorescent intensity (MFI). n=9 
subjects.  
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Figure 4.7. O3 exposure primes Mac for an enhanced inflammatory response to ATP. 
Bronchoalveolar lavage cells collected 1 hour after exposure to 0.3ppm O3 or Air were 
stimulated ex vivo with ATP (1mM) or vehicle control (PBS) for 30 minutes. (A) Caspase-1 
activity was measured as % FLICA positive by flow cytometry. Production of (B) IL-1β, (C) IL-
8, and (D) lactate dehydrogenase (LDH) was measured in the media supernatants from ex vivo 
stimulated bronchoalveolar cells. (E) Correlation between LDH and IL-1β in the media 
supernatants.  LLOD, lower limit of detection. P-value determined by Two-way ANOVA with 
Bonferfoni post-hoc analysis.*p<0.05. n=8 subjects. 
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Chapter 5: Airway Macrophage and Epithelial Cell Interaction Modifies the Innate 
Immune Response to Ozone
1,25
 
5.1 Introduction 
Inhalation of O3 causes immediate nociceptive decreases in lung function and increased 
airway inflammation that can exacerbate preexisting diseases, such as asthma and chronic 
obstructive pulmonary disease (1, 2). Despite regulations to reduce ambient O3, in 2008 
approximately 36.2% of the U.S. population lived in counties that did not meet the National 
Ambient Air Quality 8-hour O3 standard (0.075ppm averaged per 8 hours) (3). Though the 
adverse health effects of O3 are well known, the cellular mechanisms by which O3 alters immune 
responses in the lung remains unclear.  
The induction of airway inflammation following exposure to O3 suggests an ongoing 
innate immune response in the lung. Since O3 is an oxidant gas, the innate immune response to 
O3 is not likely mediated by recognition through discreet receptors (4). Rather, previous studies 
suggest that O3 reacts with components of the airway lining fluid and cellular membrane, such as 
surfactants and phospholipids, generating reactive intermediates that damage the respiratory 
epithelium and induce endogenous danger signals that initiate innate immune responses (2, 5, 6). 
For example, short fragments of hyaluronic acid (HA), an extracellular matrix 
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glycosaminoglycan produced by airway epithelial cells and submucosal glands, have been shown 
to serve as danger signals in the response to O3 (7-9). Levels of HA are elevated in the airways of 
mice 24 hours after exposure to O3 (7) and 4-6 hours after in vivo O3 exposure in sputum from 
atopic asthmatic (10). HA fragments can induce airway hyperreactivity and activate 
inflammatory responses via pattern recognition receptors including toll-like receptor (TLR)2, 
TLR4, and CD44 (7, 11, 12). 
Pulmonary macrophages (Mac) and epithelial cells are two of the most abundant cell 
types in the lower and conducting airways and thus serve as crucial first responders to O3-
induced airway damage (13). The airway epithelium acts as both a physical barrier against the 
inhaled environment and orchestrator of the innate immune response (14). Acute O3 exposure 
has been previously shown to damage epithelial cells, leading to increased airway permeability, 
cell death, and the release of cytokines/chemokines and danger signals that can activate local 
immune cells, such as Mac (2, 15, 16). Airway Mac reside along the airway epithelium and act 
as key members of the innate immune system by clearing pathogens and debris via phagocytosis, 
killing pathogens via respiratory burst, and releasing cytokines and chemokines to regulate the 
inflammatory response (13, 17). Previous studies have shown that Mac play a key role in O3-
induced lung injury, as Mac numbers increase following O3 exposure and blocking Mac activity 
during O3 exposure in rats reduces airway inflammation (18). Yet, Mac also play a protective 
role in the response to O3 by clearing reactive intermediates and cellular debris and releasing 
mediators that are anti-inflammatory to initiate wound repair (5, 17). This yin-yang characteristic 
of Mac led to the classification of Mac as either “classically activated,” or proinflammatory, or 
“alternatively activated”, or anti-inflammatory/wound healing (17). Studies in rats suggest that 
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inhalation of O3 is associated with accumulation of both classically and alternatively activated 
Mac in the lung (17).  
The close proximity between airway epithelial cells and Mac suggests that they encounter 
inhaled stimuli simultaneously and regulate the inflammatory response in tandem. Additionally, 
the tissue microenvironment has been shown to play a key role in determining Mac phenotype 
and function (19). Yet, most in vitro studies investigating the cellular inflammatory response to 
O3 have used monoculture systems, which do not address the interaction between multiple cell 
types in the airway and have limited applicability to in vivo situations (15, 16, 20-23). We 
developed a co-culture model of human bronchial epithelial cells (16HBE) and primary human 
airway Mac to test the hypothesis that signals from 16HBE modifies Mac phenotype and 
response to O3, and that communication between these two cell types is a key determinate of the 
inflammatory response to O3.  
  
 184 
 
5.2 Materials and Methods 
Preparation of 16HBE-Mac co-cultures, 16HBE monocultures, and Mac monocultures. 
16HBE14o- (16HBE) cells, a SV-40 transformed human bronchial epithelial cell line were a gift 
from Dr. D.C. Gruenert (University of California, San Francisco, CA) (24). 16HBE were plated 
on fibronectin coated [(LHC Basal Medium (Life Technologies, Carlsbad, CA),  0.01% bovine 
serum albumin (Sigma), 1% Vitrocol (Advanced Bio Matrix, San Diego, CA), and  1% human 
fibronectin (BD Biosciences)] 0.4-μm Transwells (Costar, Corning, NY, USA) and grown 
submerged in 1X MEM media (Life Technologies) supplemented with 10% fetal bovine serum 
(FBS, Carlsbad, CA), 1% penicillin-streptomycin, and 1% l-glutamine (Life technologies) for six 
days and one day at air-liquid interface (ALI) before use. Primary human airway macrophages 
(Mac) were obtained by bronchoalveolar lavage (BAL) of healthy volunteers in collaboration 
with the U.S. Environmental Protection Agency using a protocol approved by the UNC-Chapel 
Hill institutional review board, as described previously (25). 1.5 x 10
5
  BAL cells were added to 
the apical side of 16HBE or grown alone on transwells for monoculture controls. An equal 
amount of media was added to the apical side of 16HBE monocultures. Mac were selected by 
adherence for two hours. Apical media containing non-adherent cells was removed and cultures 
were incubated 18 hours at ALI before exposure (see schematic Figure 5.1).  
In vitro ozone (O3) exposure. Cell cultures at ALI were exposed to filtered air or 0.4 ppm 
O3 for 4 hours in exposure chambers (80% relative humidity, 5% CO2) operated by the U.S. 
Environmental Protection Agency. The dose used here was selected for maximal innate immune 
response to O3 with relatively minimal cytotoxicity and has been used previously by our group in 
several other reports (22, 26). Samples were collected 1 and 24 hours after exposure.  
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Flow cytometry. Cells harvested with Accutase (Millipore, Billerica, MA) and washed 
with staining buffer [PBS (Life Technologies), 1% heat-inactivated FBS, and 0.09% Sodium 
azide (Sigma, St. Louis, MO, USA)]. Cells were incubated with antibodies for CD45, CD3, 
CD206 (BD Biosciences, San Jose, CA), and CD14 (Beckman Coulter, Indianapolis, IN) for 20 
minutes at room temperature in the dark and fixed with 0.5% paraformaldehyde (PFA; Sigma).  
Samples were stored at 4°C in the dark and acquired within 24 hours.  For cytotoxicity analysis, 
the cells were incubated with antibodies for CD45, washed and then incubated with propidium 
iodide (PI; ImmunoChemistry Technologies, Bloomington, MN). Samples were analyzed using a 
BD Biosciences LSRII flow cytometer. Isotype-matched controls and unstained cells were used 
to control for nonspecific staining and set analysis gates. Mac were identified by positive CD45 
staining and forward-scatter/side scatter properties. 
Phagocytosis assay. Opsonized pHrodo Green Staphylococcus aureus (S. aureus) 
BioParticles® (Life Technologies) were incubated with co-cultures and Mac monocultures on 
the apical side for 1 hour at 37ᵒC. Cells were harvested, stained with antibodies for CD45, fixed 
in 0.5% PFA, and analyzed by flow cytometry as above. 
Analysis of IL-8 and hyaluronic acid (HA). Apical washes from co-cultures, 16HBE 
monocultures, and Mac monocultures were analyzed for concentrations of IL-8 (BD 
Biosciences) and HA (R&D Systems, Minneapolis, MN) using a commercially available assays. 
Immunofluorescence. For visualization of the 16HBE-Mac co-culture, BAL cells were 
labeled with a fluorescein-emitting dye (Vybrant Multicolor Cell-Labeling Kit; Life 
Technologies) before composition of the co-culture as described above. The co-cultures were 
fixed with 4% PFA and stained for F-actin cytoskeleton with phalloidin-rhodamine (Sigma). 
Transwells were mounted with Vectashield mounting media containing DAPI (Vector 
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Laboratories Burlingame, CA). For cleaved caspase-3 immunofluorescence, co-cultures, 16HBE 
monocultures, and AM monocultures on transwells were fixed in 4% PFA and probed with anti-
rabbit cleaved-caspase-3 (Cell Signaling Technology, Beverly, Massachusetts), anti-mouse-
HLA-DR (eBioscience) and appropriate secondary antibodies (Life Technologies). Transwells 
were mounted with DAPI as above. Images were captured using a Nikon C1Si laser-scanning 
confocal microscope, and processed using EZ-C1 FreeViewer software (Nikon Instruments, 
Melville, NY). 
Conditioned media experiments. 1 x 10
5
 BAL cells were plated on 24-well tissue culture 
plates, and Macs were selected for by adherence for 2 hours as above. Apical washes from 
16HBE mono-cultures exposed to 0.4ppm O3 or Air for 4 hours were collected at 1 or 24 hours 
post-exposure in 100ul RPMI media (Life Technologies) as “conditioned media.” Mac were 
incubated with 100ul of the conditioned media or RPMI media control for 4 hours and assessed 
for phagocytosis, CD14 and CD206 expression, and PI staining by flow cytometry as described 
above.  
Statistical analysis. To assess effects of co-culturing or O3 on surface receptor 
expression, phagocytosis, PI staining, and soluble mediator levels, a non-parametric, paired 
Wilcoxin signed rank test was used. The effect of culture type on O3-induced PI staining was 
assessed by non-parametric one way analysis of variance (Kruskall Wallis Test). Graphs show 
mean ± standard error of the mean (SEM). Significance was set at a p < 0.05. 
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5.3 Results 
Characterization of the 16HBE-Mac co-culture model 
To examine the interaction between Mac and airway epithelial cells, we developed a co-
culture model using primary pulmonary Mac and the 16HBE14o- (16HBE) cell line. 
Bronchoalveolar lavage (BAL) cells from healthy volunteers, which are comprised of over 80% 
Mac, 10% lymphocytes (largely T lymphocytes), and small populations of neutrophils, 
basophils, and eosinophils (27), were added to the apical side of 16HBE, and Mac were selected 
by adherence (Figure 5.1). Immunofluorescence analysis of the co-culture indicated that the Mac 
became embedded within the 16HBE monolayer, suggesting close cell-cell interaction between 
Mac and 16HBE (Figure 5.2 A-B). Flow cytometric analysis of the co-cultures using CD45 and 
forward scatter/side scatter properties to distinguish Mac from 16HBE revealed that on average 
6.9% of all cells in the co-culture were Mac (Figure 5.2 C). A small population of CD3+ T 
lymphocytes (on average 0.67% of all cells) was also identified in the co-culture. Previous 
studies have found that activated T lymphocytes can adhere to plastics and epithelial cells (27, 
28). For the purposes of this study, we did not further characterize the T lymphocytes, but rather 
focused our analysis on the effects of co-culture with 16HBE on Mac phenotype and response to 
O3. 
Co-culture of Mac with 16HBE alters Mac immunophenotype and reduces phagocytic activity  
We investigated the effect of co-culturing with 16HBE on Mac immunophenotype and 
phagocytic activity by flow cytometry. We assessed expression of CD14, a pattern recognition 
receptor commonly used to identify monocytes and macrophages and previously implicated in 
the response to O3 (29), and CD206, the macrophage mannose receptor, which is a maker of 
alternatively active macrophages (17). We found that Mac in co-culture had enhanced expression 
 188 
 
of CD14 and CD206 after both 24 and 48 hours of co-culturing compared to Mac in monoculture 
(Figure 5.3 A-B, Air exposed). We measured Mac phagocytosis of opsonized S. aureus 
bioparticles and found that co-cultured Mac had reduced phagocytic activity compared to Mac in 
monoculture (Figure 5.3 C, Air exposed). Notably, the effects of co-culture on Mac phenotype 
and phagocytic activity were not due to soluble mediators, as exposure of Mac mono-cultures to 
conditioned media from 16HBE did not alter surface marker expression or phagocytic activity 
(Figure 5.7, Air exposures). Together, these results suggest that signals derived from 16HBE 
alter Mac immunophenotype and phagocytic function. 
Co-culture of Mac with 16HBE modifies Mac response to O3 
 We next assessed how co-culture of Mac with 16HBE modifies Mac immunophenotype 
and phagocytic activity in the context of O3 exposure. Expression of CD14 and C206 by Mac 
was analyzed by flow cytometry 1 and 24 hours after exposure to Air or O3. Flow cytometric 
analysis showed that exposure to O3 significantly enhanced surface expression of CD14 by Mac 
in monoculture only at 24 hours post-exposure, and that there was similar, albeit non-significant 
trend for O3-induced CD14 by Mac in co-culture (Figure 5.3 A). Conversely, O3 significantly 
enhanced surface expression of CD206 both at 1 and 24 hours only by Mac in co-culture and had 
no effect on CD206 expression by Mac in monoculture (Figure 5.3 B). 
 Previous studies have shown that O3 exposure reduces Mac phagocytosis, which may 
contribute to enhanced susceptibility to infections following O3 exposure (25, 30, 31). Similarly, 
we found that exposure to O3 reduced phagocytosis of opsonized S. Aureus bioparticles by Mac 
both in co-culture and in monoculture at 1 and 24 hours post-exposure (Figure 5.4 A). Notably, 
at 1 hour post-exposure, the reduction in phagocytosis was greater in co-cultured Mac compared 
to Mac in monoculture (Figure 5.4 B). The effects of co-culture on Mac phenotype and 
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phagocytic activity following exposure to O3 were not due to soluble mediators, as exposure of 
Mac mono-cultures to conditioned media from O3-exposed 16HBE did not alter surface marker 
expression or phagocytic activity (Figure 5.7 A-C). Taken together, these results indicate that co-
culture modifies Mac immunophenotype and phagocytosis in response to O3. 
Co-culture modifies O3-induced cytotoxicity of Mac, but not 16HBE 
Exposure to O3 has been previously shown to damage airway epithelial cells, leading to 
cell death and the release of danger signals that can activate local immune cells, such as Mac (2, 
16, 21). Similarly, Mac from O3-exposed rats had increased markers of cytotoxicity (32). We 
investigated how co-culture of Mac with 16HBE modified O3-induced cytotoxicity by propidium 
iodide (PI) staining, a marker of cell lysis. We found that O3 significantly enhanced the 
percentage of PI+ Mac at 1 hour after exposure in Mac both in monoculture and co-culture, but 
that Mac in co-culture had significantly increased cytotoxicity (Figure 5.5 A). Conversely, 
neither 16HBE in co-culture nor monoculture had significant increases in PI+ staining following 
O3 exposure (Figure 5.5 B). Notably, O3 did not enhance cleaved caspase-3, in any of the 
cultures, suggesting that O3 exposure did not induce caspase-3 dependent apoptosis (Figure 5.6). 
Similar to above, the effects of co-culture on Mac cytotoxicity were not mediated by soluble 
mediators, as exposure of Mac mono-cultures to conditioned media from 16HBE did not alter 
Mac cytotoxicity (Figure 5.7 D).Together our results show that Mac, but not 16HBE, are 
susceptible to O3-induced cytotoxicity, which is enhanced by co-culturing Mac with 16HBE. 
Co-culture of Mac with 16HBE has no effect on O3-induced IL-8 production 
 The chemokine, interleukin (IL)-8, is secreted by both Mac and airway epithelial cells 
and plays a major role in the recruitment of neutrophils to the site of O3-induced airway damage  
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(1). In chapter 4, we assessed levels of IL-8 in bronchoalveolar lavage (BAL) fluid from healthy 
volunteers collected at 1 and 24 hours after in vivo exposure to 0.3ppm O3 or air for 2 hours, and 
found significantly enhanced IL-8 at both 1 and 24 hours after exposure (Figure 4.5). Here, we 
assessed how co-culture of Mac with 16HBE alters O3-induced IL-8 production. Our results 
indicate that O3 significantly enhanced IL-8 production by Mac in monoculture at 1 hour but not 
24 hours post-exposure, and that there was a similar, albeit non-significant trend for enhanced 
IL-8 production in 16HBE-Mac co-cultures and 16HBE monocultures (Figure 5.8A). These 
results suggest that co-culture of 16HBE and Mac does not modify O3-induced IL-8 production. 
O3 modifies Mac regulation of hyaluronic acid in co-cultures 
 Elevated levels of the extracellular matrix protein hyaluronic acid (HA) in the lung 
contribute to airway hyperresponiveness and pro-inflammatory cytokine production following 
acute O3 exposure (7, 12). We assessed how O3 alters levels of HA in the Mac monocultures, 
16HBE monocultures, and 16HBE-Mac co-cultures. Our results indicate that in air-exposed 
cultures, 16HBE constitutively produce large amounts of HA, whereas HA was largely non-
detectable in Mac monocultures (Figure 5.8B). Interestingly, when Mac were co-cultured with 
16HBE, the concentration of HA in the cultures was starkly reduced, suggesting that Mac 
regulate the availability of HA in the co-cultures. Exposure to O3 did not significantly alter 
production of HA by 16HBE in monoculture at 1 or 24 hours post-exposure; however, we 
measured increased concentrations of HA in the 16HBE-Mac co-cultures at 24 hours after 
exposure. These results were similar to our findings in chapter 4, where we assessed HA levels in 
BAL fluid from healthy volunteers collected at 1 and 24 hours after in vivo exposure to 0.3ppm 
O3 or air for 2 hours and found HA levels were increased in the BAL fluid only at 24 hours after  
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O3 exposure, albeit not significantly (p=0.054, Figure 4.3A). These results demonstrate that the 
16HBE-Mac co-culture model closely resembles the in vivo response to O3 in the airway, and 
demonstrate that Mac regulation of epithelial cell derived-HA is altered by exposure to O3. 
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5.4  Discussion 
 The adverse health effects of inhaled O3 are orchestrated by multiple cell types in the 
lung, including structural cells, such as airway epithelial cells, and resident immune cells, such as 
pulmonary macrophages (Mac). Most studies that have investigated the innate immune response 
to O3 focused on an individual cell type, which does not address the important interaction 
between epithelial cells and Mac in the innate immune response to O3. We developed a human 
bronchial epithelial cell (16HBE)-Mac co-culture model to investigate how the interaction 
between airway epithelial cells and Mac contributes to the innate immune response observed in 
humans exposed to O3. Our results suggest that epithelial cells and Mac exist in a homeostatic 
state, whereby Mac maintain a quiescent phenotype, as indicated by reduced phagocytic activity 
and enhanced CD206 expression. O3 exposure disrupts this homeostatic relationship, leading to 
enhanced cytotoxicity in Mac and further reduced phagocytosis. Production of the danger signal 
hyaluronic acid (HA) by epithelial cells alone was not affected by O3 exposure, but availability 
of HA both in the in vitro co-culture and in bronchoalveolar lavage (BAL) fluid from volunteers 
exposed in vivo was increased with O3 exposure, indicating that effects of O3 on Mac 
phagocytosis potentially manifests in impaired regulation of HA. Taken together, these results 
demonstrate that signals from epithelial cells influence Mac immunophenotype and that O3 
exposure modifies epithelial cell-Mac homeostasis, leading to O3-induced changes in innate 
immune responses that mimic the effects of O3 exposure observed in vivo. 
 Epithelial cells and Mac compose the majority of resident innate immune cells in the 
lung, suggesting that they initiate and regulate the initial response to injurious stimuli such as O3 
in tandem. Our results suggest that signals derived from epithelial cells modify Mac response to 
O3, resulting in higher cytotoxicity and lower phagocytosis, similar to what has been observed in 
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vivo (33, 34). When co-cultured with 16HBE, Mac had enhanced expression of CD206, 
increased cytotoxicity, and reduced phagocytic activity following O3 exposure compared to Mac 
in monoculture (Figures 5.3-5). However, there was no effect of co-culture on patterns of O3-
induced production of the chemokine IL-8 (Figure 5.8 A). Our result suggest that in vitro study 
of Mac response to O3 in isolation may mask the important interaction with other cell types, such 
as airway epithelial cells, that influence the inflammatory response to O3. 
Results shown here suggest that signals from 16HBE promote an alternative Mac 
phenotype in response to O3, as indicated by reduced phagocytosis and increased expression of 
CD206.  CD206 (macrophage mannose receptor) is a C-type lectin binding protein that is 
commonly associated with alternatively activated macrophages (35). A previous study in rats 
identified both classical/pro-inflammatory Mac and alternative/anti-inflammatory Mac in the 
lung within 24 hours after exposure to O3 (36). Interestingly, suppression of classically activated 
Mac activity using gadolinium chloride has been shown to protect against O3-induced lung injury 
(18). While the alternatively activated state of Mac is necessary to resolve airway damage and 
control inflammation, it may also contribute to the enhanced susceptibility to and severity of 
respiratory infections that is associated with in vivo exposure to oxidant pollutants such as O3 
(34, 37-39). Previous studies have shown that in vivo O3 exposure of healthy human volunteers is 
associated with reduced phagocytic activity of Mac and several murine studies have shown that 
reduced Mac phagocytosis following O3 exposure is associated with enhanced susceptibility to 
bacterial infections, including Klebsiella pneumonia and Streptococcus zooepidemicus (30, 40, 
41). Additional studies have suggested that reduction in phagocytosis may be attributed to 
oxidation of surfactant protein (SP)-A, an epithelial cell-derived component of the lung lining 
fluid and known inducer of Mac phagocytosis (30). Our results indicate that Mac in co-culture 
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had further reduced phagocytosis at 1 hour after exposure to O3 compared to Mac in mono-
culture (Figure 5.4). Thus, O3-induced oxidation of 16HBE-derived mediators or epitopes may 
further impair phagocytosis by Mac, contributing to increased susceptibility to respiratory 
infections following O3 exposure. 
In the absence of secondary infections, exposure to O3 causes sterile inflammation, 
suggested to be mediated by the release of damage-associated signals. The airway damage 
caused by O3 exposure generates inflammatory danger signals in the airway, such as short 
fragments of hyaluronic acid (HA) (7, 11). Elevated levels of HA have been observed in sputum 
from allergic asthmatic volunteers exposed to O3 and murine studies have shown that 
accumulation of HA in the airway following exposure to O3 is associated with airway 
hyperresponsiveness and inflammation (7, 10, 11). HA is a nonsulfonated glycosaminoglycan 
that is produced by airway epithelial cells and submucosal glands as long strands (high molecular 
weight) that serve anti-inflammatory functions, but with tissue injury short HA fragments (low 
molecular weight) accumulate and induce inflammation (9, 42). Clearance of degraded 
extracellular matrix components, such as HA fragments, is necessary to limit inflammation and 
resolve tissue injury and occurs via CD44-mediated uptake by cells such as Mac, suggesting that 
the interaction between Mac and epithelial cells regulate HA levels (9, 43). Our results indicate 
that 16HBE constitutively produce HA, and that co-culture with Mac led to a stark reduction in 
HA availability (Figure 5.8B). Surprisingly, we did not observe an effect of O3 on HA production 
by 16HBE; however, Mac-dependent regulation of 16HBE-derived HA was impaired by O3 
exposure, thus leading to accumulation of HA in the cultures at 24 hours post-exposure. These 
data were confirmed in BAL fluid from healthy volunteers exposed in vivo, demonstrating 
elevated HA levels  24 hours after exposure to O3 (albeit not statistically significantly, p=0.054, 
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Figure 4.3 A). Considering the impaired phagocytosis of Mac co-cultured with epithelial cells, 
we hypothesize that increased availability of HA in the airway after O3 exposure observed in 
vivo is not due to enhanced production by epithelial cells, but rather caused by a loss in Mac-
dependent clearance. Future assessment of Mac CD44 expression is necessary to determine if 
CD44-mediated uptake of HA by Mac is also impaired by O3 exposure. 
Previous murine studies have found that O3-induced airway hyperresponsiveness is 
dependent on low molecular weight HA, whereas high molecular weight HA protects against O3-
induced airway hyperresponsivenss (7). Additionally, oxidative stress has been directly shown to 
cause fragmentation of HA produced by airway epithelial cells (44). Due to limited sample 
volumes, we were unable to assess HA size. Future studies will be necessary to determine how 
O3 and co-culture affects 16HBE-derived HA size in vitro and if low molecular weight HA 
accumulates in the airway after in vivo O3 exposure in humans. 
 The immune response in the airways represents a complex interaction between structural, 
resident, and circulating cells to clear the injurious stimuli and resolve the resulting injury. In 
vitro co-culture models present a controlled system to investigate the role of cell-cell interaction 
during immune cell activation. Compared to other macrophages in the body, pulmonary Mac 
have a unique phenotype that is determined by the tissue-microenvironment of the lung (19, 45). 
Mac are constantly assailed with inhaled stimuli, and must maintain a quiescent state with 
relatively low phagocytic activity and cytokine production in order to prevent unnecessary 
inflammation in response to innocuous stimuli (46). The adherence of Mac to airway epithelial 
cells suggests that Mac are bathed in epithelial cell-derived mediators, including cytokines, 
growth factors, and surfactants, and interact with epithelial cell receptors and adhesion receptors 
that may influence Mac phenotype (19, 47). In support of this hypothesis, we demonstrate that 
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Mac cultured with 16HBE had enhanced expression of the surface receptors CD14 and CD206 
and reduced phagocytic activity compared to Mac in monoculture (Figure 5.3). The enhanced 
expression of CD206, a marker of alternatively active macrophages, and low phagocytic function 
suggests that Mac interaction with epithelial cells promotes a quiescent state at baseline 
conditions similar to that which has been previously observed of alveolar macrophages (46).  
 Interestingly, treatment of Mac with conditioned media from air or O3 exposed 16HBE 
had no effect on Mac immunophenotype, phagocytic activity, or viability, suggesting that the 
effects of co-culture on Mac baseline phenotype or response to O3 were not due to soluble 
mediators derived from 16HBE (Figure 5.7). Though it is possible that the conditioned media 
was too dilute, our data suggest that direct interaction between 16HBE and Mac was necessary to 
affect Mac response to O3. These results are in line with previous airway epithelial cell-Mac co-
culture models that found contact-dependent effects were necessary to potentiate inflammatory 
responses to particles or particulate matter (48, 49). These effects could be due to signaling 
through integrins, which mediate cell-cell and cell-extracellular matrix interactions; yet, blocking 
I-CAM-1 or β1/β2/β3-integrins in previous studies did not inhibit the effects of epithelial cell-
Mac co-culture on response to particles (48, 49). Furthermore, we have previously shown that 
co-culture of natural killer (NK) cells with O3-exposed nasal epithelial cells modifies NK cell 
activity, and that these effects were mediated by direct cell-cell interaction and the expression of 
the NK cell receptor ligands ULBP3 and MICA/B by nasal epithelial cells (26). Future studies 
will be necessary to determine the specific receptor-ligand interactions that mediate the effects of 
co-culture on Mac immunophenotype and response to O3. 
 In conclusion, we show here a co-culture model to study the interaction between airway 
epithelial cells and Mac in the response to O3 that replicates in vivo findings. Our results indicate 
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that signals from 16HBE influence Mac phenotype and that the interaction between 16HBE and 
Mac is a determinate of the innate immune response to O3. As previous studies have shown that 
mediators from O3-exposed Mac enhance alveolar epithelial cell chemokine production (50), 
future studies are necessary to focus on the effect of Mac on epithelial cell phenotype and 
response to O3.Our results add to the literature suggesting that monoculture systems do not fully 
reconstitute the biological response to pollutants such as O3, and may mask the complex 
interaction between cell types that is required for these responses (26, 48-50). Furthermore, these 
results suggest that epithelial cells not only serve as structural barriers against the inhaled 
environment, but also function as orchestrators of immunity that can significantly influence 
immune cell phenotype and activity. Improved understanding of the interaction between airway 
epithelial cells and immune cells such as Mac may reveal new therapeutic targets to modify 
immune cell function in the lung.  
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Figure 5.1. Schematic of the human bronchial epithelial cell (16HBE) and airway 
macrophage (Mac) co-culture model. 16HBE14o- cells (16HBE) were grown to confluency on 
transwell membrane supports and differentiated at air-liquid interface for 24 hours before co-
culture. Bronchoalveolar lavage (BAL) cells from healthy volunteers were added to the apical 
side of 16HBE and Mac were selected by adherence for 2 hours. 16HBE and Mac were co-
cultured for 18 hours before exposure to 0.4ppm O3 or air for 4 hours. Samples were collected 1 
and 24 hours after exposure.  
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Figure 5.2. Characterization of the human bronchial epithelial cell (16HBE) and airway 
macrophage (Mac) co-culture model. A-B) Bronchoavleolar lavage cells (green) were stained 
with a fluorescein-emitting dye before addition to the apical side of the 16HBE. Mac were 
selected by adherence for 2 hours. The entire co-culture was stained with phalloidin-rhodamine 
for the F-actin cytoskeleton (red) of the 16HBE and Mac. Cell nuclei (blue) were stained with 
DAPI.  Images were acquired by laser-scanning microscopy. A) En face view of the co-culture 
shows the presence of Mac on the apical side of the 16HBE monolayer. B) Cross-sectional view 
of the co-culture shows the Mac are embedded within the 16HBE monolayer. C) Flow 
cytometric analysis of the co-culture shows a large population of CD45
+
, SSC
high
 Mac adhere to 
the 16HBE, as well as a small population of T lymphocytes CD45
+
, SSC
low
.  
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Figure 5.3. Co-culture of Mac with 16HBE modifies Mac immunophenotype in response to 
O3 exposure. Surface expression of A) CD14 and B) CD206 by Mac co-cultured with 16HBE 
(co-culture) or grown on transwells alone (mac alone) was measured by flow cytometry at 1 and 
24 hours after exposure to 0.4ppm O3 or air for 4 hours. Mac were distinguished from 16HBE by 
positive CD45 staining. Data shown as mean fluorescent intensity (MFI). n=7-9. P-value 
determined by Wilcoxin Signed Rank Test. *p<0.05, **p<0.01. 
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Figure 5.4. Exposure to O3 reduces Mac phagocytosis of S. Aureus bioparticles. 1 or 24 
hours after exposure to 0.4ppm O3 or air for 4 hours, Mac-16HBE co-cultures or Mac 
monocultures were incubated with fluorescent S. Aureus bioparticles for 1 hour and assessed for 
phagocytosis by flow cytometry. Macs were distinguished from 16HBE by CD45+ staining. 
Data expressed as A) % phagocytosis positive Macs or B) fold change (% phagocytosis positive 
Macs Air/O3). n=6-8. P-value determined by Wilcoxin Signed Rank Test. *p<0.05, **p<0.01. 
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Figure 5.5. Mac in co-culture have enhanced cytotoxicity following exposure to O3. 
Cytotoxicity in Mac-16HBE co-cultures or Mac monocultures at 1 or 24 hours after exposure to 
0.4ppm O3 or air for 4 hours was measured by propidium iodide (PI) staining. Macs were 
distinguished from 16HBE by CD45+ staining. Data expressed as A) % PI positive Macs or B) 
% PI positive 16HBE. n=6-8. P-value determined by Wilcoxin Signed Rank Test (*p<0.05, 
**p<0.01) or non-parametric one way analysis of variance (Kruskall Wallis Test, ###p<0.001). 
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Figure 5.6. No effect of O3 or co-culture on cleaved caspase-3. 16HBE monoculture, Mac 
monoculture, and 16HBE-Mac co-culture were fixed 1 or 24 hours after exposure to 0.4ppm O3 
or Air and probed for cleaved caspase-3 (green), HLA-DR (Mac, red), and DAPI (nuclei, blue) 
with appropriate fluorescent antibodies. Images were acquired by laser-scanning microscopy. 
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Figure 5.7. Exposure of Mac to conditioned media from 16HBE exposed to Air or O3 does 
not mimic the effects of co-culturing. Apical washes from 16HBE exposed to 0.4ppm O3 or air 
for 4 hours was collected in RPMI media at 1 or 24 hours after exposure as conditioned media. 
Mac were incubated with conditioned media or RPMI media control for 4 hours and then 
assessed for surface expression of (A) CD14 and (B) CD206, (C) phagocytosis of S. aureus 
bioparticles (expressed as %phagocytic+), and (D) viability using propidium iodide staining 
(expressed as %PI+) by flow cytomtery.  
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Figure 5.8. Effect of co-culture on O3-induced IL-8 and hyaluronic acid (HA) production. 
Concentrations of A) IL-8 and B) HA were measured in the apical washes from Mac 
monocultures, 16HBE monocultures, and 16HBE-Mac co-cultures collected 1 and 24 hours after 
exposure to 0.4ppm O3 or air for 4 hours.  n=7-11. P-value determined by Wilcoxin Signed Rank 
Test (*p<0.05). 
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Chapter 6: Discussion 
 
In 1989, Charles Janeway coined the term “pattern recognition receptor” (PRR) in a 
seminal essay for the Cold Spring Harbor Symposia on Quantitative Biology and predicted that 
sensing of microbes by these innate immune receptors was the critical link between innate and 
adaptive immunity (1). Until this time, innate immunity was considered a primitive component 
of the immune system intended only to initiate more refined adaptive immune responses (2). The 
discovery of the surface receptor Toll in Drosophila melanogaster in the early 1990s facilitated 
the identification of a number of Toll-like receptors (TLRs) and other innate immune receptors in 
humans and demonstrated that innate immunity is a highly evolved and necessary mechanism for 
host defense (3).  
The innate immune system serves as the first line of defense against the inhaled 
environment in the lung, and is composed of a network of both structural cells, such as airway 
epithelial cells, and immune cells, such as macrophages (4). Interaction between these cell types 
determines the appropriate inflammatory response to inhaled stimuli, and informs adaptive 
immune cells of specific pathogens (5). The immune response requires a tight balance between 
inflammatory events that clear the injury and anti-inflammatory responses that mediate healing. 
“…innate immunity has usually been treated as a minor curiosity, shunted 
to the beginning or the end of treatises on immunology, and given short 
shrift in study sections bound and determined to spare no effort first to 
solve the antibody problem and later the T-cell receptor and MHC-
restricted antigen recognition receptor” – Charles Janeway, 1989, from 
Approaching the Asymptote? Evolution and Revolution in Immunology. 
Cold Spring Harb Symp Quant Biol. 54:1–13. 
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Exaggerated or prolonged immune responses can lead to chronic inflammation of the airways 
and the development of diseases such as asthma (6). 
Innate immunity is initiated by recognition of microbial pathogen-associated molecular 
patterns (PAMPs) or endogenously derived damage-associated molecular patterns (DAMPs) 
from damaged tissue by PRRs (5). Recently, several PRRs, including a number of Nod-like 
receptors (NLRs), retinoic acid-inducible gene 1 (RIG-I), and absent in melanoma 2 (AIM2), 
have received increased attention for their involvement in an intracellular signaling complex 
termed the inflammasome (7). The inflammasome is composed of a PRR, the protease caspase-1, 
and, in some cases, the PYD and CARD domain containing (PYCARD) adaptor protein. 
Formation of the inflammasome complex induces activation of caspase-1, which can then 
mediate the processing and release of IL-1β and IL-18. Caspase-1 also performs a number of 
other functions, including initiation of a pro-inflammatory form of programmed cell death 
termed pyroptosis, signaling through NF-kB, and cleavage of proteins involved in glycolysis, 
cell survival, and cytoskeleton function (8). The NLRP3 inflammasome has received special 
attention for its involvement in the response to a diverse range of pathogens and environmental 
pollutants, suggesting that the NLRP3 inflammasome may be a general sensor of cellular stress 
(9, 10). 
 Asthma is a chronic inflammatory disease of the conducting airways that is associated 
with airway obstruction and variable airway hyperresponsiveness in response to a challenge, 
often an allergen, virus, or environmental pollutant (11). Though expansion of type 2 helper 
(Th2) T lymphocytes and IgE produced by B lymphocytes of the adaptive immune system are 
considered central mediators of asthma pathogenesis, innate immunity is essential for the 
initiation and propagation of adaptive immune responses and may be of particular importance 
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during exacerbation by stimuli such as viruses or pollutants (6). Stimulation of PRRs by an 
viruses, allergens, pollutants, etc. activates cytokine and chemokine production by innate 
immune cells and the expression of co-stimulatory molecules by dendritic cells (DC) that drive T 
lymphocyte differentiation (13). Additionally, inflammatory mediators produced in response to 
PRR activation can exacerbate asthma symptoms (14). 
As NLRP3 is an innate immune receptor broadly implicated in the response to cellular 
stress, several murine studies have investigated the contribution of NLRP3 to the development of 
allergic airway inflammation and have found conflicting results (15-18). Despite involvement of 
inflammasome signaling in the response to a number of stimuli that exacerbate asthma 
symptoms, a role for the inflammasome in asthma exacerbation has not been investigated. In this 
dissertation, we sought to determine the contribution of the inflammasome to asthma 
exacerbation caused by respiratory viral infection or inhalation of the environmental air 
pollutants and elucidate the function of the inflammasome in the development of allergic asthma. 
We focused our analysis on caspase-1, which is common component of all inflammasome 
complexes.  Our results yield insight on the innate immune mechanisms involved in the response 
to viruses and pollutants and how these pathways may contribute to asthma pathogenesis.  
6.1 The inflammasome in the airway epithelial cell response to influenza virus 
In chapter 2, we investigated inflammasome signaling in response to influenza A virus 
(IAV) and how these pathways are altered by asthma. Respiratory viral infection is the leading 
source of asthma exacerbation, and IAV-induced exacerbation is of particular concern during 
seasonal epidemics (11). Previous studies in mice have shown that NLRP3 and caspase-1 are 
activated by IAV and protect against IAV-related mortality in mice (19, 20). In bone marrow-
derived macrophages, the NLRP3 inflammasome was shown to be activated by changes in 
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intracellular ion concentration induced by the influenza M2 channel during infection (21). Since 
airway epithelial cells are the main target of IAV infection and have not been well characterized 
for inflammasome signaling, we focused our analysis on describing the function of the 
inflammasome in human bronchial epithelial cells (HBEC) in the response to IAV and how these 
pathways may be altered by asthma (22). Our results suggest that caspase-1 plays an important 
role in the airway epithelial cell innate immune response to IAV infection, which may be 
independent of IL-1β production and is enhanced in epithelial cells from asthmatics. 
Though our result suggest that caspase-1 contributes to the HBEC innate immune 
response to IAV, the PRR that mediates inflammasome complex mediates inflammasome 
complex formation in HBEC is less clear. We observed co-localization of caspase-1 with the 
adaptor protein PYCARD during infection suggesting inflammasome complex formation (Figure 
2.3), but were unable to detect gene expression of many NOD-like receptors in HBEC, including 
NLRP3. Since enhanced NLRP3 gene expression is important priming step for activation of the 
NLRP3 inflammasome, our results suggest that NLRP3 may have a less pronounced function 
than caspase-1 and other PRRs in the HBEC response to IAV infection (23). Of the NLRs that 
we could detect by gene expression (NLRC4, NLRC5, NLRP1, NLRP6, NLRP9, NLRX1, and 
NOD2), only NLRC4, NLRP1, and NLRP6 are known to form inflammasome complexes (and 
only in response to bacteria), whereas the others may be regulators of inflammasome signaling, 
activate NF-kB, or preform unknown functions (24). Beyond the NLRs, we detected IAV-
induced expression of two other receptors that have been shown to form complexes with 
caspase-1 in response to viral infections: RIG-I, a sensor of single stranded RNA previously 
implicated in the innate immune response to IAV, and AIM2, a double stranded DNA sensor 
(Figures 2.2 and 2.7). The detection of enhanced AIM2 was perplexing since IAV is an RNA 
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virus, but as AIM2 is an interferon-inducible gene, may be a reflection of IAV-induced 
interferon production (25).  
Since publication of these findings, a subsequent report found that RIG-I forms 
inflammasome complexes with caspase-1 and PYCARD to produce IL-1β and also regulates 
downstream NLRP3 gene expression in primary HBEC (26). Thus, in contrast to macrophages, 
RIG-I may be the pivotal IAV-induced activator of caspase-1 and IL-1β release in airway 
epithelial cells, and downstream activation of NLRP3 transcription may be a secondary response 
to the virus (21, 26). Notably, this study used H1N1 viruses (Influenza A/Puerto Rico/8/1934 and 
A/USSR/90/77 ) and found large amounts of IL-1β production from human bronchial epithelial 
cells (>400 pg/mL), whereas we and a previou study (Allen et al.) used H3N2 viruses (Influenza 
A/Bangkok/1/79 and A/Victoria/3/75, respectively) and found very low levels of IL-1β 
production (<20 pg/mL), suggesting the capacity to produce IL-1β production may differ across 
IAV subtypes (Figure 2.1) (20, 26). The influenza non-structural 1 (NS1) protein has been shown 
to inhibit RIG-I-mediated IFNβ and IL-1β production, and previous studies have shown variation 
in NS1 function across IAV subtypes, suggesting that diversity in the NS1 protein may affect 
IAV-induced IL-1β production (26-28). 
Since we were unable to detect significant IL-1β (Figure 2.1) or IL-18 (data not shown) 
produced by HBEC, we sought to further define a role for caspase-1 in the HBEC response to 
IAV infection. We infected tracheal epithelial cells from caspase-1 deficient (Casp1
-/-
) and wild 
type (WT) mice with IAV, and found that caspase-1 deficiency was associated with diminished 
IAV-induced expression of several inflammatory and antiviral genes (Ifnα, Ifnβ, Cxcl10, Rig-i, 
and Il6, Figure 2.10). Likewise, a previous study in mice found reduced quantities of several 
inflammatory cytokines in the bronchoalveolar lavage fluid of Casp1-/- mice infected with IAV 
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in vivo (19). Many of these inflammatory genes are regulated by the transcription factor NF-kB. 
We found that expression of RIPK2, a kinase that interacts with caspase-1 to mediate NF-kB 
activation, was also enhanced with IAV infection (Figure 2.2), suggesting that caspase-1 may 
signal independently of the inflammasome to activate NF-kB (29).  In addition, we found that 
MTEC from Casp1
-/-
 mice had reduced IAV replication (Figure 2.11), and that in HBEC CASP1 
expression positively correlated with viral replication (Figure 2.9), suggesting that caspase-1 
may be a determinate of viral replication. Previous studies suggest that caspases may be 
harnessed by viruses, including IAV, to cleave viral-proteins involved in viral replication (31). 
Several studies indicate that the IAV nuclear protein and matrix protein 2 may be cleaved by 
caspases leading to enhanced virulence, though caspase-1 cleavage of these viral proteins has not 
been shown (32). Caspase-1 specifically has been shown to cleave components of Epstein-Barr 
virus, contributing to more productive infection (33). Thus, caspase-1 may have additional non-
inflammsoame functions during a viral infection that may include regulation of antiviral  and 
pro-inflammatory gene expression possibly via activation of NF-kB and/or cleavage of IAV 
proteins that may enhance viral replication. 
In summary, our findings suggest caspase-1 plays an important role in the airway 
epithelial cell innate immune response to IAV infection. Activation of caspase-1 by IAV may 
differ between macrophages, where NLRP3 is highly expressed and well characterized, and 
structural airway epithelial cells, where other immune receptors such as RIG-I may be of greater 
importance (26). Airway epithelial cells are the primary target of IAV, which hijacks the cell for 
to produce virus progeny. The key objectives of epithelial cells are to halt viral replication and 
secrete cytokines and chemokines to attract immune cells for clearance of apoptotic cells and 
virus particles (34). Comparatively, replication of IAV in macrophages is typically lower than in 
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epithelial cells and infection is often abortive depending on the strain and type of macrophage 
(35). Unlike airway epithelial cells, macrophages are specialized phagocytes that function not 
only to alert other cells of the infection, but also to clear virus particles and virus-infected cells; 
thus activation of different signaling pathways may be necessary to mediate these functions (36). 
Furthermore, our results indicate that caspase-1 may have inflammasome-independent functions 
in airway epithelial cells that include regulation of inflammatory and antiviral gene expression or 
involvement in viral replication. There is clear evidence that caspase-1 and other inflammasome 
components such as PYCARD have inflammasome-independent functions, yet current 
understanding of these activities and their contribution to viral infection are limited (8, 37, 38).  
Future studies will be necessary to investigate inflammasome-independent functions of caspase-1 
in airway epithelial cells, and how these pathways may differ in myeloid versus non-myeloid 
cells. 
6.2 The inflammasome in response to ozone 
 Inhalation of environmental air pollutants, such as particulate matter, diesel exhaust, and 
ozone (O3), is associated with increased hospitalization for asthma exacerbation (39-41). 
Pollutants may directly induce airway inflammation that contributes to asthma exacerbation or 
act as an adjuvant whereby the pollutant primes the airway for enhanced response to a 
subsequent challenge (42, 43). Unlike viruses, which may be directly recognized by PRRs via 
PAMPs, air pollutants are thought to primarily activate PRRs via DAMPs derived from damaged 
cells and tissue (44, 45). Interestingly, many of the receptors for DAMPs and PAMPs are shared, 
such TLR4 and NLRP3, suggesting overlap between non-infectious and pathogen-mediated 
inflammatory responses (43). The NLRP3 inflammasome has been deemed a general sensor of 
cellular stress and is implicated in the innate immune response to a number of environmental 
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pollutants, including asbestos fibers, silica particles, and nanoparticles (37, 38). A recent study 
found that NLRP3 and the inflammasome components caspase-1 and PYCARD contribute to O3-
induced airway inflammation and hyperresponsiveness in mice via activation of the 
inflammasome by the DAMP hyaluronic acid (HA); however these findings have not been 
confirmed in humans (39). Thus, before investigating the involvement of caspase-1 in O3-
induced asthma exacerbation, we sought to determine a role for DAMPs and inflammasome 
signaling in the innate immune response to in vivo O3 exposure in healthy individuals.  
Our results indicate that inhalation of O3 induces a number of DAMPs in the airway, and 
that the presence of these DAMPs differs over time after exposure. Of the early DAMPs, we 
found significantly increased levels of several oxidized cholesterols (oxysterols) in the airway 1 
hour after O3 exposure (Figures 4.4). Oxysterols have been best characterized in the context of 
atherosclerosis. Lipid loading of blood macrophages enhances activation of TLR4 and 
intracellular cholesterol crystals are recognized by the NLRP3 inflammasome leading to the 
release of pro-inflammatory mediators (48, 49). However, activation of the innate immune 
system by oxidized lipids and cholesterol overload has not been well studied in the lung.  
Cholesterol composes a large component of surfactant and antioxidants (e.g. γ-
tocopherol) in the lung lining fluid (50). Previous studies have shown that ex vivo exposure of 
bovine surfactant to O3 or in vivo O3 exposure of rodents is associated with the presence of 
oxysterols in the airway similar to those we detected after human in vivo exposure, particularly 
cholesterol epoxide β, and that these oxysterols are mediators of inflammation and cytotoxicity 
in airway epithelial cells and monocytes (51-54, 57). Clearance of oxysterols is primarily 
mediated by reverse cholesterol transport in macrophages via uptake by scavenger receptors and 
efflux through cholesterol transports such as ATP binding casette (ABC) A1 and G1, which are 
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regulated by the oxysterol-responsive transcription factor liver X receptor (LXR) (55-56). Mice 
deficient in Abcg1 have enhanced neutrophil and inflammatory response to LPS inhalation, 
whereas treatment of mice with LXR agonists may reduce neutrophil influx and inflammation in 
response to LPS inhalation or infection (58-60). These studies suggest that LXR agonists may 
serve as a useful therapeutic to enhance clearance of oxysterols and reduce inflammation and 
neutrophil influx in the lung after O3 exposure. However, it should be noted that Abcg1
-/-
 mice 
had reduced Th2 responses responses in an OVA-allergen sensitization model, suggesting that 
ABCG1 may promote Th2 immunity (61). Moreover, treatment of mice with an LXR agonist 
(GW 3965) during OVA sensitization increased airway smooth muscle mass and airway 
reactivity, but had no effect on airway inflammation (62). Thus, the function of oxysterols and 
LXR in allergy and immunology is not clear and should be further investigated to determine the 
utility of LXR agonists as therapeutics.  
As the oxysterols subsided by 24 hours after O3 exposure, we detected enhanced levels of 
hyaluronic acid (HA) in the BAL fluid and in our in vitro co-culture model of airway epithelial 
cells (16HBE) and pulmonary macrophages (Mac), suggesting that HA may be a late mediator of 
O3-induced airway inflammation (Figure 4.3A and 5.8B). HAis an extracellular matrix 
component produced by epithelial cells that when fragmented by tissue injury or oxidative stress 
activates PRRs and pro-inflammatory responses (65, 66). HA has been previously shown to 
contribute to O3-induced airway hyperresponsiveness (AHR) and inflammation via signaling 
through TLR4, CD44 (the HA receptor), and the NLRP3 inflammasome in mice (67-69). These 
studies showed accumulation of HA in the airway beginning 12-24 hours after exposure to O3 
and peaking at 48 post-exposure, which is in agreement with our findings (69). Using the 
16HBE-Mac co-culture model, we determined that enhanced HA in the airway after O3 is not 
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likely due to increased production by epithelial cells, but rather altered regulation of epithelial 
cell-derived HA by Mac (Figure 5.8B). Similar to previous studies, we found that Mac have 
reduced phagocytosis in response to O3 (Figure 5.4), and propose that reduced Mac phagocytosis 
may lead to the accumulation HA. Studies in mice have also found that CD44 mediates 
endocytic clearance of HA and degradation by Mac, suggesting that altered CD44-endocytosis 
by Mac may contribute to reduced clearance of HA (67, 70). Future studies are necessary to 
specifically determine the mechanism by which O3-induced Mac dysfunction induces HA 
accumulation. 
A shortcoming of our study is that our results do not address the downstream effect of 
HA on the human inflammatory response to O3. Additionally, due to limited sample volume we 
were unable to determine the size of HA that accumulates in the BAL fluid or co-cultures with 
O3. As size is an important determinate of the inflammatory potential of HA, this will be an 
important end point for future human studies (65). Surprisingly, treatment of Mac with 
conditioned media from O3-exposed 16HBE did not mimic the effects of direct O3 exposure on 
Mac phenotype, viability, or phagocytic function, suggesting that soluble mediators from 
16HBE, such as HA, may not mediate O3-induced Mac dysfunction (Figure 5.8). Accumulation 
of HA may rather affect the function of other cells besides Mac or epithelial cells, such as 
neutrophils, which are highly present in the airway at 24 hours post-exposure (71, 72).  
Despite detection of several DAMPs that have been previously shown to activate the 
inflammasome, including HA and uric acid, we did not find strong evidence to support activation 
of the inflammasome in humans after O3 exposure in vivo. IL-1β, a major endpoint of 
inflammasome activity, was not detectable in any BAL fluid samples at either 1 or 24 hours post-
exposure (data not shown). Likewise, we did not observe O3-induced IL-1β production in 
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16HBE mono-cultures, Mac mono-cultures, or 16HBE-Mac co-cultures (data not shown). We 
also did not observe changes in Mac caspase-1 activity 1 hour after O3 exposure, or a priming 
effect  of O3 on inflammasome activation (Figure 4.7). These results were surprising because 
HA-mediated activation of the NLRP3 inflammasome and IL-1β signaling have been previously 
shown in the response to O3 in mice (69, 73, 74). We believe that the data we show here in 
humans is preliminary and should be considered with several qualifications in mind: 1) We only 
measured caspase-1 activity 1 hour after exposure to O3, when the immune response to O3 is just 
beginning and HA has not accumulated in the lung. The studies in mice found the greatest 
evidence of inflammasome activity 24 hours after O3 exposure when  HA is elevated (69); 2) the 
BAL fluid may have been too dilute to detect IL-1β and we did not assess IL-18 levels; and 3) 
caspase-1 may have alternative functions beyond IL-1β release that we did not measure, such as 
activation of NF-kB signaling, and some of these functions may occur independent of caspase-1 
enzymatic activity (75, 76). Despite these qualifications, we believe our data does not suggest a 
strong contribution of inflammasome-mediated IL-1β to the early human innate immune 
response to O3. 
In summary, using a combination of in vivo and in vitro models of O3 exposure in 
humans, we found evidence that O3-induces the accumulation of DAMPs in the airway that may 
mediate the innate immune response to O3. Our results uncovered a potential role for oxysterols 
as early mediators of O3-induced lung injury that we speculate could serve as therapeutic targets 
for pharmacological regulation with LXR agonists. Notably, as inhalation of oxidant air 
pollutants such as O3 is associated with increased risk for cardiovascular events, future studies 
should assess migration of oxysterols from the airway to the blood stream after O3 exposure and 
the contribution of these oxysterols to atherosclerosis and cardiovascular disease (63, 64). 
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Moreover, we provide mechanistic insight on accumulation of HA in the response to O3 and 
propose that accumulation of HA is not due to a direct effect of O3 on HA generation, but is 
rather a secondary effect of immune cell dysfunction induced by O3.Though we found a number 
of DAMPs increased in the airway after exposure to O3, we did not find evidence of caspase-1 
and inflammasome activation. Thus, future studies are necessary to determine the signaling 
pathways by which O3-induced DAMPs activate the innate immune response, and how these 
pathways may contribute to pathogenesis of diseases such as asthma and cardiovascular disease. 
6.3 The inflammasome and asthma  
 Asthma is a chronic inflammatory disease characterized by airway obstruction and 
bronchoconstriction in response to a challenge (12). Though asthma is traditionally considered a 
disease of adaptive immunity, mediated by T and B lymphocytes, innate immune cells contribute 
to asthma by secreting mediators that promote inflammation, mucus production, and 
bronchoconstriction and informing the development of adaptive immune responses (6). Innate 
cells are of even greater importance during acute asthma exacerbation, where inflammation 
caused by viral infection or inhalation of air pollutants provokes asthma symptoms (11). Though 
the role of IL-1 and inflammasome signaling in asthma development has proven controversial, 
the inflammasome response to PAMPs and DAMPs induces inflammatory mediators that likely 
contribute to exacerbation of asthma symptoms (15-17, 77). Since the inflammasome is involved 
in the response to both viruses and air pollutants, two major causes of asthma exacerbation, we 
hypothesized that inflammasome signaling may be a common pathway that contributes to virus- 
and pollutant- induced asthma exacerbation. 
As described above, epithelial cells are the primary target cell for infection by respiratory 
viruses, such influenza A virus (IAV). An increasing number of studies have underscored the 
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important contribution of airway epithelial cells to asthma pathogenesis (22). Epithelial cells 
release cytokines and chemokines that attract effector cells to the airway and promote Th2 
responses in neighboring DC (6, 78-80). In addition, in vitro and in vivo studies have shown that 
epithelial cells from asthmatics have deficient barrier functions, possibly due to altered tight 
junction formation, which increases the likelihood of antigen interaction with underlying DC (78, 
81). At the molecular level, epithelial cells from asthmatics may be more susceptible to oxidative 
stress and have modified innate immune responses to viral infection, which may be due to 
inherent differences in expression of genes involved in epithelial repair and immune response, 
including IL1B (82-86). As the inflammasome was previously shown to mediate antiviral 
responses to IAV (20), and virus-induced IL1B expression was enhanced in human bronchial 
epithelial cells (HBEC) from asthmatics (82), we hypothesized that innate immune and 
inflammasome signaling may be altered in HBEC from asthmatics and contribute to virus-
induced asthma exacerbation.  
In line with our hypothesis, we found that compared to HBEC from non-asthmatics, 
HBEC from asthmatics had increased IAV-induced IL-1β production that was associated with 
increased expression of a number of inflammasome or NLR-related genes, including all of the 
“inflammatory caspases” (CASP1, CASP4, and CASP5) and two NLRs (NLRC5 and NOD2) 
(Figure 2.1 and Table 2.6). By immunofluorescence, we observed that caspase-1 and PYCARD 
co-localization was enhanced in HBEC from asthmatics with IAV infection (Figure 2.3). 
Additionally, we found increased expression of RIG-I and downstream markers of the interferon 
signaling pathway, including IFNβ and IP10, in HBEC from asthmatics (Figure 2.7).  As RIG-I 
has been shown to both regulate interferon production and form inflammasome complexes with 
PYCARD to induce caspase-1-mediated IL-1β release, these results suggest that RIG-I mediated 
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inflammasome signaling may be enhanced in HBEC from asthmatics (26). Notably, production 
of IL-1β by HBEC from asthmatics was low, suggesting that caspase-1 may also have 
inflammasome-independent functions, such as caspase-1 activation of NF-kB signaling through 
RIPK2 (29). Notably, RIPK2 expression was also enhanced in HBEC from asthmatics (Table 
2.6). Though increased caspase-1 and innate immune gene expression was associated with 
enhanced IAV replication, we did not detect a significant difference in viral replication between 
HBEC from asthmatics or non-asthmatics. Likewise, a number of previous studies investigating 
RV or RSV that found no difference in virus replication between HBEC from asthmatics and 
non-asthmatics, suggesting that an increased inflammatory response, but not increased virus 
replication, contributes to virus-induced asthma exacerbation (82, 83, 85). In summary, we found 
that intrinsic differences in HBEC from asthmatics contribute to enhanced IAV-induced innate 
immune and inflammasome signaling, and propose that enhanced inflammatory responses to 
IAV may exacerbate asthma symptoms.  
We next sought to confirm a role for caspase-1 in virus-induced asthma exacerbation in 
vivo in mice. Before doing so, we needed to first establish a mouse model of allergic asthma and 
investigate the role of caspase-1 in asthma development (Chapter 3). Previous studies that have 
investigated the contribution of IL-1, caspase-1 and NLRP3 signaling to asthma development 
have yielded conflicint results (15-18, 77, 87, 88). These inconsistent findings may be in part due 
to differences in allergen sensitization protocols and reagents (e.g. endotoxin contamination can 
vary significantly across HDM formulations (89)) though a comprehensive study of asthma 
development in Nlrp3
-/-
 mice that compared multiple models of OVA and HDM sensitization 
could not identify a role for NLRP3 in allergic lung disease (15). To add to this confusing 
literature, we found that HDM sensitization of Caspase-1 deficient (Casp1
-/-
) and wild type 
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(WT) mice revealed divergent roles for caspase-1 in the development of allergic inflammation, 
whereby HDM-sensitized Casp1-/- mice had enhanced airway inflammation, but reduced airway 
hyperresponsiveness (AHR) compared to HDM-sensitized WT mice (Chapter 3). Our results 
show that increased inflammation in Casp1
-/-
 mice was largely localized to the alveolar tissue, 
but we found no evidence of increased airway resistance in the alveolar tissue (G) compared to 
WT mice (Figure 3.5B and 3.9B).  Conversely, we observed similar inflammation along the large 
airways in both Casp1
-/- 
and WT mice, but increased resistance of the large airways (Raw) in 
Casp1
-/-
 mice (Figure 3.5A and 3.9C). These results were surprising as airway inflammation has 
been previously shown to contribute to AHR (90-92). However, AHR is also determined by 
airway smooth muscle (ASM) mechanics and structural changes to the airway, such as increased 
ASM mass and extracellular matrix deposition (72, 93, 94). Thus, our results indicate that 
caspase-1 may have different functions in structural cells versus inflammatory cells. These 
results are in accordance with our previous findings (chapter 2) and those of other that suggest 
inflammasome signaling pathways may differ in structural versus non-myeloid cells, and 
suggests alternative functions for caspase-1 beyond IL-1β production (26, 95, 96). Indeed, we 
surprisingly saw enhanced IL-1β in the airway of HDM-sensitized Casp1-/- mice compared to 
HDM-sensitized WT mice, suggesting non-caspase-1 mediated production of IL-1β, as can occur 
via neutrophil proteases or release from lytic cells (Table 3.1) (97). Since airway remodeling is 
not typically observed in acute models of allergen sensitization, a chronic sensitization model 
will be necessary to better determine the contribution of caspase-1 to structural changes in the 
lung. 
Though we advise that the results of the caspase-1 and asthma development study are 
preliminary, we believe that these findings indicate a possible role for caspase-1 in the 
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pathogenesis of allergic asthma and predict that caspase-1 will more strongly contribute to 
asthma exacerbation as caused by IAV. Based on our findings that caspase-1 signaling is 
enhanced in HBEC from asthmatics and MTEC from Casp1
-/-
 mice (chapter 2), we hypothesize 
that IAV-induced asthma symptoms will be less severe in Casp1
-/-
 mice, and that innate immune 
responses in epithelial cells may be major determinates of IAV-induced asthma exacerbation. 
However, the fact that Casp1
-/-
 mice had increased airway inflammation after HDM sensitization 
suggests that the role of caspase-1 in innate immunity and allergy is very complex and may 
depend on the exact stimulus. In addition, future studies investigating the contribution of 
caspase-1 to asthma development exacerbation should use new models of Casp1
-/-
 mice, as the 
strain most commonly used for caspase-1 studies (including that shown here in chapters 2 and 3) 
was recently found to also be deficient in caspase-11 (98). The implications of this double-
deficiency will be discussed in the “Further Insights” section below. 
 We were unable to address the function of the inflammasome in O3-induced asthma 
exacerbation in this dissertation, but will speculate on this topic here. As described in chapter 4, 
we found increased levels of several DAMPs in the airway after exposure to O3 (uric acid, 
hyaluronic acid (HA), oxysterols), but no evidence of O3-induced inflammasome signaling. 
However, our results in chapter 2 show that the inflammasome response to IAV is enhanced in 
HBEC from asthmatics, suggesting that inflammasome signaling may be more active in 
individuals with asthma and contribute to asthma exacerbation. A previous study of O3 exposure 
in humans found that atopic asthmatics had enhanced HA and IL-1β in induced sputum collected 
6 hours after in vivo O3 exposure compared to healthy volunteers, suggesting that O3-induced HA 
may activate inflammasome signaling in asthmatics (69, 99, 100). Notably, the increased HA and 
IL-1β were also associated with increased neutrophil numbers in the sputum (99). In addition to 
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IL-1β cleavage by caspase-1, neutrophils contain proteases that can mediate secretion of active 
IL-1β, such as neutrophil elastase, proteinase-3, and cathepsin G can cleave extracellular IL-1β 
(97, 101, 102). As neutrophils are the primary cell recruited to the airway after O3 exposure, 
neutrophil-derived proteases rather than caspase-1 may mediate the release of IL-1β after 
exposure to O3 (103-194). Thus, future studies must carefully distinguish between inflammasome 
and non-inflammasome mediated- IL-1β production after pollutant exposure. 
Our results also indicate that the DAMP uric acid was increased in the airway of healthy 
volunteers 1 hour after O3 exposure (Figure 4.3B). High concentrations of uric acid form 
monosodium urate crystals that have been shown to activate the NLRP3 inflammasome (105, 
106). Increased uric acid has been previously shown in BAL fluid from asthmatics after in vivo 
allergen challenge, and in mice uric acid crystals had an adjuvant effect on OVA-induced Th2 
inflammation, though this effect was independent of NLRP3, PYCARD, and caspase-1 (17). 
Previous controlled exposure studies found that allergic asthmatics exposed to O3 have 
heightened responses to subsequent allergen challenge, suggesting that DAMPs such uric acid 
produced after O3 may prime for enhanced response to subsequent challenge (107). Thus, O3-
induced uric acid in the airway may induce inflammation that exacerbates asthma symptoms or 
prime the airway for an enhanced response to a subsequent challenge, though whether this occurs 
through inflammasome signaling is unclear.   
In summary, we believe that our results suggest that caspase-1 and inflammasome 
signaling may contribute to both asthma development and exacerbation, but that the involvement 
of these pathways in asthma pathogenesis is complex and likely varies with stimuli. In the 
context of IAV infection, the enhanced innate immune response to IAV by HBEC from 
asthmatics, which we found to be associated with enhanced caspase-1 expression and activity, 
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may contribute to virus-induced asthma exacerbation in vivo. In addition, we suggest that O3-
induced DAMPs have the potential to signal through the inflammasome to induce airway 
inflammation that exacerbates asthma symptoms or primes the airway for an adverse response to 
subsequent challenge. 
6.4 Epithelial cells as orchestrators of innate immunity and asthma 
 The respiratory mucosal surface is lined by a layer of epithelial cells that protects the 
underlying tissue from the inhaled environment (108). Epithelial cells have been traditionally 
considered bystander cells of the immune response, serving only as a site of gas exchange and as 
a structural barrier against inhaled pathogens, antigens, and particulates. An increasing number 
of studies have demonstrated that epithelial cells are active components of the innate immune 
response that secrete a number of mediators important for host defense, including 
cytokines/chemokines, surfactants, mucins, proteases/anti-proteases, and defensins (34, 109, 
110). Moreover, epithelial cells are among the first cells to interact with inhaled stimuli, 
suggesting that epithelial cell response is a determinate of subsequent innate and adaptive 
immunity. A number of findings in this dissertation demonstrate an active role for epithelial cells 
in maintaining immunologic homeostasis and activating innate immune responses in the lung, 
thus supporting the notion that epithelial cells are orchestrators, rather than bystanders, of innate 
immunity that can significantly contribute to airway disease. 
 The respiratory surface is constantly exposed to a broad range of stimuli that may activate 
immune responses in the lung. Resident cells, consisting predominately of epithelial cells, 
macrophages, and underlying dendritic cells (DC), must discriminate between innocuous and 
pathogenic stimuli to determine the appropriate immune responses, and also prevent against 
unnecessary inflammation that may damage the airway (4). Resident immune cells must exist in 
 229 
 
a subdued state in order to prevent against excessive inflammatory response to harmless stimuli 
(111). Resident pulmonary macrophages (Mac) have been previously shown to exist in a 
quiescent state with relatively lower phagocytic capabilities compared to other tissue resident or 
peritoneal macrophages (111-115). Our results in chapter 5 show that airway epithelial cells 
promote a quiescent Mac phenotype, as evidence by increased expression of CD206, a marker of 
anti-inflammatory “alternatively” activate macrophages, and reduced phagocytic activity (Figure 
5.3). In addition, we found that Mac regulate the availability of HA produced by epithelial cells, 
suggesting a homeostatatic relationship between the two cell types (Figure 5.8).  
 When the airway is presented with an injurious stimulus, the resident immune cells are 
quickly activated and recruit inflammatory cells to the airway. In the response to IAV infection, 
we showed that epithelial cells produce cytokines and chemokines such as IL-6, IL-1β, TNFα, 
IP-10, IFNβ, and CCL5 to activate local immune cells and promote inflammatory cell influx to 
the airway and that caspase-1 may be an important regulator of these responses (Chapter 2). In 
the context of a pollutant exposure, we showed that signals from epitheial cells modify Mac 
immunophenotype and activity in response to O3 (Figures 5.3-5.5). Interestingly, we found that 
treatment of Mac with media from O3 or Air-exposed epithelial cells had no effect on Mac 
immunophenotype or activity, suggesting that local or direct cell-cell interaction is necessary to 
mediate the effects of co-culture on Mac phenotype and response to O3 (Figure 5.8). These 
findings are in agreement with previous airway epithelial cell-Mac co-culture studies that 
demonstrated cell-cell interaction was necessary to mediate the effects of co-culture on the 
response to particles or particulate matter (116, 117). Moreover, our group has shown that 
epithelial cells can interact with other inflammatory cells in the airway to influence innate 
immune responses. In the context of O3, NK cells co-cultured with O3-exposed nasal epithelial 
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cells have altered phenotype and cytotoxic activity, and these effects were mediated by direct 
cell-cell interaction (118). Using a nasal epithelial cell and dendritic cell co-culture model, our 
group also showed that nasal epithelial cells from smokers have deficient interferon responses to 
IAV infection, which promotes altered DC response to IAV (119, 120). Taken together, our 
results and those of others show that that the response of epithelial cells to inflammatory stimuli, 
such as viruses or pollutants, influence the activation of Mac, DC, and NK cells, demonstrating 
that epithelial cells are indeed important orchestrators of the innate immune response. 
The important function of epithelial cells as regulators of immunologic homeostasis and 
as orchestrators of immunity is highlighted by diseases such as asthma, where altered epithelial 
cell barrier and inflammatory functions contributes to pathogenesis (22, 78, 121). For example, 
altered ability of epithelial cells from asthmatics to form tight junctions may increase access of 
antigens to underlying DC and promote allergen sensitization (78, 81). In addition, epithelial 
cells produce mediators in response to inhaled allergens, pollutants, or viruses that promote DC 
activation and Th2 lymphocyte differentiation and also induce inflammation that exacerbates 
asthma symptoms (6, 78-80). Finally, goblet cell metaplasia during asthma is associated with 
increased mucus production and airway obstruction (22, 122). Our findings suggest that 
epithelial cells have intrinsic differences that are associated with enhanced inflammatory 
responses. We found that at baseline conditions, HBEC from asthmatics produced several pro-
inflammatory cytokines, IL-1β, IL-6, and TNFα, that were not present in HBEC from non-
asthmatics (Figure 2.1) and had increased expression of CCL5 (Table 2.6). With IAV-infection, 
HBEC from asthmatics had even further increased cytokine production and enhanced expression 
of many innate immune and inflammasome genes compared to HBEC from non-asthmatics, 
including CASP1, RIG-I, IP-10, IFNβ, and CCL5 (Figure 2.1 and Table 2.6). Of particular 
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interest is elevated expression of the eosinophil and T lymphocyte chemoattractant CCL5 in 
HBEC from asthmatics both at baseline and in response to IAV, as enhanced CCL5 protein 
expression has likewise been shown in bronchial biopsies from asthmatics (125, 126). These 
findings suggest that HBEC from asthmatics have intrinsic differences in inflammatory status 
that are maintained after several weeks of culturing ex vivo and may contribute to enhanced 
inflammatory responses to viral infection. Similar modifications in inflammation, repair, and 
proliferation have been previously shown in studies of cultured epithelial cells from asthmatics, 
suggesting that the chronic inflammatory environment of the asthmatic airway may cause 
intrinsic changes in the epithelium (83, 123, 124, 127).  
The intrinsic differences in HBEC from asthmatics may be due to inherent genetic or 
epigenetic changes. Asthma has a clear hereditary component, and a number of studies have 
identified candidate genes involved in innate immunity and epithelial cell function that are 
associated with susceptibility to asthma or allergy, including polymorphisms in CCL5  and Clara 
cell 16-kD protein (CC16) (128-130). However, not all individuals with familiar history or 
genetic susceptibility develop asthma, suggesting that environmental factors, such as early life 
viral infection or exposure to second hand tobacco smoke, play a major role in asthma 
development (131-133). Epigenetics, or changes in gene function that are not due to a change in 
the DNA sequence, may shed light on the interaction between genetic susceptibility and 
environmental exposures in asthma pathogenesis (134). A number of studies have shown 
epigenetic alterations are associated with asthma, though relatively few have assessed epigenetic 
changes specifically in epithelial cells (134, 135). Of these studies, a concordant increase in 
methylation and decreases in gene expression of STAT5A, a transcription factor associated with 
Th2 cell differentiation and epithelial cell proliferation, was identified in epithelial cells from 
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asthmatics (136). Additionally, bronchial biopsy samples from asthmatics were shown to have 
reduced histone deacetylase (HDAC) 1 and 2 expression and function, and increased histone 
acetyltransferase activity, which are associated with global hyperacetylation and an open 
chromatin structure that promotes gene transcription (137). Clearly, additional studies are 
necessary to determine if specific genetic or epigenetic mechanisms in HBEC from asthmatics 
contribute to altered function and response to inhaled stimuli.  
In summary, our results demonstrate epithelial cells play an important role in 
orchestrating the innate immune responses to viruses and pollutants in the lung and provide 
evidence that intrinsic differences in epithelial cells from asthmatics contribute to an altered 
response to respiratory viral infections. Moreover, we identify caspase-1 and the inflammasome 
pathway as an important innate signaling pathway in airway epithelial cells that is altered in 
epithelial cells from asthmatics. These results are consistent with recently described epithelial-
centric models of asthma pathogenesis, in which unresolved epithelial injury is proposed to be 
the basis for the chronic inflammation and airway remodeling assocatied with asthma, and 
clearly demonstrate that airway epithelial cells are central to respiratory immunity and airway 
disease (22, 123, 127). 
6.5 Final Insights 
 In this dissertation, we investigated the role of the inflammasome in the innate immune 
response to viruses and air pollutants in the lung, and how these pathways may contribute to 
asthma pathogenesis. We show that caspase-1 contributes to the airway epithelial cell innate 
immune response to influenza a virus (IAV) infection, and that this pathway is enhanced in 
epithelial cells from asthmatics, but that caspase-1 may have divergent functions in the 
development of allergic asthma in mice. Additionally, we show that many damage associated 
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molecular patterns (DAMPs) are found in the airway after exposure to O3, but these DAMPs are 
not associated with caspase-1-mediated IL-1β production. Using an airway epithelial cell and 
macrophage co-culture model, we demonstrated how exposure to O3 alters the homeostatic 
relationship between airway epithelial cells and macrophages, leading to dysregulation of the 
DAMP hyaluronic acid (HA). These results provide insight on the human innate immune 
response to viruses and pollutants and highlight many future directions for inflammasome 
research.  
Studies of the inflammasome signaling, including those presented here, have largely 
focused on mechanisms of inflammasome-mediated IL-β release. Though IL-1β is a traditional 
marker of inflammasome and caspase-1 activity, neutrophil and mast cell-derived proteases may 
also cleave and activate IL-1β (97, 101, 102). As neutrophils are heavily recruited to the airway 
upon infection or injury as caused by many inflammasome stimuli, the contribution of neutrophil 
mediated IL-1β release in the airway should be better investigated. In addition, many interesting 
studies have highlighted alternative activites of many inflammasome components, and data 
shown here suggest caspase-1 may have alternative functions in the response to IAV and asthma, 
such as NF-kB activation (8, 38, 138, 139). These alternative pathways may be of even greater 
importance in non-phagocytic cells, such as epithelial cells, which serve very different functional 
roles in innate immunity than macrophages or monocytes and vary in the capacity to release IL-
1β.  
The results presented here are unique in that we studied the inflammasome in human 
cells. Though animal studies have been successful in revealing inflammasome mechanisms, 
species differences in inflammasome signaling between human and mice has not been well 
studied. The human genome encodes 22 NLRs whereas the mouse encodes at least 30 NLRs, and 
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species differences in the function of the same NLR have been observed (140,141). Likewise, the 
inflammatory (non-apoptotic) caspases differ between mice and humans. The mouse genome 
encodes caspase-1, caspase-11, and caspase-12, whereas the human genome encodes caspase-1, 
caspase-4, and caspase-5 (142). Caspase-4 and 5 are thought to be orthologs of murine caspase-
11 based on similar sequences, though the function of these caspases in humans is not clear 
(143). Our results demonstrate that CASP4 and CASP5 expresssion is induced with IAV 
infection in airway epithelial cells and is further enhanced in epithelial cells from asthmatics, 
suggesting a yet-to-be-determined contribution to the innate immune response to IAV. Further 
underscoring the need for increased research on human caspase-4/5 and murine caspase-11 is the 
recent discoveries that the commonly used C57BL/6 caspase-1 knockout model (Casp1
-/- 
) is also 
deficient for caspase-11 (Casp11), and that caspase-1 and -11 have non-redundant functions (10, 
98). In initial characterization studies using the caspase-1 and caspase-11 double knockout mice 
concluded that Casp1
-/-
 mice were resistant to endotoxic (LPS-induced) shock (144). More recent 
studies corrected these findings and showed that caspase-11, but not caspase-1, mice are resistant 
to endotoxic shock, suggesting distinct functions (98-145). Since the mice used in the studies 
shown here in chapters 2 and 3 are actually caspase-1 and caspase-11 double knockout mice, 
these results should be interpreted with caution and future studies will be necessary to delineate 
the roles of caspase-1 and caspase-11 in the innate immune response to IAV or in the 
development of allergic asthma. More importantly, future studies are needed to better understand 
the functions of caspase-4 and -5 in the human innate immune response and their similarity to 
murine caspase-11. 
 If this discussion of the complexities of inflammasome research is of any indication, 
Charles Janeway was correct in 1989 when he predicted that innate immunity is a highly evolved 
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(and still evolving) first line of defense against infection and injury (1). The innate immune 
system is composed of a network of structural cells and immune cells that have the difficult job 
of distinguishing between harmless and harmful stimuli and beckoning the appropriate 
inflammatory reinforcements. Innate immune cells do so by employing pattern recognition 
receptors that bind to PAMPs and DAMPs to recognize the harmful stimuli and initiate 
appropriate immune responses, such as formation of the inflammasome complex. The research 
shown here sheds light on the function of inflammasome signaling in the response to viruses and 
oxidant air pollutants in the human airway and how these same pathways may contribute to 
asthma pathogenesis. We specifically highlight the role of the airway epithelium as a key 
orchestrator of innate immunity, and demonstrate that asthma is associated with dysfunctional 
epithelial cell innate immune responses. It is our hope that in the future, these findings contribute 
to the development of improved therapeutics for the treatment of chronic airway diseases such as 
asthma and implementation of more informed standards for air pollutants such as O3.  
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